TW201527846A - Liquid crystal aligning agent and liquid crystal display element using same - Google Patents

Liquid crystal aligning agent and liquid crystal display element using same Download PDF

Info

Publication number
TW201527846A
TW201527846A TW103133595A TW103133595A TW201527846A TW 201527846 A TW201527846 A TW 201527846A TW 103133595 A TW103133595 A TW 103133595A TW 103133595 A TW103133595 A TW 103133595A TW 201527846 A TW201527846 A TW 201527846A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
formula
crystal alignment
carbon atoms
Prior art date
Application number
TW103133595A
Other languages
Chinese (zh)
Other versions
TWI673548B (en
Inventor
Hisashi Tetsutani
Hiroyuki Sakurai
Kazuyoshi Hosaka
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201527846A publication Critical patent/TW201527846A/en
Application granted granted Critical
Publication of TWI673548B publication Critical patent/TWI673548B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nonlinear Science (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)

Abstract

A liquid crystal aligning agent which contains the component (A) and the component (B) described below. Component (A): a polymer containing at least one material selected from among polyimides and polyimide precursors having a structure having a nitrogen atom Component (B): a polymer containing at least one material selected from among polyimides and polyimide precursors having a urea structure or a thiourea structure In this connection, the polymer of the component (A) and/or the polymer of the component (B) contains a specific side chain structure.

Description

液晶配向處理劑及使用其之液晶顯示元件 Liquid crystal alignment treatment agent and liquid crystal display element using same

本發明為有關,液晶顯示元件的製造中所使用的液晶配向處理劑、由此液晶配向處理劑所得之液晶配向膜及使用此液晶配向膜所得之液晶顯示元件。 The present invention relates to a liquid crystal alignment treatment agent used in the production of a liquid crystal display element, a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent, and a liquid crystal display element obtained by using the liquid crystal alignment film.

液晶顯示元件,於被作為可實現薄型‧輕量之顯示裝置,而目前被廣泛地使用。通常,此液晶顯示元件中,多使用可決定液晶配向狀態之液晶配向膜。 The liquid crystal display element is currently widely used as a display device capable of realizing a thin type and a light weight. Usually, in this liquid crystal display element, a liquid crystal alignment film which can determine a liquid crystal alignment state is often used.

液晶配向膜所尋求之特性之一為,對於基板面之液晶分子的配向傾斜角可保持於任意之值,即所謂對液晶的預傾角之控制。已知此預傾角之大小,可經由所選擇之構成液晶配向膜的聚醯亞胺之結構予以變更。於使用聚醯亞胺之結構控制預傾角的技術之中,又以使用具有側鏈之二胺作為聚醯亞胺原料中之一部份的方法,就可以此二胺的使用比例控制預傾角,而可更容易得到所需要之目的預傾角之觀點,而極適合作為擴大預傾角之手段(例如專利文獻1)。又,同時也有對於可增大液晶之預傾角的二胺成份,就改善預傾角之安定性或製程之依賴性等目的, 而對結構進行研究。而其中所使用之側鏈結構,即有提出使用含有苯基或環己基等環結構之提案(例如專利文獻2)。 One of the characteristics sought for the liquid crystal alignment film is that the alignment tilt angle of the liquid crystal molecules on the substrate surface can be maintained at an arbitrary value, that is, the control of the pretilt angle of the liquid crystal. It is known that the magnitude of the pretilt angle can be changed by the structure of the selected polyimine which constitutes the liquid crystal alignment film. In the technique of controlling the pretilt angle using the structure of polyimine, and using a diamine having a side chain as a part of the polyimine raw material, the pretilt angle can be controlled by the ratio of the use of the diamine. In view of the fact that the pretilt angle of the desired purpose can be more easily obtained, it is highly suitable as a means for expanding the pretilt angle (for example, Patent Document 1). Moreover, there is also a purpose of improving the stability of the pretilt angle or the dependence of the process on the diamine component which can increase the pretilt angle of the liquid crystal. And study the structure. Further, a side chain structure used therein has been proposed to use a ring structure containing a phenyl group or a cyclohexyl group (for example, Patent Document 2).

又,伴隨液晶顯示元件之高精密化,就抑制液晶顯示元件對比之劣化或降低殘影現象等觀點,所使用之液晶配向膜中,就維持高電壓保持率,或於施加直流電壓之際如何降低蓄積電荷,或如何快速減緩經由直流電壓所蓄積之電荷等特性,將變得更為重要。 Further, with the increase in the precision of the liquid crystal display element, it is possible to maintain a high voltage holding ratio in the liquid crystal alignment film to be used, or to suppress the deterioration of the liquid crystal display element or to reduce the image sticking phenomenon. It is becoming more important to reduce the accumulated charge, or how to quickly slow down the charge accumulated by the DC voltage.

聚醯亞胺系之液晶配向膜中,可縮短因直流電壓所產生之殘影至消失為止的時間者,已知例如使用,除聚醯胺酸或含有醯亞胺基的聚醯胺酸以外,尚含有特定結構之三級胺的液晶配向處理劑者(例如專利文獻3),或使用具有吡啶骨架等之特定二胺作為原料之含可溶性聚醯亞胺的液晶配向處理劑者(例如專利文獻4)等。又,具有高電壓保持率,且可縮短因直流電壓所產生之殘影至消失為止的時間者,已知例如,使用除聚醯胺酸或其醯亞胺化聚合物等以外,尚含有極少量的由分子內含有1個羧酸基的化合物、分子內含有1個羧酸酐基的化合物及分子內含有1個三級胺基的化合物所選出之化合物的液晶配向處理劑者(例如專利文獻5)。 In the polyimine-based liquid crystal alignment film, the time until the disappearance of the residual voltage due to the DC voltage can be shortened, and it is known to use, for example, polyacetamide or polyamido acid containing a ruthenium group. A liquid crystal alignment treatment agent containing a tertiary amine of a specific structure (for example, Patent Document 3), or a liquid crystal alignment treatment agent containing a soluble polyimine having a specific diamine such as a pyridine skeleton as a raw material (for example, a patent) Literature 4) and so on. Further, it has a high voltage holding ratio and can shorten the time until the image is broken due to the DC voltage. For example, it is known to use a polyelectron acid or a ruthenium imidized polymer. A small amount of a liquid crystal alignment treatment agent of a compound selected from a compound containing one carboxylic acid group in the molecule, a compound having one carboxylic acid anhydride group in the molecule, and a compound having one tertiary amino group in the molecule (for example, patent document) 5).

[先前技術文獻] [Previous Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]特開平2-282726號公報 [Patent Document 1] JP-A-2-282726

[專利文獻2]特開平9-278724號公報 [Patent Document 2] JP-A-9-278724

[專利文獻3]特開平9-316200號公報 [Patent Document 3] JP-A-9-316200

[專利文獻4]特開平10-104633號公報 [Patent Document 4] Japanese Patent Publication No. Hei 10-104633

[專利文獻5]特開平8-76128號公報 [Patent Document 5] Japanese Patent Publication No. 8-76128

液晶配向膜,亦被使用於控制相對於基板之液晶的角度,即使用於對液晶之預傾角進行控制之際。特別是VA(Vertical Alignment)模式或PSA(Polymer Sustained Alignment)模式等,必須使液晶形成垂直配向時,於液晶配向膜中,則尋求可使液晶進行垂直配向之能力(亦稱為垂直配向性或高預傾角)。此外,液晶配向膜中,不僅僅高垂直配向性,對於其之安定性亦為極重要者。特別是,為得到高亮度之目的,而增大發熱量,使用光線照射量極多之背光源的液晶顯示元件,例如,汽車導航系統或大型電視中,多為長時間暴露於高溫及光線照射環境下使用,或放置之情形。於該嚴苛條件之中,若垂直配向性降低時,也會引起無法得到初期之顯示特性,或產生顯示斑紋等問題。 The liquid crystal alignment film is also used to control the angle of the liquid crystal with respect to the substrate, even when used to control the pretilt angle of the liquid crystal. In particular, in the VA (Vertical Alignment) mode or the PSA (Polymer Sustained Alignment) mode, when the liquid crystal must be vertically aligned, in the liquid crystal alignment film, the ability to vertically align the liquid crystal (also referred to as vertical alignment or High pretilt angle). In addition, in the liquid crystal alignment film, not only the high vertical alignment property but also the stability of the liquid crystal alignment film is extremely important. In particular, in order to obtain high brightness, the heat generation amount is increased, and a liquid crystal display element of a backlight which uses a large amount of light irradiation, for example, a car navigation system or a large television, is exposed to a high temperature and a light irradiation environment for a long time. Use under, or place. Among the severe conditions, if the vertical alignment property is lowered, the initial display characteristics or the display streaks may not be obtained.

此外,有關液晶顯示元件之電氣特性之一的電壓保持率,亦尋求於上述嚴苛條件下之高度安定性。即,電壓保持率若受到背光源產生之光照射而降低時,將容易產生液晶顯示元件顯示不良的狀況之一的殘影缺陷 (亦稱為線性殘影),而無法製得具有高信賴性的液晶顯示元件。因此,液晶配向膜,除尋求一種初期特性需為良好以外,例如,長時間暴露於光線照射之後,電壓保持率也不容易降低之特性。此外,對於另一個殘影缺陷之介面熔融現象,也需求一種即使受到背光源產生光照射,也可快速減緩因直流電壓而蓄積之殘留電荷的液晶配向膜。 Further, the voltage holding ratio of one of the electrical characteristics of the liquid crystal display element is also sought to be highly stable under the above severe conditions. In other words, when the voltage holding ratio is lowered by the light generated by the backlight, the image defect of one of the display failures of the liquid crystal display element is likely to occur. (Also known as linear afterimage), it is impossible to produce a liquid crystal display element with high reliability. Therefore, the liquid crystal alignment film is required to have a good initial characteristic, for example, a characteristic that the voltage holding ratio is not easily lowered after exposure to light for a long period of time. Further, for the interface melting phenomenon of another afterimage defect, there is also a need for a liquid crystal alignment film which can quickly alleviate the residual charge accumulated by the DC voltage even if it is irradiated with light by a backlight.

因此,本發明為,以提供兼備上述特性的液晶配向處理劑為目的。即,本發明之目的為,提供一種即使暴露於長時間高溫及光照射之後,也具有安定的預傾角之液晶配向膜為目的。此外,並以提供一種即使長時間暴露於光線照射之後,也可抑制電壓保持率之降低,且可快速減緩直流電壓所蓄積之殘留電荷的液晶配向膜為目的。 Therefore, the present invention has an object of providing a liquid crystal alignment treatment agent having the above characteristics. That is, an object of the present invention is to provide a liquid crystal alignment film having a stable pretilt angle even after exposure to high temperature for a long period of time and light irradiation. Further, in order to provide a liquid crystal alignment film which can suppress a decrease in voltage holding ratio even after long-time exposure to light irradiation, and can quickly alleviate residual charges accumulated by a DC voltage.

此外,並提供一種可以提供具有上述液晶配向膜的液晶顯示元件、可提供上述液晶配向膜的液晶配向處理劑。 Further, a liquid crystal display element which can provide the liquid crystal display element having the above liquid crystal alignment film and which can provide the above liquid crystal alignment film is provided.

此外,本發明亦以提供對應於上述要求的具備液晶配向膜之液晶顯示元件為目的。 Further, the present invention has an object of providing a liquid crystal display element having a liquid crystal alignment film corresponding to the above requirements.

本發明者們,進行深入研究結果,發現具有具特定結構的2個聚合物之液晶配向處理劑,就達成上述目的之觀點極為有效,進而完成本發明。 The present inventors have conducted intensive studies and found that liquid crystal alignment treatment agents having two polymers having a specific structure are extremely effective in achieving the above object, and the present invention has been completed.

即,本發明為具有以下主要特徵者。 That is, the present invention is the one having the following main features.

(1)一種含有下述(A)成份及(B)成份之液晶配向處理 劑。 (1) A liquid crystal alignment treatment containing the following (A) component and (B) component Agent.

(A)成份:含有由具有含氮原子之結構的聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物。 (A) Component: a polymer containing at least any one selected from the group consisting of a polyimide intermediate having a structure containing a nitrogen atom and a polyimine.

(B)成份:含有由具有下述式〔2〕所示之結構的聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物。 (B) Component: a polymer containing at least one selected from the group consisting of a polyimine precursor having a structure represented by the following formula [2] and a polyimine.

又,(A)成份及(B)成份之聚合物中之至少任一者,為含有下述式〔3〕所示之結構。 Further, at least one of the components (A) and (B) has a structure represented by the following formula [3].

(式〔2〕中,Y1及Y7各自獨立表示單鍵、碳數1~10之伸烷基、-O-、-N(R1)-(R1表示氫原子或碳數1~3之伸烷基)、-CON(R2)-(R2表示氫原子或碳數1~3之伸烷基)、-N(R3)CO-(R3表示氫原子或碳數1~3之伸烷基)、-CH2O-、-COO-及-OCO-所選出之至少1種的有機基,Y2及Y6各自獨立表示碳數1~10之伸烷基,Y3及Y5各自獨立表示氫原子或碳數1~10之伸烷基,Y4表示氧原子或硫原子)。 (In the formula [2], Y 1 and Y 7 each independently represent a single bond, an alkylene group having 1 to 10 carbon atoms, -O-, -N(R 1 )- (R 1 represents a hydrogen atom or a carbon number of 1~). 3 alkylene), -CON(R 2 )- (R 2 represents a hydrogen atom or an alkylene group having 1 to 3 carbon atoms), -N(R 3 )CO- (R 3 represents a hydrogen atom or a carbon number of 1) At least one organic group selected from ~3 alkylene), -CH 2 O-, -COO-, and -OCO-, and Y 2 and Y 6 each independently represent an alkylene group having 1 to 10 carbon atoms, Y 3 and Y 5 each independently represent a hydrogen atom or an alkylene group having 1 to 10 carbon atoms, and Y 4 represents an oxygen atom or a sulfur atom).

(式〔3〕中,B1表示單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-,B2表示單鍵或-(CH2)b-(b為1~15之整數),B3表示單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-,B4表示由苯環、環己烷環或雜環所選出的2價之環狀基,或具有膽固醇骨架之碳數17~51的2價之有機基,前述環狀基上的任意之氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,B5表示由苯環、環己烷環或雜環所選出的2價之環狀基,該些環狀基上的任意之氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,n表示0~4之整數,B6表示碳數1~18之烷基、碳數1~18之含氟烷基、碳數1~18之烷氧基或碳數1~18之含氟烷氧基)。 (In the formula [3], B 1 represents a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-, B 2 Represents a single bond or -(CH 2 ) b - (b is an integer from 1 to 15), B 3 represents a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-, B 4 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, or a divalent group having a carbon number of 17 to 51 having a cholesterol skeleton The organic group, any hydrogen atom on the above cyclic group, may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, and a carbon number of 1 to 3; 3 is substituted by a fluorine-containing alkoxy group or a fluorine atom, and B 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, and any hydrogen atom on the ring group may be It is substituted by an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom, and n is represented by n. An integer of 0 to 4, and B 6 represents an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms. ).

(2)如上述(1)所記載之液晶配向處理劑,其中,前述(B)成份中之具有氮原子的結構,為由下述式〔1a〕~式〔1c〕所示之結構所選出之至少1種的結構。 (2) The liquid crystal alignment treatment agent according to the above (1), wherein the structure having a nitrogen atom in the component (B) is selected from the structures represented by the following formulas [1a] to [1c]. At least one of the structures.

(式〔1a〕中,X1表示苯環或含氮芳香族雜環,X2表示被氫原子或碳數1~12的脂肪族基所取代之二取代胺基,式〔1b〕中,X3及X7各自獨立表示具有6~15個碳原子,且具有1~2個苯環之芳香族基,X4及X6各自獨立表示氫原子或碳數1~5之伸烷基,X5表示碳數2~5之伸烷基或聯苯基,m表示0或1之整數,式〔1c〕中,X8及X10各自獨立表示由下述式〔1c-a〕及式〔1c-b〕所示之結構所選出之至少1種的結構,X9表示碳數1~5之伸烷基或苯環)。 (In the formula [1a], X 1 represents a benzene ring or a nitrogen-containing aromatic hetero ring, and X 2 represents a disubstituted amino group substituted with a hydrogen atom or an aliphatic group having 1 to 12 carbon atoms, in the formula [1b], X 3 and X 7 each independently represent an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings, and X 4 and X 6 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms. X 5 represents an alkylene group or a biphenyl group having 2 to 5 carbon atoms, and m represents an integer of 0 or 1. In the formula [1c], X 8 and X 10 each independently represent a formula [1c-a] and a formula The structure of at least one selected from the structures shown in [1c-b], and X 9 represents an alkylene group having a carbon number of 1 to 5 or a benzene ring).

(3)如上述(1)或上述(2)所記載之液晶配向處理劑,其中,前述(A)成份之聚合物為,使用下述式〔1-1〕所示二胺化合物作為原料的一部份而製得之聚合物。 (3) The liquid crystal alignment treatment agent according to the above (1), wherein the polymer of the component (A) is a raw material using a diamine compound represented by the following formula [1-1]. A part of the polymer produced.

(式〔1-1〕中,XA表示具有由前述式〔1a〕~式〔 1c〕所示之結構所選出之至少1種的結構之有機基,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基)。 (In the formula [1-1], X A represents an organic group having at least one structure selected from the structures represented by the above formulas [1a] to [1c], and A 1 and A 2 each independently represent a hydrogen atom. Or an alkyl group having a carbon number of 1 to 5).

(4)如上述(3)所記載之液晶配向處理劑,其中,前述二胺化合物,為使用下述式〔1a-1〕~式〔1c-1〕所示二胺化合物作為原料的一部份而製得之聚合物。 (4) The liquid crystal alignment treatment agent according to the above (3), wherein the diamine compound is a raw material using a diamine compound represented by the following formula [1a-1] to formula [1c-1] as a raw material. The obtained polymer.

(式〔1a-1〕中,X1表示苯環或含氮芳香族雜環,X2表示被氫原子或碳數1~12的脂肪族基所取代之二取代胺基,式〔1b-1〕中,X3及X7各自獨立表示具有6~15個碳原子,且具有1~2個苯環之芳香族基,X4及X6各自獨立表示氫原子或碳數1~5之伸烷基,X5表示碳數2~5之伸烷基或聯苯基,m表示0或1之整數,式〔1c-1〕中,X8及X10各自獨立表示由前述式〔1c-a〕及式〔1c-b〕所示之結構所選出之至少1種的結構,X9表示碳數1~5之伸烷基或苯環,式〔1a-1〕~式〔1c-1〕中,A1~A6各自獨立表示氫原子或碳數1~5之伸烷基)。 (In the formula [1a-1], X 1 represents a benzene ring or a nitrogen-containing aromatic hetero ring, and X 2 represents a disubstituted amino group substituted by a hydrogen atom or an aliphatic group having 1 to 12 carbon atoms, and the formula [1b- In 1], X 3 and X 7 each independently represent an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings, and X 4 and X 6 each independently represent a hydrogen atom or a carbon number of 1 to 5. An alkyl group, X 5 represents an alkylene group or a biphenyl group having a carbon number of 2 to 5, and m represents an integer of 0 or 1. In the formula [1c-1], X 8 and X 10 each independently represent the formula [1c] -a) and at least one structure selected from the structures represented by the formula [1c-b], and X 9 represents an alkylene group or a benzene ring having a carbon number of 1 to 5, and a formula [1a-1] to a formula [1c- In 1], A 1 to A 6 each independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms.

(5)如上述(4)所記載之液晶配向處理劑,其中,前述二胺化合物為由下述式〔1-1a〕~式〔1-4a〕所示二胺化合物所選出之至少1種的二胺化合物。 (5) The liquid crystal alignment treatment agent according to the above (4), wherein the diamine compound is at least one selected from the diamine compounds represented by the following formula [1-1a] to formula [1-4a]. Diamine compound.

(式〔1-3a〕中,R1表示氫原子或碳數1~5之伸烷基,式〔1-4a〕中,n表示1~10之整數,式〔1-1a〕~式〔1-4a〕中,A1~A8各自獨立表示氫原子或碳數1~5之伸烷基)。 (In the formula [1-3a], R 1 represents a hydrogen atom or an alkylene group having 1 to 5 carbon atoms; in the formula [1-4a], n represents an integer of 1 to 10, and the formula [1-1a] to the formula [ In 1-4a], A 1 to A 8 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

(6)如上述(1)~上述(5)之任一者所記載的液晶配向處理劑,其中,前述(B)成份之聚合物為使用下述式〔2-1〕所示二胺化合物作為原料的一部份而製得之聚合物。 The liquid crystal alignment treatment agent according to any one of the above (1), wherein the polymer of the component (B) is a diamine compound represented by the following formula [2-1]. A polymer produced as part of a raw material.

(式〔2-1〕中,YA表示具有前述式〔2〕所示之結構的有機基,A1及A2各自獨立表示氫原子或碳數1~5之伸 烷基)。 (In the formula [2-1], Y A represents an organic group having a structure represented by the above formula [2], and each of A 1 and A 2 independently represents a hydrogen atom or an alkylene group having 1 to 5 carbon atoms).

(7)如上述(6)所記載之液晶配向處理劑,其中,前述二胺化合物為使用下述式〔2a〕所示二胺化合物作為原料的一部份而製得之聚合物。 (7) The liquid crystal alignment treatment agent according to the above (6), wherein the diamine compound is a polymer obtained by using a diamine compound represented by the following formula [2a] as a raw material.

(式〔2a〕中,Y1及Y7各自獨立表示單鍵、碳數1~10之伸烷基、-O-、-N(R1)-(R1表示氫原子或碳數1~3之伸烷基)、-CON(R2)-(R2表示氫原子或碳數1~3之伸烷基)、-N(R3)CO-(R3表示氫原子或碳數1~3之伸烷基)、-CH2O-、-COO-及-OCO-所選出之至少1種的有機基,Y2及Y6各自獨立表示碳數1~10之伸烷基,Y3及Y5各自獨立表示氫原子或碳數1~10之伸烷基,Y4表示氧原子或硫原子,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基)。 (In the formula [2a], Y 1 and Y 7 each independently represent a single bond, an alkylene group having 1 to 10 carbon atoms, -O-, -N(R 1 )- (R 1 represents a hydrogen atom or a carbon number of 1~). 3 alkylene), -CON(R 2 )- (R 2 represents a hydrogen atom or an alkylene group having 1 to 3 carbon atoms), -N(R 3 )CO- (R 3 represents a hydrogen atom or a carbon number of 1) At least one organic group selected from ~3 alkylene), -CH 2 O-, -COO-, and -OCO-, and Y 2 and Y 6 each independently represent an alkylene group having 1 to 10 carbon atoms, Y 3 and Y 5 each independently represent a hydrogen atom or an alkylene group having 1 to 10 carbon atoms, Y 4 represents an oxygen atom or a sulfur atom, and A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms) .

(8)如上述(7)所記載之液晶配向處理劑,其中,前述二胺化合物為由下述式〔2-1a〕~式〔2-3a〕所示二胺化合物所選出之至少1種的二胺化合物。 The liquid crystal alignment treatment agent according to the above-mentioned (7), wherein the diamine compound is at least one selected from the diamine compounds represented by the following formula [2-1a] to formula [2-3a]. Diamine compound.

(式〔2-1a〕~式〔2-3a〕中,A1~A6各自獨立表示氫原子或碳數1~5之伸烷基)。 (In the formula [2-1a] to the formula [2-3a], A 1 to A 6 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms).

(9)如上述(1)~上述(8)之任一者所記載的液晶配向處理劑,其中,前述(A)成份及(B)成份中之至少任一者的聚合物,為使用下述式〔3a〕所示二胺化合物作為原料的一部份。 The liquid crystal alignment treatment agent according to any one of the above (1), wherein the polymer of at least one of the components (A) and (B) is used. The diamine compound represented by the formula [3a] is used as a part of the raw material.

(式〔3a〕中,B表示前述式〔3〕,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基,m表示1~4之整數)。 (In the formula [3a], B represents the above formula [3], and A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms, and m represents an integer of 1 to 4).

(10)如上述(1)~上述(9)之任一者所記載的液晶配向處理劑,其中,前述(A)成份之聚合物及(B)成份之 聚合物為,由使用下述式〔4〕所示四羧酸成份所得之聚醯亞胺前驅體及聚醯亞胺所選出之至少1種的聚合物。 (10) The liquid crystal alignment treatment agent according to any one of the above (1), wherein the polymer of the component (A) and the component (B) The polymer is at least one polymer selected from the group consisting of a polyimine precursor obtained by using a tetracarboxylic acid component represented by the following formula [4] and a polyimine.

(式〔4〕中,Z表示由下述式〔4a〕~式〔4k〕所示之結構所選出之至少1種的結構)。 (In the formula [4], Z represents a structure selected from at least one of the structures represented by the following formulas [4a] to [4k]).

(式〔4a〕中,Z1~Z4表示氫原子、甲基、乙基、丙基、氯原子或苯環,其可分別為相同亦可、相異亦可,式〔4g〕中,Z5及Z6表示氫原子或甲基,其可分別為相同亦可、相異亦可)。 (In the formula [4a], Z 1 to Z 4 represent a hydrogen atom, a methyl group, an ethyl group, a propyl group, a chlorine atom or a benzene ring, which may be the same or different, respectively, in the formula [4g], Z 5 and Z 6 represent a hydrogen atom or a methyl group, which may be the same or different, respectively.

(11)如上述(10)所記載之液晶配向處理劑,其中,前述四羧酸成份為,前述式〔4〕中之Z為由前述式〔4a〕及式〔4e〕~式〔4g〕所示之結構所選出之至少1種的結構的四羧酸成份。 (11) The liquid crystal alignment treatment agent according to the above (10), wherein the tetracarboxylic acid component is such that Z in the above formula [4] is from the above formula [4a] and formula [4e] to formula [4g]. The tetracarboxylic acid component of at least one structure selected for the structure shown.

(12)如上述(4)~上述(11)之任一者所記載的液晶配向處理劑,其中,前述(A)成份之聚合物中,前述式〔1a-1〕~式〔1c-1〕所示二胺化合物,於全部的二胺成份100莫耳%中,為5莫耳%~95莫耳%。 The liquid crystal alignment treatment agent according to any one of the above (1), wherein the polymer of the component (A) has the formula [1a-1] to the formula [1c-1]. The diamine compound shown in the formula is from 5 mol% to 95 mol% in 100 mol% of the total diamine component.

(13)如上述(7)~上述(12)之任一者所記載的液晶配向處理劑,其中,前述(B)成份之聚合物中,前述式〔2a〕所示二胺化合物,於全部的二胺成份100莫耳%中,為5莫耳%~95莫耳%。 The liquid crystal alignment treatment agent according to any one of the above (1), wherein the diamine compound represented by the above formula [2a] is used in the polymer of the component (B). The diamine component is 100 mol%, and is 5 mol% to 95 mol%.

(14)如上述(1)~上述(13)之任一者所記載的液晶配向處理劑前述(B)成份之聚合物,其中,相對於前述(A)成份之聚合物100質量份,為0.5質量份~950質量份。 (14) The polymer of the component (B) of the liquid crystal alignment treatment agent according to any one of the above (1), wherein the polymer of the component (A) is 100 parts by mass of the polymer. 0.5 parts by mass to 950 parts by mass.

(15)如上述(1)~上述(14)之任一者所記載的液晶配向處理劑,其中,液晶配向處理劑的溶劑為,含有由N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮及γ-丁內酯所選出之至少1種的溶劑。 The liquid crystal alignment treatment agent according to any one of the above-mentioned (1), wherein the solvent of the liquid crystal alignment treatment agent contains N-methyl-2-pyrrolidone and N- At least one solvent selected from ethyl-2-pyrrolidone and γ-butyrolactone.

(16)如上述(1)~上述(15)之任一者所記載的液晶配向處理劑,其中,液晶配向處理劑的溶劑為,含有由1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁醚、乙二醇單丁醚及二丙二醇二甲醚所選出之至少1種 的溶劑。 The liquid crystal alignment treatment agent according to any one of the above-mentioned (1), wherein the solvent of the liquid crystal alignment treatment agent contains 1-hexanol, cyclohexanol, 1,2- At least one selected from ethylene glycol, 1,2-propylene glycol, propylene glycol monobutyl ether, ethylene glycol monobutyl ether, and dipropylene glycol dimethyl ether Solvent.

(17)如上述(1)~上述(16)之任一者所記載的液晶配向處理劑,其中,液晶配向處理劑中,含有由具有環氧基、異氰酸酯基、環氧丙烷基或環碳酸酯基的交聯性化合物、具有由羥基、羥烷基或低級烷氧基烷基所成群所選出之至少1種的取代基的交聯性化合物,及由具有聚合性不飽和鍵結的交聯性化合物所選出之至少1種的交聯性化合物。 The liquid crystal alignment treatment agent according to any one of the above-mentioned (1), wherein the liquid crystal alignment treatment agent contains an epoxy group, an isocyanate group, an oxypropylene group or a cyclic carbonic acid. a crosslinkable compound of an ester group, a crosslinkable compound having at least one substituent selected from a group consisting of a hydroxyl group, a hydroxyalkyl group or a lower alkoxyalkyl group, and a polymerizable unsaturated bond At least one crosslinkable compound selected from the crosslinkable compound.

(18)一種液晶配向膜,其特徵為,由上述(1)~上述(17)之任一者所記載的液晶配向處理劑所製得。 (18) A liquid crystal alignment film obtained by the liquid crystal alignment treatment agent according to any one of the above (1) to (17).

(19)一種液晶配向膜,其特徵為,使用上述(1)~上述(17)之任一者所記載的液晶配向處理劑,經由噴墨法而製得。 (19) A liquid crystal alignment film obtained by the inkjet method using the liquid crystal alignment treatment agent according to any one of the above (1) to (17).

(20)一種液晶顯示元件,其特徵為,具有上述(18)或上述(19)所記載之液晶配向膜。 (20) A liquid crystal display element comprising the liquid crystal alignment film according to (18) or (19) above.

(21)一種如上述(18)或上述(19)所記載之液晶配向膜,其為使用於液晶顯示元件,其特徵為,該液晶顯示元件為,於具備有電極之一對的基板之間具有液晶層,前述一對的基板之間,配置含有經由活性能量線及熱中至少一者而聚合之聚合性化合物的液晶組成物,該液晶組成物係經由於前述電極間持續施加電壓,而使前述聚合性化合物聚合之步驟所製得者。 (21) A liquid crystal alignment film according to the above (18) or (19), which is used in a liquid crystal display device, characterized in that the liquid crystal display element is between a substrate having one pair of electrodes A liquid crystal layer having a liquid crystal composition containing a polymerizable compound polymerized by at least one of an active energy ray and heat is disposed between the pair of substrates, and the liquid crystal composition is continuously applied with a voltage between the electrodes The step of polymerizing the aforementioned polymerizable compound is obtained.

(22)一種液晶顯示元件,其特徵為,具有上述(21)之液晶配向膜者。 (22) A liquid crystal display device comprising the liquid crystal alignment film of (21) above.

(23)如上述(18)或上述(19)之液晶配向膜,其係使用於液晶顯示元件,其特徵為,該液晶顯示元件為,於具備有電極之一對的基板之間具有液晶層,前述一對的基板之間,配置有含有經由活性能量線及熱中至少一者而聚合的聚合性基之液晶配向膜,該液晶配向膜係經由於前述電極間持續施加電壓,而使前述聚合性基聚合之步驟所製得者。 (23) The liquid crystal alignment film according to the above (18) or (19), which is used in a liquid crystal display device, characterized in that the liquid crystal display element has a liquid crystal layer between substrates having one pair of electrodes A liquid crystal alignment film containing a polymerizable group polymerized by at least one of an active energy ray and a heat is disposed between the pair of substrates, and the liquid crystal alignment film is continuously applied with a voltage between the electrodes to cause the polymerization. Produced by the steps of the radical polymerization.

(24)一種液晶顯示元件,其特徵為,具有上述(23)之液晶配向膜。 (24) A liquid crystal display element comprising the liquid crystal alignment film of (23) above.

本發明之含有2種類的由具有特定結構之聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物之液晶配向處理劑為,一種即使長時間暴露於高溫及光照射之後,也可得到具有安定的預傾角之液晶配向膜。此外,亦為一種即使長時間暴露於光線照射之後,可抑制電壓保持率之降低,且可快速減緩因直流電壓所蓄積之殘留電荷液晶配向膜。因此,具有由本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件,為具有優良信賴性者,極適合使用於大畫面且具有高精密度的液晶電視等。 The liquid crystal alignment treatment agent containing two types of polymers selected from the group consisting of a polyimine precursor having a specific structure or a polyimine is a long-term exposure to high temperature and light irradiation. A liquid crystal alignment film having a stable pretilt angle can also be obtained. In addition, it is also a kind of residual charge liquid crystal alignment film which can suppress the decrease of the voltage holding ratio even after long-term exposure to light irradiation, and can quickly alleviate the accumulation of the DC voltage. Therefore, the liquid crystal display element having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is excellent in reliability, and is highly suitable for a liquid crystal television having a large screen and high precision.

[實施發明之形態] [Formation of the Invention]

以下,將對本發明作詳細之說明。 Hereinafter, the present invention will be described in detail.

本發明為,一種含有下述(A)成份及(B)成份之 液晶配向處理劑、使用該該液晶配向處理劑所得之液晶配向膜,及,具有該液晶配向膜之液晶顯示元件。 The present invention is a composition comprising the following (A) component and (B) component A liquid crystal alignment treatment agent, a liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent, and a liquid crystal display element having the liquid crystal alignment film.

一種含有下述(A)成份及(B)成份之液晶配向處理劑。 A liquid crystal alignment treatment agent containing the following (A) component and (B) component.

(A)成份:含有由具有含氮原子之結構的聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物(亦稱為特定聚合物(A))。 (A) Component: a polymer (also referred to as a specific polymer (A)) containing at least any one selected from a polyimine precursor having a structure containing a nitrogen atom and a polyimine.

(B)成份:含有由具有下述式〔2〕所示之結構(亦稱為特定結構(2))的聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物(亦稱為特定聚合物(B))。 (B) Component: a polymer containing at least one selected from the group consisting of a polyimine precursor having a structure represented by the following formula [2] (also referred to as a specific structure (2)) and a polyimine ( Also known as a specific polymer (B)).

又,(A)成份及(B)成份之聚合物中之至少任一者,為含有下述式〔3〕所示之結構(亦稱為特定側鏈結構)。 Further, at least one of the polymer of the component (A) and the component (B) contains a structure represented by the following formula [3] (also referred to as a specific side chain structure).

(式〔2〕中,Y1及Y7各自獨立表示單鍵、碳數1~10之伸烷基、-O-、-N(R1)-(R1表示氫原子或碳數1~3之伸烷基)、-CON(R2)-(R2表示氫原子或碳數1~3之伸烷基)、-N(R3)CO-(R3表示氫原子或碳數1~3之伸烷基)、-CH2O-、-COO-及-OCO-所選出之至少1種的有機基,Y2及Y6各自獨立表示碳數1~10之伸烷基,Y3及Y5各自獨 立表示氫原子或碳數1~10之伸烷基,Y4表示氧原子或硫原子)。 (In the formula [2], Y 1 and Y 7 each independently represent a single bond, an alkylene group having 1 to 10 carbon atoms, -O-, -N(R 1 )- (R 1 represents a hydrogen atom or a carbon number of 1~). 3 alkylene), -CON(R 2 )- (R 2 represents a hydrogen atom or an alkylene group having 1 to 3 carbon atoms), -N(R 3 )CO- (R 3 represents a hydrogen atom or a carbon number of 1) At least one organic group selected from ~3 alkylene), -CH 2 O-, -COO-, and -OCO-, and Y 2 and Y 6 each independently represent an alkylene group having 1 to 10 carbon atoms, Y 3 and Y 5 each independently represent a hydrogen atom or an alkylene group having 1 to 10 carbon atoms, and Y 4 represents an oxygen atom or a sulfur atom).

(式〔3〕中,B1表示單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-,B2表示單鍵或-(CH2)b-(b為1~15之整數),B3表示單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-,B4表示由苯環、環己烷環或雜環所選出的2價之環狀基,或具有膽固醇骨架之碳數17~51的2價之有機基,前述環狀基上的任意之氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,B5表示由苯環、環己烷環或雜環所選出的2價之環狀基,該些環狀基上的任意之氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,n表示0~4之整數,B6表示碳數1~18之烷基、碳數1~18之含氟烷基、碳數1~18之烷氧基或碳數1~18之含氟烷氧基)。 (In the formula [3], B 1 represents a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-, B 2 Represents a single bond or -(CH 2 ) b - (b is an integer from 1 to 15), B 3 represents a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-, B 4 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, or a divalent group having a carbon number of 17 to 51 having a cholesterol skeleton The organic group, any hydrogen atom on the above cyclic group, may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, and a carbon number of 1 to 3; 3 is substituted by a fluorine-containing alkoxy group or a fluorine atom, and B 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, and any hydrogen atom on the ring group may be It is substituted by an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom, and n is represented by n. An integer of 0 to 4, and B 6 represents an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms. ).

本發明之液晶配向處理劑所製得液晶配向膜,其可解決本發明問題之理由,仍未完全明瞭,但應為 下述說明內容。 The liquid crystal alignment film prepared by the liquid crystal alignment treatment agent of the present invention, which can solve the problem of the present invention, is not fully understood, but should be The following instructions.

即,本發明之特定聚合物(A)及特定聚合物(B)中之至少任一者所含有的前述式〔3〕所示特定側鏈結構為,側鏈部位具有苯環、環己基環或雜環,或具有膽固醇骨架之碳數17~51的2價之有機基。該些環及有機基的側鏈結構,具有較作為液晶垂直配向之以往技術的長鏈烷基之側鏈結構為更剛直的結構。如此,由具有本發明之特定側鏈結構的液晶配向處理劑所製得液晶配向膜,與以往具有長鏈烷基的側鏈結構者相比較時,可得到更高且安定之液晶垂直配向性。 That is, the specific side chain structure represented by the above formula [3] contained in at least one of the specific polymer (A) and the specific polymer (B) of the present invention has a benzene ring or a cyclohexyl ring at a side chain portion. Or a heterocyclic ring, or a divalent organic group having a carbon number of 17 to 51 of a cholesterol skeleton. The side chain structure of the ring and the organic group has a more rigid structure than a side chain structure of a long-chain alkyl group which is a vertical alignment of a liquid crystal. Thus, a liquid crystal alignment film obtained from a liquid crystal alignment treatment agent having a specific side chain structure of the present invention can provide a higher and stable liquid crystal vertical alignment when compared with a conventional side chain structure having a long-chain alkyl group. .

又,本發明之特定側鏈結構,與以往的長鏈烷基之側鏈結構相比較時,得知對紫外線等之光線具有安定性。因此,本發明之特定側鏈結構,即使長時間暴露於光照射下,也可以抑制電壓保持率之降低,且可抑制經直流電壓而蓄積殘留電荷的側鏈成份之分解物。 Further, when the specific side chain structure of the present invention is compared with the side chain structure of the conventional long-chain alkyl group, it is known that it has stability to light such as ultraviolet rays. Therefore, the specific side chain structure of the present invention can suppress the decrease in the voltage holding ratio even when exposed to light for a long period of time, and can suppress the decomposition of the side chain component which accumulates the residual electric charge by the direct current voltage.

此外,藉由本發明之特定聚合物(A)中所含有的含氮原子之結構中之氮原子與特定聚合物(B)中的羧基(COOH基)相互作用,與特定聚合物(B)中之前述式〔2〕中之氮原子與特定聚合物(A)中之羧基的相互作用,推想可引起該些之間的電荷移動。伴隨此反應,所蓄積之殘留電荷,可有效率地在聚合物的分子內或分子間進行移動。即,推想可促進解除因直流電壓所產生的殘留電荷。 Further, the nitrogen atom in the structure of the nitrogen atom-containing structure contained in the specific polymer (A) of the present invention interacts with the carboxyl group (COOH group) in the specific polymer (B), and the specific polymer (B) The interaction of the nitrogen atom in the above formula [2] with the carboxyl group in the specific polymer (A) is thought to cause a charge shift between the atoms. Along with this reaction, the accumulated residual charge can be efficiently moved in or between molecules of the polymer. That is, it is assumed that the residual charge generated by the DC voltage can be released.

此外,本發明之特定聚合物(A)中之具有氮原子的結構,推測可捕集造成電壓保持率降低要因之離子性 雜質成份。即,液晶顯示元件,可捕集因長時間暴露於光線照射所發生的離子性雜質,因此同時也可以抑制電壓保持率之下降。 Further, the structure having a nitrogen atom in the specific polymer (A) of the present invention is presumed to be trapped to cause a decrease in the voltage retention rate. Impurity ingredients. In other words, the liquid crystal display element can trap ionic impurities generated by exposure to light for a long period of time, and therefore, it is also possible to suppress a decrease in the voltage holding ratio.

由以上各點得知,本發明之含有2種類的由具有特定結構之聚醯亞胺前驅體或聚醯亞胺所選出之至少1種的聚合物之液晶配向處理劑為,一種即使長時間暴露於高溫及光照射之後,也可得到具有安定的預傾角之液晶配向膜。此外,亦為一種即使長時間暴露於光線照射之後,可抑制電壓保持率之降低,且可快速減緩因直流電壓所蓄積之殘留電荷液晶配向膜。 From the above, it is known that the liquid crystal alignment treatment agent containing at least one polymer selected from the group consisting of a polyimine precursor having a specific structure or a polyimine is a long time A liquid crystal alignment film having a stable pretilt angle can also be obtained after exposure to high temperature and light irradiation. In addition, it is also a kind of residual charge liquid crystal alignment film which can suppress the decrease of the voltage holding ratio even after long-term exposure to light irradiation, and can quickly alleviate the accumulation of the DC voltage.

<具有氮原子的結構> <Structure with nitrogen atom>

本發明之特定聚合物(A)為,含有由具有含氮原子之結構的聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物。 The specific polymer (A) of the present invention is a polymer containing at least one selected from the group consisting of a polyimine precursor having a structure containing a nitrogen atom and a polyimine.

含氮原子的結構之具體性結構,可列舉如,下述式〔1a〕~式〔1c〕所示之結構等。 The specific structure of the structure containing a nitrogen atom is, for example, a structure represented by the following formula [1a] to formula [1c].

式〔1a〕中,X1表示苯環或含氮芳香族雜 環。 In the formula [1a], X 1 represents a benzene ring or a nitrogen-containing aromatic hetero ring.

式〔1a〕中,X2表示被氫原子或碳數1~12之脂肪族基所取代的二取代胺基。 In the formula [1a], X 2 represents a disubstituted amino group substituted with a hydrogen atom or an aliphatic group having 1 to 12 carbon atoms.

又,式〔1a〕中,X2為氫原子之情形,X1表示含氮芳香族雜環,X2為被碳數1~12之脂肪族基所取代的二取代胺基之情形,X1表示苯環。 Further, in the formula [1a], when X 2 is a hydrogen atom, X 1 represents a nitrogen-containing aromatic heterocyclic ring, and X 2 is a disubstituted amino group substituted with an aliphatic group having 1 to 12 carbon atoms, X 1 represents a benzene ring.

式〔1b〕中,X3及X7各自獨立表示具有6~15個碳原子,且具有1~2個苯環的芳香族基。 In the formula [1b], X 3 and X 7 each independently represent an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings.

式〔1b〕中,X4及X6各自獨立表示氫原子或碳數1~5之伸烷基。 In the formula [1b], X 4 and X 6 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

式〔1b〕中,X5表示碳數2~5之伸烷基或聯苯基。 In the formula [1b], X 5 represents an alkylene group or a biphenyl group having 2 to 5 carbon atoms.

式〔1b〕中,m表示0或1之整數。 In the formula [1b], m represents an integer of 0 or 1.

式〔1c〕中,X8及X10各自獨立表示由下述式〔1c-a〕及式〔1c-b〕所示之結構所選出之至少1種的結構。 In the formula [1c], X 8 and X 10 each independently represent at least one structure selected from the structures represented by the following formulas [1c-a] and [1c-b].

式〔1c〕中,X9表示碳數1~5之伸烷基或苯環。 In the formula [1c], X 9 represents an alkylene group or a benzene ring having 1 to 5 carbon atoms.

<特定結構(2)> <Specific structure (2)>

本發明之特定聚合物(B),為含有由下述式〔2〕所示具有特定結構之聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物。 The specific polymer (B) of the present invention is a polymer containing at least one selected from the group consisting of a polyimine precursor having a specific structure represented by the following formula [2] and a polyimine.

式〔2〕中,Y1及Y7各自獨立表示單鍵、碳數1~10之伸烷基、-O-、-S-、-N(R1)-(R1表示氫原子或碳數1~3之伸烷基)、-CON(R2)-(R2表示氫原子或碳數1~3之伸烷基)、-N(R3)CO-(R3表示氫原子或碳數1~3之伸烷基)、-CH2O-、-COO-及-OCO-所選出之至少1種的有機基。其中,又以單鍵、-O-、-S-、-OCO-或-COO-為佳。更佳者,就液晶配向性與液晶配向膜之膜硬度等觀點,可例如,單鍵、-O-或-S-。 In the formula [2], Y 1 and Y 7 each independently represent a single bond, an alkylene group having 1 to 10 carbon atoms, -O-, -S-, -N(R 1 )- (R 1 represents a hydrogen atom or carbon. a number 1 to 3 alkylene), -CON(R 2 )- (R 2 represents a hydrogen atom or a C 1 to 3 alkyl group), -N(R 3 )CO- (R 3 represents a hydrogen atom or At least one organic group selected from the group consisting of a C 1 to 3 alkyl group, -CH 2 O-, -COO-, and -OCO-. Among them, a single bond, -O-, -S-, -OCO- or -COO- is preferred. More preferably, the liquid crystal alignment property and the film hardness of the liquid crystal alignment film may be, for example, a single bond, -O- or -S-.

式〔2〕中,Y2及Y6各自獨立表示碳數1~10之伸烷基。其中,又以碳數1~3之伸烷基為佳,其結構可為直鏈或支鏈之任一者皆可。具體而言,就液晶配向性與液晶配向膜之膜硬度等觀點,以具有自由迴轉部位,且立體障礙較小的結構之伸甲基(-CH2-)、伸乙基(-CH2CH2-)、伸丙基(-(CH2)3-)或異丙基(-C(CH2)2-)為佳。 In the formula [2], Y 2 and Y 6 each independently represent an alkylene group having 1 to 10 carbon atoms. Among them, an alkylene group having 1 to 3 carbon atoms is preferred, and the structure may be either linear or branched. Specifically, from the viewpoints of the liquid crystal alignment property and the film hardness of the liquid crystal alignment film, a methyl group (-CH 2 -) or an extended ethyl group (-CH 2 CH) having a structure having a freely rotating portion and having a small steric hindrance is preferable. 2 -), propyl (-(CH 2 ) 3 -) or isopropyl (-C(CH 2 ) 2 -) is preferred.

式〔2〕中,Y3及Y5各自獨立表示氫原子或碳數1~10之烷基。其中,又以氫原子或碳數1~3之烷基為佳。特佳為氫原子。 In the formula [2], Y 3 and Y 5 each independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms. Among them, a hydrogen atom or an alkyl group having 1 to 3 carbon atoms is preferred. Particularly preferred is a hydrogen atom.

式〔2〕中,Y4表示氧原子或硫原子。其中,就液晶配向膜之膜硬度之觀點,又以氧原子為佳。 In the formula [2], Y 4 represents an oxygen atom or a sulfur atom. Among them, in view of the film hardness of the liquid crystal alignment film, an oxygen atom is preferred.

<特定側鏈結構> <specific side chain structure>

本發明之特定聚合物(A)及特定聚合物(B)中之至少任一者所含有的前述式〔3〕所示特定側鏈結構,為下述式〔3〕所示之結構。 The specific side chain structure represented by the above formula [3] contained in at least one of the specific polymer (A) and the specific polymer (B) of the present invention is a structure represented by the following formula [3].

式〔3〕中,B1表示單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-。其中,就原料取得與合成之容易性等觀點,又以單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-或-COO-為佳。更佳者為單鍵、-(CH2)a-(a為1~10之整數)、-O-、-CH2O-或-COO-。 In the formula [3], B 1 represents a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Among them, from the viewpoints of availability of raw materials and ease of synthesis, a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O- or -COO- is preferred. . More preferably, it is a single bond, -(CH 2 ) a - (a is an integer of 1 to 10), -O-, -CH 2 O- or -COO-.

式〔3〕中,B2表示單鍵或-(CH2)b-(b為1~15之整數)。其中,又以單鍵或-(CH2)b-(b為1~10之整數)為佳。 In the formula [3], B 2 represents a single bond or -(CH 2 ) b - (b is an integer of 1 to 15). Among them, a single bond or -(CH 2 ) b - (b is an integer of 1 to 10) is preferred.

式〔3〕中,B3表示單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-。其中,就合 成之容易性等觀點,又以單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-或-COO-為佳。更佳者為單鍵、-(CH2)c-(c為1~10之整數)、-O-、-CH2O-或-COO-。 In the formula [3], B 3 represents a single bond, -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Among them, a single bond, -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O- or -COO- is preferable from the viewpoint of easiness of synthesis and the like. More preferably, it is a single bond, -(CH 2 ) c - (c is an integer of 1 to 10), -O-, -CH 2 O- or -COO-.

式〔3〕中,B4表示由苯環、環己烷環或雜環所選出的2價之環狀基,該些環狀基上的任意氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代亦可。此外,B4可為由具有膽固醇骨架之碳數17~51的有機基所選出的2價之有機基。其中,就合成之容易性等觀點,又以苯環、環己烷環或具有膽固醇骨架之碳數17~51的有機基為佳。 In the formula [3], B 4 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, and any hydrogen atom on the ring group may be an alkane having 1 to 3 carbon atoms. The group may be substituted with an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom. Further, B 4 may be a divalent organic group selected from an organic group having a carbon number of 17 to 51 of a cholesterol skeleton. Among them, in view of easiness of synthesis, etc., it is preferred to use a benzene ring, a cyclohexane ring or an organic group having a carbon number of 17 to 51 having a cholesterol skeleton.

式〔3〕中,B5表示由苯環、環己烷環或雜環所選出的2價之環狀基,該些環狀基上的任意氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代亦可。其中,又以苯環或環己烷環為佳。 In the formula [3], B 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, and any hydrogen atom on the ring group may be an alkane having 1 to 3 carbon atoms. The group may be substituted with an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom. Among them, a benzene ring or a cyclohexane ring is preferred.

式〔3〕中,n表示0~4之整數。其中,就原料取得與合成之容易性等觀點,又以0~3為佳。更佳者為0~2。 In the formula [3], n represents an integer of 0 to 4. Among them, from the viewpoints of the availability of raw materials and the ease of synthesis, it is preferably 0 to 3. The better is 0~2.

式〔3〕中,B6表示碳數1~18之烷基、碳數1~18之含氟烷基、碳數1~18之烷氧基或碳數1~18之含氟烷氧基。其中,又以碳數1~18之烷基、碳數1~10之含氟烷基、碳數1~18之烷氧基或碳數1~10之含氟烷氧基為佳。更佳為,碳數1~12之烷基或碳數1~12之烷 氧基。特佳為,碳數1~9之烷基或碳數1~9之烷氧基。 In the formula [3], B 6 represents an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms. . Among them, an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 10 carbon atoms is preferred. More preferably, it is an alkyl group having 1 to 12 carbon atoms or an alkoxy group having 1 to 12 carbon atoms. Particularly preferred are an alkyl group having 1 to 9 carbon atoms or an alkoxy group having 1 to 9 carbon atoms.

式〔3〕中之B1~B6及n的較佳組合,可列舉如,國際公開公報WO2011/132751(2011.10.27公開)之13頁~34頁的表6~表47所揭示之(2-1)~(2-629)為相同之組合等。又,國際公開公報的各表中,如本發明中之B1~B6為Y1~Y6之表示方式般,Y1~Y6為以B1~B6替代者。又,國際公開公報的各表所揭示之(2-605)~(2-629)中,本發明中之具有膽固醇骨架之碳數17~51的有機基,為以具有膽固醇骨架之碳數12~25的有機基方式表示,故具有膽固醇骨架之碳數12~25的有機基係以具有膽固醇骨架之碳數17~51的有機基予以替代者。 Preferred combinations of B 1 to B 6 and n in the formula [3] are as disclosed in Tables 6 to 47 of pages 13 to 34 of International Publication WO2011/132751 (2011.10.27). 2-1)~(2-629) are the same combination and the like. Further, in each table of the international publication, as in the present invention, B 1 to B 6 are represented by Y1 to Y6, and Y1 to Y6 are replaced by B 1 to B 6 . Further, in (2-605) to (2-629) disclosed in the respective tables of the International Publications, the organic group having a carbon number of 17 to 51 having a cholesterol skeleton in the present invention has a carbon number of 12 having a cholesterol skeleton. The organic basis of ~25 indicates that the organic group having a carbon number of 12 to 25 having a cholesterol skeleton is replaced by an organic group having a carbon number of 17 to 51 having a cholesterol skeleton.

<特定聚合物(A)‧特定聚合物(B)> <Specific polymer (A) ‧ Specific polymer (B) >

本發明之特定聚合物(A)及特定聚合物(B),為由聚醯亞胺前驅體及聚醯亞胺(亦統稱為聚醯亞胺系聚合物)所選出之至少1種的聚合物。其中,本發明之聚醯亞胺系聚合物,又以由二胺成份與四羧酸成份反應所得之聚醯亞胺前驅體或聚醯亞胺為佳。 The specific polymer (A) and the specific polymer (B) of the present invention are at least one selected from the group consisting of a polyimide precursor and a polyimine (also collectively referred to as a polyimine polymer). Things. Among them, the polyimine-based polymer of the present invention is preferably a polyimide precursor or a polyimine which is obtained by reacting a diamine component with a tetracarboxylic acid component.

聚醯亞胺前驅體為,如下述式〔A〕所示之結構。 The polyimine precursor is a structure represented by the following formula [A].

(式〔A〕中,R1為4價之有機基,R2為2價之有機基,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基,A3及A4各自獨立表示氫原子、碳數1~5之伸烷基或乙醯基,n表示正整數)。 (In the formula [A], R 1 is a tetravalent organic group, R 2 is a divalent organic group, and A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms, and A 3 and A; 4 each independently represents a hydrogen atom, an alkylene group or an ethylidene group having a carbon number of 1 to 5, and n represents a positive integer).

前述二胺成份,例如,分子內具有2個一級或二級之胺基的二胺化合物等。 The above diamine component is, for example, a diamine compound having two primary or secondary amine groups in the molecule.

又,前述四羧酸成份,可列舉如,四羧酸化合物、四羧酸二酐、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物等。 Further, examples of the tetracarboxylic acid component include a tetracarboxylic acid compound, a tetracarboxylic dianhydride, a tetracarboxylic acid dihalide compound, a tetracarboxylic acid dialkyl ester compound, or a tetracarboxylic acid dialkyl ester dihalide compound. .

欲製得式〔A〕中之A1及A2為氫原子之聚醯胺酸時,例如,可使前述分子內具有2個一級或二級之胺基的二胺化合物,與四羧酸化合物或四羧酸酐進行反應而可製得。 When a polyphthalic acid in which A 1 and A 2 in the formula [A] are a hydrogen atom is produced, for example, a diamine compound having two primary or secondary amine groups in the molecule may be obtained, and a tetracarboxylic acid. A compound or a tetracarboxylic anhydride can be obtained by reacting.

欲製得式〔A〕中之A1及A2為碳數1~5之伸烷基的聚醯胺酸烷酯之方法,例如,可使前述二胺化合物,與四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物進行反應而可製得。又,亦可於前述方法所製得之聚醯胺酸中,導入式〔A〕所示A1及A2之碳數1~5的伸烷基。 A method for producing a polyalkyl amide of A 1 and A 2 in the formula [A] which is an alkylene group having 1 to 5 carbon atoms, for example, the diamine compound and the tetracarboxylic acid dihalide can be obtained. A compound, a tetracarboxylic acid dialkyl ester compound or a tetracarboxylic acid dialkyl ester dihalide compound can be obtained by reacting. Further, an alkylene group having 1 to 5 carbon atoms of A 1 and A 2 represented by the formula [A] may be introduced into the polyamic acid obtained by the above method.

本發明之特定聚合物(A),為具有含氮原子之 結構的聚合物。其中,又以前述式〔1a〕~式〔1c〕所示之結構為佳。 The specific polymer (A) of the present invention has a nitrogen-containing atom Structure of the polymer. Among them, the structure represented by the above formula [1a] to formula [1c] is preferred.

將含氮原子的結構導入特定聚合物(A)中之方法,並未有特別之限定,又以使用具有前述式〔1a〕~式〔1c〕所示之結構的二胺化合物作為原料的一部份使用者為佳。 The method of introducing a structure containing a nitrogen atom into the specific polymer (A) is not particularly limited, and a diamine compound having a structure represented by the above formula [1a] to formula [1c] is used as a raw material. Some users are better.

具體而言,又以使用下述式〔1-1〕所示二胺化合物(亦稱為特定二胺化合物(1))為佳。 Specifically, a diamine compound (also referred to as a specific diamine compound (1)) represented by the following formula [1-1] is preferably used.

式〔1-1〕中,XA表示具有由前述式〔1a〕~式〔1c〕所示之結構所選出之至少1種的結構的碳數5~50的有機基。 In the formula [1-1], X A represents an organic group having 5 to 50 carbon atoms having at least one structure selected from the structures represented by the above formulas [1a] to [1c].

式〔1-1〕中,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基。 In the formula [1-1], A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

更具體而言,以使用下述式〔1a-1〕~式〔1c-1〕所示二胺化合物為佳。 More specifically, it is preferred to use a diamine compound represented by the following formula [1a-1] to formula [1c-1].

式〔1a-1〕中,X1表示苯環或含氮芳香族雜環。 In the formula [1a-1], X 1 represents a benzene ring or a nitrogen-containing aromatic hetero ring.

式〔1a-1〕中,X2表示被氫原子或碳數1~12之脂肪族基所取代的二取代胺基。 In the formula [1a-1], X 2 represents a disubstituted amino group substituted with a hydrogen atom or an aliphatic group having 1 to 12 carbon atoms.

又,式〔1a-1〕中,X2為氫原子之情形,X1表示含氮芳香族雜環,X2為被碳數1~12之脂肪族基所取代的二取代胺基之情形,X1表示苯環。 Further, in the formula [1a-1], when X 2 is a hydrogen atom, X 1 represents a nitrogen-containing aromatic heterocyclic ring, and X 2 is a disubstituted amino group substituted with an aliphatic group having 1 to 12 carbon atoms. , X 1 represents a benzene ring.

式〔1b-1〕中,X3及X7各自獨立表示具有6~15個碳原子,且具有1~2個苯環的芳香族基。 In the formula [1b-1], X 3 and X 7 each independently represent an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings.

式〔1b-1〕中,X4及X6各自獨立表示氫原子或碳數1~5之伸烷基。 In the formula [1b-1], X 4 and X 6 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

式〔1b-1〕中,X5表示碳數2~5之伸烷基或聯苯基。 In the formula [1b-1], X 5 represents an alkylene group or a biphenyl group having 2 to 5 carbon atoms.

式〔1b-1〕中,m表示0或1之整數。 In the formula [1b-1], m represents an integer of 0 or 1.

式〔1c-1〕中,X8及X10各自獨立表示由下述式〔1c-a〕及式〔1c-b〕所示之結構所選出之至少1種的結構。 In the formula [1c-1], X 8 and X 10 each independently represent at least one structure selected from the structures represented by the following formulas [1c-a] and [1c-b].

式〔1c-1〕中,X9表示碳數1~5之伸烷基或苯環。 In the formula [1c-1], X 9 represents an alkylene group or a benzene ring having 1 to 5 carbon atoms.

本發明之特定二胺化合物(1)之具體的二胺化合物,可列舉如,下述式〔1-1a〕~式〔1-4a〕所示二胺化合物等。 Specific examples of the specific diamine compound of the specific diamine compound (1) of the present invention include a diamine compound represented by the following formula [1-1a] to formula [1-4a].

式〔1-3a〕中,R1表示氫原子或碳數1~5之伸烷基。 In the formula [1-3a], R 1 represents a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

式〔1-4a〕中,n表示1~10之整數。 In the formula [1-4a], n represents an integer of 1 to 10.

式〔1-1a〕~式〔1-4a〕中,A1~A8各自獨立表示氫原子或碳數1~5之伸烷基。 In the formula [1-1a] to the formula [1-4a], A 1 to A 8 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

其中,又以使用前述式〔1-3a〕或式〔1-4a〕所示二胺化合物為佳。 Among them, the diamine compound represented by the above formula [1-3a] or the formula [1-4a] is preferably used.

本發明之特定聚合物(A)中之特定二胺化合物(1),相對於二胺成份100莫耳%中,以1莫耳%~95莫耳 %為佳。其中,又以5莫耳%~95莫耳%為佳。更佳者為20莫耳%~80莫耳%。 The specific diamine compound (1) in the specific polymer (A) of the present invention is 1 mol% to 95 mol% based on 100 mol% of the diamine component. % is better. Among them, it is preferably 5 mol% to 95 mol%. More preferably, it is 20% by mole to 80% by mole.

本發明之特定二胺化合物(1),就本發明之特定聚合物(A)對溶劑之溶解性或液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶配向性、電壓保持率、蓄積電荷等特性之觀點,可將1種類或2種類以上混合使用。 Specific diamine compound (1) of the present invention, solubility of a specific polymer (A) of the present invention to a solvent or coating property of a liquid crystal alignment treatment agent, liquid crystal alignment property as a liquid crystal alignment film, and voltage retention From the viewpoint of characteristics such as rate and charge accumulation, one type or two types or more may be used in combination.

本發明之特定聚合物(B),為具有特定結構(2)之聚合物。 The specific polymer (B) of the present invention is a polymer having a specific structure (2).

將本發明之特定結構(2)導入特定聚合物(B)中之方法,並未有特別之限定,又以使用具有特定結構(2)之二胺化合物為佳。特佳為使用具有前述式〔2〕所示之結構的二胺化合物。 The method of introducing the specific structure (2) of the present invention into the specific polymer (B) is not particularly limited, and it is preferred to use a diamine compound having a specific structure (2). It is particularly preferred to use a diamine compound having the structure represented by the above formula [2].

具體而言,以使用下述式〔2-1〕所示二胺化合物(亦稱為特定二胺化合物(2))為佳。 Specifically, a diamine compound (also referred to as a specific diamine compound (2)) represented by the following formula [2-1] is preferably used.

式〔2-1〕中,YA表示具有前述式〔2〕所示之結構之有機基。 In the formula [2-1], Y A represents an organic group having a structure represented by the above formula [2].

式〔2-1〕中,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基。 In the formula [2-1], A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

更具體而言,以使用下述式〔2a〕所示二胺 化合物為佳。 More specifically, the diamine represented by the following formula [2a] is used. The compound is preferred.

式〔2a〕中,Y1及Y7各自獨立表示單鍵、碳數1~10之伸烷基、-O-、-S-、-N(R1)-(R1表示氫原子或碳數1~3之伸烷基)、-CON(R2)-(R2表示氫原子或碳數1~3之伸烷基)、-N(R3)CO-(R3表示氫原子或碳數1~3之伸烷基)、-CH2O-、-COO-及-OCO-所選出之至少1種的有機基。其中,又以單鍵、-O-、-S-、-OCO-或-COO-為佳。更佳為,就液晶配向性與膜硬度等觀點,以使用盡可能柔軟,且具有更小立體障礙的結構之單鍵、-O-或-S-為佳。 In the formula [2a], Y 1 and Y 7 each independently represent a single bond, an alkylene group having 1 to 10 carbon atoms, -O-, -S-, -N(R 1 )- (R 1 represents a hydrogen atom or carbon. a number 1 to 3 alkylene), -CON(R 2 )- (R 2 represents a hydrogen atom or a C 1 to 3 alkyl group), -N(R 3 )CO- (R 3 represents a hydrogen atom or At least one organic group selected from the group consisting of a C 1 to 3 alkyl group, -CH 2 O-, -COO-, and -OCO-. Among them, a single bond, -O-, -S-, -OCO- or -COO- is preferred. More preferably, from the viewpoints of liquid crystal alignment and film hardness, it is preferred to use a single bond of a structure which is as soft as possible and has a smaller steric hindrance, -O- or -S-.

式〔2a〕中,Y2及Y6各自獨立表示碳數1~10之伸烷基。其中,又以碳數1~3之伸烷基為佳,其結構可為直鏈或支鏈之任一者皆可。具體而言,就液晶配向性與液晶配向膜之膜硬度等觀點,以具有自由迴轉部位,且立體障礙較小的結構之伸甲基(-CH2-)、伸乙基(-CH2CH2-)、伸丙基(-(CH2)3-)或異丙基(-C(CH2)2-)為佳。 In the formula [2a], Y 2 and Y 6 each independently represent an alkylene group having 1 to 10 carbon atoms. Among them, an alkylene group having 1 to 3 carbon atoms is preferred, and the structure may be either linear or branched. Specifically, from the viewpoints of the liquid crystal alignment property and the film hardness of the liquid crystal alignment film, a methyl group (-CH 2 -) or an extended ethyl group (-CH 2 CH) having a structure having a freely rotating portion and having a small steric hindrance is preferable. 2 -), propyl (-(CH 2 ) 3 -) or isopropyl (-C(CH 2 ) 2 -) is preferred.

式〔2a〕中,Y3及Y5各自獨立表示氫原子或碳數1~10之烷基。其中,又以氫原子或碳數1~3之烷基為佳。特佳為氫原子。 In the formula [2a], Y 3 and Y 5 each independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms. Among them, a hydrogen atom or an alkyl group having 1 to 3 carbon atoms is preferred. Particularly preferred is a hydrogen atom.

式〔2a〕中,Y4表示氧原子或硫原子。其 中,就液晶配向膜之膜硬度之觀點,又以氧原子為佳。 In the formula [2a], Y 4 represents an oxygen atom or a sulfur atom. Among them, in view of the film hardness of the liquid crystal alignment film, an oxygen atom is preferred.

式〔2a〕中Y1、Y2、Y3、Y4、Y5、Y6及Y7之較佳組合,例如,下述表1所示之內容。 Preferred combinations of Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 and Y 7 in the formula [2a] are, for example, those shown in Table 1 below.

其中,又以式〔2-1a〕、式〔2-2a〕、式[2-4a]、式〔2-5a〕、式[2-7a]及式〔2-8a〕所示組合為佳。 Among them, the combination of the formula [2-1a], the formula [2-2a], the formula [2-4a], the formula [2-5a], the formula [2-7a], and the formula [2-8a] is preferred. .

式〔2a〕中,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基。 In the formula [2a], A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms.

本發明之特定二胺化合物(2)之具體的二胺化合物,可列舉如,下述式〔2-1a〕~式〔2-3a〕所示二胺化合物。 Specific examples of the specific diamine compound of the specific diamine compound (2) of the present invention include a diamine compound represented by the following formula [2-1a] to formula [2-3a].

(式〔2-1a〕~式〔2-3a〕中,A1~A6各自獨立表示氫原子或碳數1~5之伸烷基)。 (In the formula [2-1a] to the formula [2-3a], A 1 to A 6 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms).

本發明之特定聚合物(B)中之特定二胺化合物(2),相對於全部的二胺成份100莫耳%,以1莫耳%~95莫耳%為佳。其中,又以5莫耳%~95莫耳%為佳。更佳為20莫耳%~80莫耳%。 The specific diamine compound (2) in the specific polymer (B) of the present invention is preferably from 1 mol% to 95 mol% based on 100 mol% of the total diamine component. Among them, it is preferably 5 mol% to 95 mol%. More preferably 20% by mole to 80% by mole.

本發明之特定二胺化合物(2),就本發明之特定聚合物(B)對溶劑之溶解性或液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶配向性、電壓保持率、蓄積電荷等特性之觀點,可將1種類或2種類以上混合使用。 Specific diamine compound (2) of the present invention, solubility of a specific polymer (B) of the present invention to a solvent or coating property of a liquid crystal alignment treatment agent, liquid crystal alignment property as a liquid crystal alignment film, and voltage retention From the viewpoint of characteristics such as rate and charge accumulation, one type or two types or more may be used in combination.

本發明之特定聚合物(A)及特定聚合物(B)之至少任一者,為含有特定側鏈結構。 At least one of the specific polymer (A) and the specific polymer (B) of the present invention contains a specific side chain structure.

將本發明之特定側鏈結構導入特定聚合物(A)或特定聚合物(B)中之方法,並未有特別之限定,又以使用具有特定側鏈結構的二胺化合物作為二胺成份使用為佳。 The method of introducing the specific side chain structure of the present invention into the specific polymer (A) or the specific polymer (B) is not particularly limited, and a diamine compound having a specific side chain structure is used as the diamine component. It is better.

具體而言,以使用下述式〔3a〕所示二胺化合物(亦稱為特定側鏈型二胺化合物)為佳。 Specifically, a diamine compound (also referred to as a specific side chain type diamine compound) represented by the following formula [3a] is preferably used.

式〔3a〕中,B表示前述式〔3〕。又,式〔3〕中之B1~B6及n之較佳組合,係如前述內容。 In the formula [3a], B represents the above formula [3]. Further, a preferred combination of B 1 to B 6 and n in the formula [3] is as described above.

式〔3a〕中,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基。其中,又以氫原子或碳數1或2之伸烷基為佳。 In the formula [3a], A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms. Among them, a hydrogen atom or an alkylene group having 1 or 2 carbon atoms is preferred.

式〔3a〕中,m表示1~4之整數。其中,又以1為佳。 In the formula [3a], m represents an integer of 1 to 4. Among them, 1 is better.

本發明之特定側鏈型二胺化合物,具體而言,例如下述式〔3a-1〕~式〔3a-31〕所示二胺化合物,此外,又如該些胺基為二級胺基的二胺化合物等。 Specifically, the specific side chain type diamine compound of the present invention is, for example, a diamine compound represented by the following formula [3a-1] to formula [3a-31], and further, such an amine group is a secondary amine group. Diamine compounds and the like.

(式〔3a-1〕~式〔3a-3〕中,R1、R3及R5各自獨立表示-O-、-OCH2-、-CH2O-、-COOCH2-或-CH2OCO-,式〔3a-1〕~式〔3a-3〕中,R2、R4及R6各自獨立表示碳數1~22之直鏈狀或支鏈狀伸烷基、碳數1~22之直鏈狀或支鏈狀烷氧基、碳數1~22之直鏈狀或支鏈狀含氟伸烷基或含氟烷氧基)。 (In the formula [3a-1] to the formula [3a-3], R 1 , R 3 and R 5 each independently represent -O-, -OCH 2 -, -CH 2 O-, -COOCH 2 - or -CH 2 OCO-, in the formula [3a-1] to the formula [3a-3], R 2 , R 4 and R 6 each independently represent a linear or branched alkyl group having 1 to 22 carbon atoms and a carbon number of 1~. a linear or branched alkoxy group of 22, a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms or a fluorine-containing alkoxy group).

(式〔3a-4〕~式〔3a-6〕中,R1、R3及R5各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-或-CH2-,式〔3a-4〕~式〔3a-6〕中,R2、R4及R6各自獨立表示碳數1~22之直鏈狀或支鏈狀伸烷基、碳數1~22之直鏈狀或支鏈狀烷氧基、碳數1~22之直鏈狀或支鏈狀含氟伸烷基或含氟烷氧基)。 (In the formula [3a-4] to the formula [3a-6], R 1 , R 3 and R 5 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O-, -OCH 2 - or -CH 2 -, in the formula [3a-4] to the formula [3a-6], R 2 , R 4 and R 6 each independently represent a carbon number of 1~ a linear or branched alkyl group of 22, a linear or branched alkoxy group having 1 to 22 carbon atoms, a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms or Fluoroalkoxy).

(式〔3a-7〕及式〔3a-8〕中,R1及R3各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-、-CH2-、-O-或-NH-,R2及R4各自獨立表示氟基、氰基、三氟甲烷基、硝基、偶氮基、甲醯基、乙醯基、乙醯氧基或羥基)。 (In the formula [3a-7] and the formula [3a-8], R 1 and R 3 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO- , -CH 2 O-, -OCH 2 -, -CH 2 -, -O- or -NH-, R 2 and R 4 each independently represent a fluoro group, a cyano group, a trifluoromethyl group, a nitro group, an azo group , formazan, acetyl, ethoxy or hydroxy).

(式〔3a-9〕及式〔3a-10〕中,R1及R2各自獨立表示碳數3~12之直鏈狀或支鏈狀伸烷基,有關1,4-伸環己基的順-反式異構性,其分別為反式異構物)。 (In the formula [3a-9] and the formula [3a-10], R 1 and R 2 each independently represent a linear or branched alkyl group having a carbon number of 3 to 12, and a 1,4-cyclohexylene group. Cis-trans isomerism, which are each a trans isomer).

(式〔3a-11〕及式〔3a-12〕中,R1及R2各自獨立表示碳數3~12之直鏈狀或支鏈狀伸烷基,有關1,4-伸環己基的順-反式異構性,其分別為反式異構物)。 (In the formula [3a-11] and the formula [3a-12], R 1 and R 2 each independently represent a linear or branched alkyl group having a carbon number of 3 to 12, and a 1,4-cyclohexylene group. Cis-trans isomerism, which are each a trans isomer).

(式〔1a-13〕中,A4為可被氟原子所取代之碳數3~20之直鏈狀或支鏈狀烷基,A3為1,4-環伸己基或1,4-伸苯基,A2為氧原子或-COO-*(其中,附有「*」之鍵結鍵為與A3鍵結),A1為氧原子或-COO-*(其中,附有「*」之鍵結鍵為與(CH2)a2)鍵結)。又,a1為0或1之整數,a2為2~10之整數,a3為0或1之整數)。 (In the formula [1a-13], A 4 is a linear or branched alkyl group having 3 to 20 carbon atoms which may be substituted by a fluorine atom, and A 3 is a 1,4-cyclohexyl group or 1,4- Phenyl is extended, A 2 is an oxygen atom or -COO-* (wherein the bond with "*" is bonded to A 3 ), and A 1 is an oxygen atom or -COO-* (where " The bond key of *" is bonded to (CH 2 )a 2 )). Further, a 1 is an integer of 0 or 1, a 2 is an integer of 2 to 10, and a 3 is an integer of 0 or 1.

上述式〔3a-1〕~〔3a-31〕中,具有特佳結構之二胺化合物,可列舉如,式〔3a-1〕~式〔3a-6〕、式〔3a-9〕~式〔3a-13〕或式〔3a-22〕~式〔3a-31〕。 In the above formulas [3a-1] to [3a-31], the diamine compound having a particularly preferred structure may, for example, be a formula [3a-1] to a formula [3a-6] or a formula [3a-9]. [3a-13] or formula [3a-22]~[3a-31].

本發明之特定側鏈型二胺化合物,可使用特定聚合物(A)及特定聚合物(B)中之至少任一種,或使用二者之特定聚合物亦可。其中,又以使用特定聚合物(A)者為佳。 The specific side chain type diamine compound of the present invention may be at least one of a specific polymer (A) and a specific polymer (B), or a specific polymer using the same. Among them, it is preferred to use a specific polymer (A).

本發明之特定聚合物(A)及/或特定聚合物(B)中之特定側鏈型二胺化合物,以佔二胺成份全體的10莫耳%以上、80莫耳%以下為佳。特佳為10莫耳%以上、70莫耳%以下。 The specific side chain type diamine compound in the specific polymer (A) and/or the specific polymer (B) of the present invention is preferably 10 mol% or more and 80 mol% or less of the entire diamine component. It is particularly preferably 10 mol% or more and 70 mol% or less.

本發明之特定側鏈型二胺化合物,就本發明之特定聚合物(A)及特定聚合物(B)對溶劑之溶解性,或液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、蓄積電荷等特性之觀點,而可使用1種類或將2種類以上混合使用。 The specific side chain type diamine compound of the present invention, the solubility of the specific polymer (A) and the specific polymer (B) of the present invention with respect to a solvent, or the coating property of a liquid crystal alignment treatment agent, as a liquid crystal alignment film From the viewpoints of characteristics such as alignment property, voltage holding ratio, and accumulated charge of the liquid crystal, one type or two types or more may be used in combination.

本發明之特定聚合物(A)及特定聚合物(B)之二胺成份,於未損害本發明之效果的範圍內,可使用特定二胺化合物(1)、特定二胺化合物(2)及特定側鏈型二胺化合物以外的其他二胺化合物(亦稱為其他二胺化合物)。 The specific diamine component (1), the specific diamine compound (2), and the specific diamine component (2) of the specific polymer (A) of the present invention and the specific polymer (B) can be used within a range not impairing the effects of the present invention. Other diamine compounds other than the specific side chain type diamine compound (also referred to as other diamine compounds).

具體而言,例如,2,4-二甲基-m-伸苯基二胺、2,6-二胺基甲苯、m-伸苯基二胺、p-伸苯基二胺、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二羧基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-聯苯基、3,3’-三氟甲基-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺基二苯醚、3,3’-二胺基二苯醚、3,4’-二胺基二苯醚、2,2’-二胺基二苯醚、2,3’-二胺基二苯醚、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽烷、雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基苯基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫代二苯胺、3,3’-硫代二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺基二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺、2,3’-二胺基二苯基胺、N-甲基(4,4’-二胺基二苯基)胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、N-甲基(2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯 甲酮、1,4-二胺基萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基萘、1,2-雙(4-胺基苯基)乙烷、1,2-雙(3-胺基苯基)乙烷、1,3-雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯、1,3-雙(4-胺基苯氧基)苯、4,4’-〔1,4-伸苯基雙(伸甲基)〕二苯胺、4,4’-〔1,3-伸苯基雙(伸甲基)〕二苯胺、3,4’-〔1,4-伸苯基雙(伸甲基)〕二苯胺、3,4’-〔1,3-伸苯基雙(伸甲基)〕二苯胺、3,3’-〔1,4-伸苯基雙(伸甲基)〕二苯胺、3,3’-〔1,3-伸苯基雙(伸甲基)〕二苯胺、1,4-伸苯基雙〔(4-胺基苯基)甲酮〕、1,4-伸苯基雙〔(3-胺基苯基)甲酮〕、1,3-伸苯基雙〔(4-胺基苯基)甲酮〕、1,3-伸苯基雙〔(3-胺基苯基)甲酮〕、1,4-伸苯基雙(4-胺基苯甲酸酯)、1,4-伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙(4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺基苯基)間苯二甲酸酯、N,N’-(1,4-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,4-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-雙(4-胺基苯基)對 酞醯胺、N,N’-雙(3-胺基苯基)對酞醯胺、N,N’-雙(4-胺基苯基)間酞醯胺、N,N’-雙(3-胺基苯基)間酞醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺基苯氧基)二苯基碸、2,2’-雙〔4-(4-胺基苯氧基)苯基〕丙烷、2,2’-雙〔4-(4-胺基苯氧基)苯基〕六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙(4-胺基苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、1,3-雙(4-胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-(3-胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-(4-胺基苯氧基)癸烷、1,10-(3-胺基苯氧基)癸烷、1,11-(4-胺基苯氧基)十一烷、1,11-(3-胺基苯氧基)十一烷、1,12-(4-胺基苯氧基)十二烷、1,12-(3-胺基苯氧基)十二烷、雙(4-胺基環己基)甲烷、雙(4-胺基-3-甲基環己基)甲烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、1,11-二胺基十一烷或1,12-二胺基十二烷,此外,又如該些之胺基為二級胺基的二胺化合物等。 Specifically, for example, 2,4-dimethyl-m-phenylenediamine, 2,6-diaminotoluene, m-phenylenediamine, p-phenylenediamine, 4,4 '-Diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3 , 3'-dihydroxy-4,4'-diaminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,3'-difluoro-4,4'- Biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2 '-Diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'- Diaminodiphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 3,3' -diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'-diaminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4'-sulfonate Mercaptodiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl-bis(4-aminophenyl) ) decane, dimethyl-bis(3-aminophenyl)decane, 4,4'- Diphenylamine, 3,3'-thiodiphenylamine, 4,4'-diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4'-diaminodiphenyl Amine, 2,2'-diaminodiphenylamine, 2,3'-diaminodiphenylamine, N-methyl(4,4'-diaminodiphenyl)amine, N- Methyl (3,3'-diaminodiphenyl)amine, N-methyl(3,4'-diaminodiphenyl)amine, N-methyl (2,2'-diaminodiyl) Phenyl)amine, N-methyl(2,3'-diaminodiphenyl)amine, 4,4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminodiphenyl Methyl ketone, 1,4-diaminonaphthalene, 2,2'-diaminobenzophenone, 2,3'-diaminobenzophenone, 1,5-diaminonaphthalene, 1,6 -diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene , 2,8-diaminonaphthalene, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(3-aminophenyl)ethane, 1,3-bis(4- Aminophenyl)propane, 1,3-bis(3-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl) Butane, bis(3,5-diethyl-4-aminophenyl)methane, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminobenzene) Oxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'-[1,4-phenylenebis(methyl)diphenylamine, 4,4'-[1,3-stretch Phenyl bis(methyl)diphenylamine, 3,4'-[1,4-phenylenebis(methyl)diphenylamine, 3,4'-[1,3-phenylene bis( Methyl)]diphenylamine, 3,3'-[1,4-phenylenebis(methyl)diphenylamine, 3,3'-[1,3-phenylene bis(methyl) Diphenylamine, 1,4-phenylene bis[(4-amino) Methyl ketone], 1,4-phenylene bis[(3-aminophenyl)methanone], 1,3-phenylene bis[(4-aminophenyl)methanone], 1, 3-phenylphenylbis[(3-aminophenyl)methanone], 1,4-phenylphenylbis(4-aminobenzoate), 1,4-phenylene bis(3-amine) Benzoate), 1,3-phenylene bis(4-aminobenzoate), 1,3-phenylene bis(3-aminobenzoate), bis(4-amine Phenylphenyl) terephthalate, bis(3-aminophenyl)terephthalate, bis(4-aminophenyl)isophthalate, bis(3-aminobenzene) Isophthalate, N,N'-(1,4-phenylene)bis(4-aminobenzamide), N,N'-(1,3-phenylene) double (4-Aminobenzamide), N,N'-(1,4-phenylene)bis(3-aminobenzamide), N,N'-(1,3-phenylene) Bis(3-aminobenzamide), N,N'-bis(4-aminophenyl) pair Indoleamine, N,N'-bis(3-aminophenyl)-p-amine, N,N'-bis(4-aminophenyl) meta-amine, N,N'-double (3 -aminophenyl)m-decylamine, 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy)diphenylanthracene, 2,2' - bis[4-(4-aminophenoxy)phenyl]propane, 2,2'-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2'-double (4-Aminophenyl)hexafluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amino-4-methylphenyl)hexa Fluoropropane, 2,2'-bis(4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'-bis(3-amino-4-methyl Phenyl)propane, 1,3-bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1,4-bis(4-aminophenoxyl) Butane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1,5-bis(3-aminobenzene Oxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-amino group Phenoxy)heptane, 1,7-(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-amino Phenoxy)octane, 1,9-bis(4-amino group Oxy) decane, 1,9-bis(3-aminophenoxy)decane, 1,10-(4-aminophenoxy)decane, 1,10-(3-aminophenoxyl) Base) decane, 1,11-(4-aminophenoxy)undecane, 1,11-(3-aminophenoxy)undecane, 1,12-(4-aminophenoxyl Dodecane, 1,12-(3-aminophenoxy)dodecane, bis(4-aminocyclohexyl)methane, bis(4-amino-3-methylcyclohexyl)methane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1 , 8-diaminooctane, 1,9-diaminodecane, 1,10-diaminodecane, 1,11-diaminoundecane or 1,12-diaminododecane Further, as the above, the amine group is a secondary amine group-containing diamine compound or the like.

此外,亦可使用二胺化合物中,具有羧基 (COOH基)或羥基(OH基)的二胺化合物。 In addition, a diamine compound may also be used, which has a carboxyl group. A diamine compound (COOH group) or a hydroxyl group (OH group).

具體而言,例如,2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄醇、2,4-二胺基苄醇、4,6-二胺基間苯二酚、2,4-二胺基安息香酸、2,5-二胺基安息香酸或3,5-二胺基安息香酸等。其中,又以2,4-二胺基安息香酸、2,5-二胺基安息香酸或3,5-二胺基安息香酸為佳。又,亦可使用下述式〔3b-1〕~式〔3b-4〕所示二胺化合物及該些之胺基為二級胺基之二胺化合物。 Specifically, for example, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diamine Resorcinol, 2,4-diaminobenzoic acid, 2,5-diamino benzoic acid or 3,5-diamino benzoic acid. Among them, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid or 3,5-diaminobenzoic acid is preferred. Further, a diamine compound represented by the following formula [3b-1] to formula [3b-4] and a diamine compound in which the amine group is a secondary amine group can also be used.

(式〔3b-1〕中,A1表示單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)2-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-,m1及m2各自獨立表示0~4之整數,且m1+m2表示1~4之整數,式〔3b-2〕中,m3及m4各自獨立表示1~5之整數,式〔3b-3〕 中,A2表示碳數1~5之直鏈或支鏈狀伸烷基,m5表示1~5之整數,式〔3b-4〕中,A3及A4各自獨立表示單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)2-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-,m6表示1~4之整數)。 (In the formula [3b-1], A 1 represents a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 ) 2 -, -O-, -CO-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -CON( CH 3 )- or -N(CH 3 )CO-, m 1 and m 2 each independently represent an integer of 0 to 4, and m 1 + m 2 represents an integer of 1 to 4, in the formula [3b-2], m 3 and m 4 each independently represent an integer of 1 to 5, and in the formula [3b-3], A 2 represents a linear or branched alkyl group having 1 to 5 carbon atoms, and m 5 represents an integer of 1 to 5, In [3b-4], A 3 and A 4 each independently represent a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 ). 2 -, -O-, -CO-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -CON(CH 3 )- or -N(CH 3 )CO-, m 6 represents an integer from 1 to 4).

此外,二胺化合物中,亦可使用具有下述式〔3c〕所示含氮雜環之二胺化合物及該些之胺基為二級胺基之二胺化合物。 Further, as the diamine compound, a diamine compound having a nitrogen-containing hetero ring represented by the following formula [3c] and a diamine compound in which the amine group is a secondary amine group can also be used.

式〔3c〕中,D1表示-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-或-N(CH3)CO-。其中,又以-O-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-或-N(CH3)CO-,就容易合成二胺化合物等,而為較佳。更佳者為-O-、-NH-、-CONH-、-NHCO-、-CH2O-、-OCO-或-CON(CH3)-。特佳為-O-、-CONH-或-CH2O-。 In the formula [3c], D 1 represents -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, -CON(CH 3 )-. Or -N(CH 3 )CO-. Among them, -O-, -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCO-, -CON(CH 3 )- or -N(CH 3 )CO- are easy to synthesize. A diamine compound or the like is preferred. More preferably, it is -O-, -NH-, -CONH-, -NHCO-, -CH 2 O-, -OCO- or -CON(CH 3 )-. Particularly preferred is -O-, -CONH- or -CH 2 O-.

式〔3c〕中,D2表示單鍵、碳數1~20之脂肪族烴基、非芳香族環式烴基或芳香族烴基。 In the formula [3c], D 2 represents a single bond, an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic cyclic hydrocarbon group or an aromatic hydrocarbon group.

碳數1~20之脂肪族烴基,可為直鏈狀亦 可、分支者亦可。又,亦可具有不飽和鍵結。其中,又以碳數1~10之伸烷基為佳。 An aliphatic hydrocarbon group having 1 to 20 carbon atoms, which may be linear Yes, branchers can also. Also, it may have an unsaturated bond. Among them, an alkylene group having a carbon number of 1 to 10 is preferred.

非芳香族烴基之具體例,例如,環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、環辛烷環、環壬烷環、環癸烷環、環十一烷環、環十二烷環、環十三烷環、環十四烷環、環十五烷環、環十六烷環、環十七烷環、環十八烷環、環十九烷環、環二十烷環、三環二十一烷環、三環二十二烷環、雙環庚烷環、十氫萘環、降莰烯環或金剛烷環等。其中,又以環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、降莰烯環或金剛烷環為佳。 Specific examples of the non-aromatic hydrocarbon group, for example, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a cyclooctane ring, a cyclodecane ring, a cyclodecane ring, and a ring Undecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, ring nineteen An alkane ring, a cyclohexadecane ring, a tricyclohexadecane ring, a tricyclotetracosane ring, a bicycloheptane ring, a decahydronaphthalene ring, a norbornene ring or an adamantane ring. Among them, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a norbornene ring or an adamantane ring is preferred.

芳香族烴基之具體例,例如,苯環、萘環、四氫萘環、薁環、茚環、茀環、蒽環、菲環或萉環等。其中,又以苯環、萘環、四氫萘環、茀環或蒽環為佳。 Specific examples of the aromatic hydrocarbon group include a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an anthracene ring, an anthracene ring, an anthracene ring, an anthracene ring, a phenanthrene ring or an anthracene ring. Among them, a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an anthracene ring or an anthracene ring is preferred.

式〔3c〕中之較佳的D2,例如,單鍵、碳數1~10之伸烷基、環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環、降莰烯環、金剛烷環、苯環、萘環、四氫萘環、茀環或蒽環。其中,又以單鍵、碳數1~5之伸烷基、環己烷環或苯環為佳。 Preferred D 2 in the formula [3c], for example, a single bond, an alkylene group having 1 to 10 carbon atoms, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring , a norbornene ring, an adamantane ring, a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an anthracene ring or an anthracene ring. Among them, a single bond, an alkylene group having 1 to 5 carbon atoms, a cyclohexane ring or a benzene ring is preferred.

式〔3c〕中,D3表示單鍵、-O-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-、-O(CH2)m-(m為1~5之整數)。其中,又以單鍵、-O-、-COO-、-OCO-或-O(CH2)m-(m為1~5之整數)為佳。更佳者為單鍵、-O-、-OCO-或-O(CH2)m-(m為1~5之整數)。 In the formula [3c], D 3 represents a single bond, -O-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -COO-, -OCO-, -CON(CH 3 ). -or-N(CH 3 )CO-, -O(CH 2 ) m - (m is an integer from 1 to 5). Among them, a single bond, -O-, -COO-, -OCO- or -O(CH 2 ) m - (m is an integer of 1 to 5) is preferred. More preferably, it is a single bond, -O-, -OCO- or -O(CH 2 ) m - (m is an integer of 1 to 5).

式〔3c〕中,D4為含氮芳香族雜環,可列舉如,含有由下述式[a〕、式〔b〕及式〔c〕所選出之至少1個之結構的芳香族雜環。 In the formula [3c], D 4 is a nitrogen-containing aromatic heterocyclic ring, and examples thereof include aromatic impurities having a structure selected from at least one of the following formulas [a], (b) and (c). ring.

(式〔c〕中,Z表示碳數1~5之伸烷基)。 (In the formula [c], Z represents an alkylene group having 1 to 5 carbon atoms).

更具體而言,例如,吡咯環、咪唑環、噁唑環、噻唑環、吡唑環、吡啶環、嘧啶環、喹啉環、吡唑啉環、異喹啉環、咔唑環、嘌呤環、噻二唑環、嗒環、吡唑啉環、三環、吡唑啶環、三唑環、吡環、苯併咪唑(Benzimidazole)環、苯併咪唑(Benzoimidazole)環、硫代喹啉環、啡啉(phenanthroline)環、吲哚環、喹噁啉(quinoxaline)環、苯併噻唑環、啡噻(phenothiazine)環、噁二唑環或吖啶環等。其中,又以吡咯環、咪唑環、吡唑環、吡啶環、嘧啶環、嗒環、三環、三唑環、吡環、苯併咪唑(Benzimidazole)環或苯併咪唑(Benzoimidazole)環為佳。更佳者為吡咯環、咪唑環、吡唑環、吡啶環或嘧啶環。 More specifically, for example, a pyrrole ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a quinoline ring, a pyrazoline ring, an isoquinoline ring, an indazole ring, an anthracene ring Thiadiazole ring, hydrazine Ring, pyrazoline ring, three Ring, pyrazolidine ring, triazole ring, pyridyl Benzimidazole ring, Benzoimidazole ring, thioquinoline ring, phenanthroline ring, anthracene ring, quinoxaline ring, benzothiazole ring, phenothiazine (phenothiazine) ring, oxadiazole ring or acridine ring. Among them, pyrrole ring, imidazole ring, pyrazole ring, pyridine ring, pyrimidine ring, hydrazine Ring, three Ring, triazole ring, pyridyl A ring, a Benzimidazole ring or a Benzoimidazole ring is preferred. More preferably, it is a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring or a pyrimidine ring.

又,式〔3c〕中之D3,以與D4所含之式〔a〕、式〔b〕及式[c]不相鄰的取代基鍵結者為佳。 Further, D 3 in the formula [3c] is preferably a bond which is not adjacent to the substituent of the formula [a], the formula [b] and the formula [c] contained in D 4 .

式〔3c〕中,n為1~4之整數,較佳就與四羧酸成份之反應性而言,為1或2。 In the formula [3c], n is an integer of 1 to 4, preferably 1 or 2 in terms of reactivity with the tetracarboxylic acid component.

式〔3c〕中特佳之D1~D4及n之組合為,D1表示-CONH-,D2表示碳數1~5之烷基,D3表示單鍵,D4表示咪唑環或吡啶環,n表示1的二胺化合物。 The combination of D 1 to D 4 and n in the formula [3c] is such that D 1 represents -CONH-, D 2 represents an alkyl group having 1 to 5 carbon atoms, D 3 represents a single bond, and D 4 represents an imidazole ring or a pyridine. Ring, n represents a diamine compound of 1.

式〔3c〕中,二個胺基(-NH2)之鍵結位置並未有特別之限定。具體而言,例如,相對於側鏈之鍵結基(B1)而言,為苯環上之2,3的位置、2,4的位置、2,5的位置、2,6的位置、3,4的位置或3,5的位置等。其中,就合成聚醯胺酸之際的反應性之觀點,以2,4的位置、2,5的位置或3,5的位置為佳。若再考量合成二胺化合物之際的容易性時,又以2,4的位置或2,5的位置為更佳。 In the formula [3c], the bonding position of the two amine groups (-NH 2 ) is not particularly limited. Specifically, for example, the bonding group (B 1 ) with respect to the side chain is a position of 2, 3 on the benzene ring, a position of 2, 4, a position of 2, 5, a position of 2, 6, 3, 4 position or 3, 5 position, etc. Among them, from the viewpoint of the reactivity at the time of synthesizing polyglycine, the position of 2, 4, the position of 2, 5, or the position of 3, 5 is preferable. Further, when the ease of synthesizing the diamine compound is considered, the position of 2, 4 or the position of 2, 5 is more preferable.

此外,其他二胺化合物,亦可使用下述式〔3d-1〕~式〔3d-13〕所示二胺化合物及該些之胺基為二級胺基之二胺化合物。 Further, as the other diamine compound, a diamine compound represented by the following formula [3d-1] to formula [3d-13] and a diamine compound in which the amine group is a secondary amine group can also be used.

(式〔3d-1〕~式〔3d-4〕中,A1~A4各自獨立表示碳數1~22之伸烷基或含氟伸烷基)。 (In the formula [3d-1] to the formula [3d-4], A 1 to A 4 each independently represent an alkylene group having 1 to 22 carbon atoms or a fluorine-containing alkyl group).

(式〔3d-5〕中,A1及A3各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,A2表示碳數1~22之直鏈狀或支鏈狀之伸烷基或碳數1~22之直鏈狀或支鏈狀的含氟伸烷基,式〔3d-6〕中,A4及A6各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,A5表示碳數1~22之直鏈狀或支鏈狀之伸烷基或碳數1~22之直鏈狀或支鏈狀的含氟伸烷基)。 (In the formula [3d-5], A 1 and A 3 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, A 2 represents a linear or branched alkyl group having 1 to 22 carbon atoms or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms, and in the formula [3d-6], A 4 and A 6 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, and A 5 represents a carbon number of 1 to 22 A chain or branched alkyl group or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms.

(式〔3d-7〕中,A1及A3各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,A2表示碳數1~22之直鏈狀或支鏈狀之伸烷基或碳數1~22之直鏈狀或支鏈狀的含氟伸烷基,式〔3d-8〕中,A4 及A6各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,A5表示碳數1~22之直鏈狀或支鏈狀之伸烷基或碳數1~22之直鏈狀或支鏈狀的含氟伸烷基)。 (In the formula [3d-7], A 1 and A 3 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, A 2 represents a linear or branched alkyl group having 1 to 22 carbon atoms or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms, in the formula [3d-8], A 4 and A 6 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, and A 5 represents a carbon number of 1 to 22 A chain or branched alkyl group or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms.

(式〔3d-9〕中,A1及A3各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,A2表示碳數1~22之直鏈狀或支鏈狀之伸烷基或碳數1~22之直鏈狀或支鏈狀的含氟伸烷基,式〔3d-10〕中,A4及A6各自獨立表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,A5表示碳數1~22之直鏈狀或支鏈狀之伸烷基或碳數1~22之直鏈狀或支鏈狀的含氟伸烷基)。 (In the formula [3d-9], A 1 and A 3 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, A 2 represents a linear or branched alkyl group having 1 to 22 carbon atoms or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms, in the formula [3d-10], A 4 and A 6 each independently represent -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, and A 5 represents a carbon number of 1 to 22 A chain or branched alkyl group or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms.

(式〔3d-11〕中,p表示1~10之整數)。 (In the formula [3d-11], p represents an integer of 1 to 10).

本發明之其他二胺化合物,就考量本發明之特定聚合物(A)及特定聚合物(B)對溶劑之溶解性或液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶配向性、電壓保持率、蓄積電荷等特性之觀點,可將1種類或2種類以上混合使用。 In the other diamine compound of the present invention, the solubility of the specific polymer (A) and the specific polymer (B) of the present invention with respect to the solvent or the coating property of the liquid crystal alignment treatment agent, and the liquid crystal in the case of the liquid crystal alignment film are considered. From the viewpoints of characteristics such as an orientation, a voltage holding ratio, and an accumulated charge, one type or two types or more may be used in combination.

本發明之特定聚合物(A)及特定聚合物(B),即,欲製作該些聚醯亞胺系聚合物時所使用的四羧酸成份者,以使用下述式〔4〕所示四羧酸二酐為佳。此時,不僅僅式〔4〕所示四羧酸二酐,亦可使用作為其四羧酸衍生物之四羧酸、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物(式〔4〕所示四羧酸二酐及其衍生物亦統稱為特定四羧酸成份)。 The specific polymer (A) and the specific polymer (B) of the present invention, that is, the tetracarboxylic acid component used in the production of the polyimine-based polymer, are represented by the following formula [4]. Tetracarboxylic dianhydride is preferred. In this case, not only the tetracarboxylic dianhydride represented by the formula [4] but also a tetracarboxylic acid, a tetracarboxylic acid dihalide compound, a dicarboxylic acid dialkyl ester compound or a tetracarboxylic acid as a tetracarboxylic acid derivative thereof may be used. The acid dialkyl ester dihalide compound (the tetracarboxylic dianhydride represented by the formula [4] and its derivative are also collectively referred to as a specific tetracarboxylic acid component).

(式〔4〕中,Z表示由下述式〔4a〕~式〔4k〕所示之結構所選出之至少1種的結構)。 (In the formula [4], Z represents a structure selected from at least one of the structures represented by the following formulas [4a] to [4k]).

式〔4a〕中,Z1~Z4表示氫原子、甲基、乙基、丙基、氯原子或苯環,其可分別為相同亦可、相異亦可。 In the formula [4a], Z 1 to Z 4 represent a hydrogen atom, a methyl group, an ethyl group, a propyl group, a chlorine atom or a benzene ring, and they may be the same or different.

式〔4g〕中,Z5及Z6表示氫原子或甲基,其可分別為相同亦可、相異亦可。 In the formula [4g], Z 5 and Z 6 represent a hydrogen atom or a methyl group, and they may be the same or different.

式〔4〕中之Z中,就合成之容易度或製造聚 合物時之聚合反應性之容易度的觀點,以式〔4a〕、式〔4c〕~式〔4g〕或式〔4k〕所示之結構之四羧酸二酐及其四羧酸衍生物為佳。更佳者為式〔4a〕或式〔4e〕~式〔4g〕所示之結構者。特佳為〔4a〕、式〔4e〕或式〔4f〕所示之結構之四羧酸二酐及其四羧酸衍生物。 In the Z in the formula [4], the ease of synthesis or the production of poly From the viewpoint of easiness of polymerization reactivity in the case of a compound, a tetracarboxylic dianhydride having a structure represented by the formula [4a], the formula [4c] to the formula [4g] or the formula [4k], and a tetracarboxylic acid derivative thereof It is better. More preferably, it is a structure represented by the formula [4a] or the formula [4e] to the formula [4g]. Particularly preferred are tetracarboxylic dianhydrides of the formula [4a], formula [4e] or formula [4f] and tetracarboxylic acid derivatives thereof.

本發明之特定聚合物(A)及特定聚合物(B)中之特定四羧酸成份,於全部的四羧酸成份100莫耳%中,以1莫耳%~100莫耳%為佳。其中,又以5莫耳%~95莫耳%為佳。更佳者為20莫耳%~80莫耳%。 The specific tetracarboxylic acid component in the specific polymer (A) and the specific polymer (B) of the present invention is preferably from 1 mol% to 100 mol% in 100 mol% of the total tetracarboxylic acid component. Among them, it is preferably 5 mol% to 95 mol%. More preferably, it is 20% by mole to 80% by mole.

本發明之特定四羧酸成份,於考量本發明之特定聚合物(A)及特定聚合物(B)對溶劑之溶解性,或液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶之配向性、電壓保持率、蓄積電荷等特性之觀點,可使用1種類或將2種類以上混合使用。 The specific tetracarboxylic acid component of the present invention is used in consideration of the solubility of the specific polymer (A) and the specific polymer (B) of the present invention in a solvent, or the coatability of a liquid crystal alignment treatment agent, as a liquid crystal alignment film. From the viewpoints of characteristics such as the alignment property of the liquid crystal, the voltage holding ratio, and the charge accumulation, one type or two types or more may be used in combination.

本發明之特定聚合物(A)及特定聚合物(B)的聚醯亞胺系聚合物中,於未損害本發明之效果的範圍內,亦可使用特定四羧酸成份以外的其他四羧酸成份。 In the polyamidene-based polymer of the specific polymer (A) and the specific polymer (B) of the present invention, other tetracarboxylic acids other than the specific tetracarboxylic acid component may be used within a range not impairing the effects of the present invention. Acidic ingredients.

其他的四羧酸成份,可列舉如,以下所示之四羧酸化合物、四羧酸二酐、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物等。 Examples of the other tetracarboxylic acid component include dicarboxylic acid compounds, tetracarboxylic dianhydrides, tetracarboxylic acid dihalide compounds, dicarboxylic acid dialkyl ester compounds or dicarboxylic acid dialkyl esters which are shown below. Compounds and the like.

即,其他之四羧酸成份,可列舉如,1,2,5,6-萘四羧酸、1,4,5,8-萘四羧酸、1,2,5,6-蒽四羧酸、3,3’,4,4’-聯苯基四羧酸、2,3,3’,4-聯苯基四羧酸、雙(3,4-二羧基苯基)醚、3,3’,4,4’-二苯甲酮四羧酸、雙(3,4-二羧 基苯基)碸、雙(3,4-二羧基苯基)甲烷、2,2-雙(3,4-二羧基苯基)丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷、雙(3,4-二羧基苯基)二甲基矽烷、雙(3,4-二羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧酸、2,6-雙(3,4-二羧基苯基)吡啶、3,3’,4,4’-二苯基碸四羧酸、3,4,9,10-苝四羧酸或1,3-二苯基-1,2,3,4-環丁烷四羧酸等。 That is, other tetracarboxylic acid components may, for example, be 1,2,5,6-naphthalenetetracarboxylic acid, 1,4,5,8-naphthalenetetracarboxylic acid, 1,2,5,6-nonanetetracarboxylic acid. Acid, 3,3',4,4'-biphenyltetracarboxylic acid, 2,3,3',4-biphenyltetracarboxylic acid, bis(3,4-dicarboxyphenyl)ether, 3, 3',4,4'-benzophenone tetracarboxylic acid, bis(3,4-dicarboxyl) Phenyl, bis(3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1,1,3,3,3-hexafluoro -2,2-bis(3,4-dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)dimethyl decane, bis(3,4-dicarboxyphenyl)diphenyl decane, 2,3,4,5-pyridinetetracarboxylic acid, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3',4,4'-diphenylphosphonium tetracarboxylic acid, 3, 4,9,10-decanetetracarboxylic acid or 1,3-diphenyl-1,2,3,4-cyclobutanetetracarboxylic acid or the like.

本發明之其他的四羧酸成份,於考量本發明之特定聚合物(A)及特定聚合物(B)對溶劑之溶解性或液晶配向處理劑之塗佈性、作為液晶配向膜之情形中的液晶配向性、電壓保持率、蓄積電荷等特性之觀點,可將1種類或2種類以上混合使用。 The other tetracarboxylic acid component of the present invention is considered as a liquid crystal alignment film in consideration of solubility of a specific polymer (A) and a specific polymer (B) of the present invention in a solvent or a coating property of a liquid crystal alignment agent. From the viewpoints of characteristics such as liquid crystal alignment, voltage holding ratio, and accumulated charge, one type or two types or more may be used in combination.

<特定聚合物(A)‧特定聚合物(B)之製作方法> <Specific Polymer (A) ‧ Specific Polymer (B) Production Method>

本發明中,特定聚合物(A)及特定聚合物(B),即,製作該些聚醯亞胺系聚合物所使用之方法並未有特別之限定。通常可由二胺成份與四羧酸成份反應而得。一般而言,為將由四羧酸二酐及其四羧酸之衍生物所成群中所選出之至少1種的四羧酸成份,與由1種或複數種的二胺化合物所成之二胺成份進行反應,而製得聚醯胺酸之方法等。具體而言,例如可使用使四羧酸二酐與一級或二級的二胺化合物進行聚縮合反應,而製得聚醯胺酸之方法、使四羧酸與一級或二級的二胺化合物進行脫水聚縮合反應而製得聚醯胺酸,或或使四羧酸二鹵化物與一級或二級的二胺化合物進行聚縮合反應,而製得聚醯胺酸之方法。 In the present invention, the specific polymer (A) and the specific polymer (B), that is, the method for producing the polyimine-based polymer are not particularly limited. It is usually obtained by reacting a diamine component with a tetracarboxylic acid component. In general, at least one tetracarboxylic acid component selected from the group consisting of tetracarboxylic dianhydride and a derivative of a tetracarboxylic acid thereof is the same as that of one or more kinds of diamine compounds. A method in which an amine component is reacted to obtain a polyamic acid. Specifically, for example, a method in which a tetracarboxylic dianhydride is subjected to a polycondensation reaction with a primary or secondary diamine compound to obtain a polyamic acid, a tetracarboxylic acid and a primary or secondary diamine compound can be used. A method of producing a poly-proline by performing a dehydration polycondensation reaction to obtain a poly-proline acid, or a polycondensation reaction of a tetracarboxylic acid dihalide with a primary or secondary diamine compound.

製得聚醯胺酸烷酯之方法中,例如可使用使羧酸基經二烷酯化而得之四羧酸與一級或二級的二胺化合物進行聚縮合之方法、使羧酸基經二烷酯化而得之四羧酸二鹵化物與一級或二級的二胺化合物進行聚縮合之方法或使聚醯胺酸的羧基變換為酯之方法。 In the method for producing a polyalkyl amide, for example, a method in which a tetracarboxylic acid obtained by dialkylating a carboxylic acid group is subjected to polycondensation with a primary or secondary diamine compound, and a carboxylic acid group can be used. A method of polycondensation of a dialkyl esterified tetracarboxylic acid dihalide with a primary or secondary diamine compound or a method of converting a carboxyl group of a polylysine to an ester.

製得聚醯亞胺之方法,例如可使用使前述聚醯胺酸或聚醯胺酸烷酯進行閉環反應以形成聚醯亞胺之方法。 As a method of producing a polyimine, for example, a method of subjecting the aforementioned polyamic acid or polyalkyl amide to a ring closure reaction to form a polyimine can be used.

二胺成份與四羧酸成份之反應,通常,為使二胺成份與四羧酸成份於溶劑中進行。此時所使用的溶劑,只要可使所生成的聚醯亞胺前驅體溶解之溶劑時,並未有特別之限定。下述內容中,將列舉反應所使用之溶劑的具體例,但並不僅限定於該些例示。 The reaction of the diamine component with the tetracarboxylic acid component is usually carried out in a solvent in which the diamine component and the tetracarboxylic acid component are carried out. The solvent to be used at this time is not particularly limited as long as it can dissolve the produced polyimide precursor. Specific examples of the solvent used in the reaction are listed below, but are not limited to the examples.

例如,N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮或γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸或1,3-二甲基-四氫咪唑酮等。又,聚醯亞胺前驅體的溶劑溶解性較高之情形,例如可使用甲基乙基酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮或下述式〔D-1〕~式〔D-3〕所示之溶劑。 For example, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone or γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamidine An amine, dimethyl hydrazine or 1,3-dimethyl-tetrahydroimidazolidone or the like. Further, in the case where the solvent solubility of the polyimide precursor is high, for example, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone or the following may be used. A solvent represented by the formula [D-1] to the formula [D-3].

(式〔D-1〕中,D1表示碳數1~3之伸烷基,式〔D-2〕中,D2表示碳數1~3之伸烷基,式〔D-3〕中,D3表示碳數1~4之伸烷基)。 (In the formula [D-1], D 1 represents an alkylene group having 1 to 3 carbon atoms, and in the formula [D-2], D 2 represents an alkylene group having 1 to 3 carbon atoms, and the formula [D-3] , D 3 represents an alkylene group having a carbon number of 1 to 4).

該些溶劑可單獨使用亦可、混合使用亦可。此外,即使為不溶解聚醯亞胺前驅體之溶劑,只要不會析出生成之聚醯亞胺前驅體之範圍,亦可與前述溶劑混合使用。又,溶劑中之水分為會阻礙聚合反應,甚至會造成生成之聚醯亞胺前驅體水解之原因,故溶劑以使用脫水乾燥者為佳。 These solvents may be used singly or in combination. Further, even if it is a solvent which does not dissolve the polyimide precursor, it may be used in combination with the solvent as long as it does not precipitate the range of the produced polyimide precursor. Further, the moisture in the solvent is a cause of hindering the polymerization reaction, and may even cause hydrolysis of the produced polyimide precursor. Therefore, it is preferred that the solvent be dehydrated and dried.

二胺成份與四羧酸成份於溶劑中進行反應之際,例如可使用,使二胺成份分散或溶解於溶劑的溶液於攪拌中,將四羧酸成份無處理下,或使其分散或溶解於溶劑下進行添加之方法,或相反地,於四羧酸成份分散於溶劑,或溶解所得之溶液中,添加二胺成份之方法、將二胺成份與四羧酸成份交互添加之方法等,上述任一種方法皆可使用。又,二胺成份或四羧酸成份分別使用複數種進行反應之情形,可以預先混合之狀態下進行反應亦可、各別依序進行反應亦可、將各別反應所得之低分子量體進行混合反應以製得之聚合物亦可。此時之聚合溫度可選擇於-20℃~150℃之任意溫度,較佳為-5℃~100℃之範圍。又,反應可於任意濃度下進行亦可,但濃度過低時將不易得到高分子量的聚合物,濃度過高時,因反應液的黏性過高而不易進行均勻的攪拌。因此,較佳為1~50質量%, 更佳為5~30質量%。也可以在反應初期以高濃度進行,其後再追加溶劑亦可。 When the diamine component and the tetracarboxylic acid component are reacted in a solvent, for example, a solution in which a diamine component is dispersed or dissolved in a solvent may be used, and the tetracarboxylic acid component may be left untreated or dispersed or dissolved. a method of adding in a solvent, or conversely, a method in which a tetracarboxylic acid component is dispersed in a solvent or dissolved, a method of adding a diamine component, a method of mutually adding a diamine component and a tetracarboxylic acid component, and the like, Any of the above methods can be used. Further, when a plurality of kinds of diamine components or tetracarboxylic acid components are used for the reaction, the reaction may be carried out in a state of being mixed in advance, or the respective reactions may be carried out in sequence, and the low molecular weight bodies obtained by the respective reactions may be mixed. The reaction can also be carried out to obtain a polymer. The polymerization temperature at this time may be selected from any temperature of from -20 ° C to 150 ° C, preferably from -5 ° C to 100 ° C. Further, the reaction may be carried out at any concentration. However, when the concentration is too low, it is difficult to obtain a polymer having a high molecular weight. When the concentration is too high, the viscosity of the reaction liquid is too high to facilitate uniform stirring. Therefore, it is preferably 1 to 50% by mass, More preferably 5 to 30% by mass. It may be carried out at a high concentration in the initial stage of the reaction, and then a solvent may be added.

聚醯亞胺前驅體的聚合反應中,二胺成份的合計莫耳數與四羧酸成份的合計莫耳數之比,以0.8~1.2為佳。其與通常之聚縮合反應相同般,該莫耳比越趨近1.0時,所生成之聚醯亞胺前驅體的分子量越大。 In the polymerization reaction of the polyimine precursor, the ratio of the total number of moles of the diamine component to the total number of moles of the tetracarboxylic acid component is preferably 0.8 to 1.2. It is the same as the usual polycondensation reaction, and the closer the molar ratio is to 1.0, the larger the molecular weight of the resulting polyimine precursor.

本發明之聚醯亞胺為使前述聚醯亞胺前驅體經閉環而得之聚醯亞胺,此聚醯亞胺中,醯胺酸基之閉環率(亦稱為醯亞胺化率),並非必須為100%,而可配合用途或目的作任意的調整。 The polyimine of the present invention is a polyimine obtained by subjecting the polyimine precursor to ring closure, and the ring closure ratio of the proline group in the polyimine (also referred to as a ruthenium imidization ratio) It does not have to be 100%, but can be adjusted to suit the purpose or purpose.

使聚醯亞胺前驅體醯亞胺化之方法,可列舉如,使聚醯亞胺前驅體的溶液於無處理下進行加熱使其熱醯亞胺化,或於聚醯亞胺前驅體的溶液中添加觸媒而進行觸媒醯亞胺化之方法等。 The method for imidating the polyimine precursor oxime may, for example, be a method in which the solution of the polyimide precursor is heated to be imidized without treatment, or in the case of a polyimide precursor. A method in which a catalyst is added to a solution to carry out a catalyst oxime imidization.

使聚醯亞胺前驅體於溶液中進行熱醯亞胺之情形的溫度為100℃~400℃,較佳為120℃~250℃,又以將醯亞胺化反應所生成的水排除於反應系外之方式進行為佳。 The temperature at which the polyimine precursor is subjected to hot imine in a solution is from 100 ° C to 400 ° C, preferably from 120 ° C to 250 ° C, and the water formed by the ruthenium reaction is excluded from the reaction. It is better to do it outside the system.

聚醯亞胺前驅體之觸媒醯亞胺化為,將鹼性觸媒與酸酐添加於聚醯亞胺前驅體之溶液中,於-20℃~250℃,較佳為於0℃~180℃中以攪拌方式進行。鹼性觸媒的量為醯胺酸基之0.5莫耳倍~30莫耳倍,較佳為2莫耳倍~20莫耳倍,酸酐的量為醯胺酸基之1莫耳倍~50莫耳倍,較佳為3莫耳倍~30莫耳倍。鹼性觸媒,可列 舉如,吡啶、三乙基胺、三甲基胺、三丁基胺或三辛基胺等,其中,又以吡啶於進行反應時可維持適當之鹼性而為較佳。酸酐,可列舉如,乙酸酐、偏苯三酸酐或苯均四酸二酐等,其中,又以使用乙酸酐時,於反應結束後容易進行精製而為較佳。觸媒醯亞胺化之醯亞胺化率,可以依調節觸媒量與反應溫度、反應時間等方式予以控制。 The catalyst of the polyimine precursor is imidized by adding a basic catalyst and an acid anhydride to the solution of the polyimide precursor at -20 ° C to 250 ° C, preferably 0 ° C to 180 ° It is carried out by stirring in °C. The amount of the basic catalyst is 0.5 moles to 30 moles, preferably 2 moles to 20 moles, of the prolyl group, and the amount of the anhydride is 1 mole of the prolyl group to 50. Mohr times, preferably 3 moles to 30 moles. Alkaline catalyst, can be listed For example, pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine is preferred, and it is preferred to maintain proper basicity when pyridine is used for the reaction. Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, and pyromellitic dianhydride. Among them, when acetic anhydride is used, it is preferred to carry out purification after completion of the reaction. The imidization rate of the imidization of the catalyst oxime can be controlled according to the amount of the catalyst, the reaction temperature, and the reaction time.

由聚醯亞胺前驅體或聚醯亞胺的反應溶液中,回收所生成之聚醯亞胺前驅體或聚醯亞胺之方式,只要將反應溶液投入溶劑中使其沈澱即可。沈澱所使用的溶劑,可列舉如,甲醇、乙醇、異丙醇、丙酮、己烷、丁基溶纖劑、庚烷、甲基乙基酮、甲基異丁酮、甲苯、苯、水等。將投入溶劑使其沈澱之聚合物經濾過回收後,可於常壓或減壓下,以常溫或加熱予以乾燥。又,重複2次~10次將沈澱回收之聚合物再溶解於溶劑、再沈澱回收之操作後,可降低聚合物中之雜質。此時之溶劑,例如,醇類、酮類或烴等,由該些之中選擇3種類以上的溶劑使用時,以其可進一步提高精製之效率而為較佳。 The method of recovering the produced polyimine precursor or polyimine from the reaction solution of the polyimine precursor or the polyimine may be carried out by adding the reaction solution to a solvent to precipitate. Examples of the solvent used for the precipitation include methanol, ethanol, isopropanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene, water, and the like. After the solvent is added and the precipitated polymer is recovered by filtration, it can be dried at normal temperature or under reduced pressure under normal pressure or reduced pressure. Further, after repeating the process of re-dissolving the precipitated polymer in the solvent and reprecipitating and recovering twice to 10 times, the impurities in the polymer can be lowered. In the case of the solvent, for example, an alcohol, a ketone or a hydrocarbon, etc., when three or more types of solvents are used, it is preferable to further improve the efficiency of purification.

<液晶配向處理劑> <Liquid alignment treatment agent>

本發明之液晶配向處理劑為,形成液晶配向膜(亦稱為樹脂被膜)所使用的塗佈溶液,其為形成含有特定聚合物(A)、特定聚合物(B)及溶劑的液晶配向膜所使用之塗佈溶液。 The liquid crystal alignment treatment agent of the present invention is a coating solution used to form a liquid crystal alignment film (also referred to as a resin film), which is a liquid crystal alignment film containing a specific polymer (A), a specific polymer (B), and a solvent. The coating solution used.

本發明之特定聚合物(A),可使用聚醯胺酸、 聚醯胺酸烷酯及聚醯亞胺中之任一種聚醯亞胺系聚合物皆可。其中,又以聚醯胺酸烷酯或聚醯亞胺為佳。更佳為聚醯亞胺。 For the specific polymer (A) of the present invention, polylysine can be used, Any of polyalkylenimine polymers and polyamidiene polymers may be used. Among them, polyalkyl amide or polyimide is preferred. More preferably, it is a polyimine.

本發明之特定聚合物(B),可使用聚醯胺酸、聚醯胺酸烷酯及聚醯亞胺中之任一種聚醯亞胺系聚合物皆可。其中,又以聚醯胺酸或聚醯胺酸烷酯為佳。更佳為聚醯胺酸。 As the specific polymer (B) of the present invention, any of polyacrylamide, polyalkylenimine and polyamidiene may be used. Among them, polylysine or polyalkyl phthalate is preferred. More preferably, it is polyamic acid.

本發明之液晶配向處理劑中,特定聚合物(A)與特定聚合物(B)之比例為,相對於特定聚合物(A)100質量份,特定聚合物(B)以0.5質量份~950質量份為佳。其中,又以10質量份~900質量份為佳,更佳者為10質量份~400質量份。 In the liquid crystal alignment treatment agent of the present invention, the ratio of the specific polymer (A) to the specific polymer (B) is 0.5 parts by mass to 950 per 100 parts by mass of the specific polymer (A). The quality is preferred. Among them, it is preferably 10 parts by mass to 900 parts by mass, more preferably 10 parts by mass to 400 parts by mass.

本發明之液晶配向處理劑中,所有的聚合物成份,可全部為本發明之特定聚合物(A)及特定聚合物(B)亦可,或與該些以外的其他聚合物混合者亦可。該些以外的聚合物,可列舉如,不具有本發明之三級氮原子的結構之聚醯亞胺系聚合物及不具有特定結構(2)之聚醯亞胺系聚合物等。此外,又例如,纖維素系聚合物、丙烯酸聚合物、甲基丙烯酸聚合物、聚苯乙烯、聚醯胺或聚矽氧烷等。此時,該些以外的其他聚合物之含量為,相對於本發明之特定聚合物(A)及特定聚合物(B)全部的特定聚合物100質量份,為0.5質量份~30質量份。其中,又以1質量份~20質量份為佳。 In the liquid crystal alignment treatment agent of the present invention, all of the polymer components may be all of the specific polymer (A) and the specific polymer (B) of the present invention, or may be mixed with other polymers other than the above. . Examples of the polymer other than the above include a polyimide-based polymer having no structure of the tertiary nitrogen atom of the present invention and a polyimide-based polymer having no specific structure (2). Further, for example, a cellulose-based polymer, an acrylic polymer, a methacrylic polymer, polystyrene, polyamine or polyoxyalkylene or the like. In this case, the content of the polymer other than the above is 0.5 parts by mass to 30 parts by mass based on 100 parts by mass of the specific polymer of the specific polymer (A) and the specific polymer (B) of the present invention. Among them, it is preferably 1 part by mass to 20 parts by mass.

又,本發明之液晶配向處理劑中之溶劑之含 量,以70質量%~99.9質量%為佳。此含量可配合液晶配向處理劑的塗佈方法或作為目的之液晶配向膜的膜厚度,作適當之變更。 Further, the solvent in the liquid crystal alignment treatment agent of the present invention contains The amount is preferably 70% by mass to 99.9% by mass. This content can be appropriately changed in accordance with the coating method of the liquid crystal alignment agent or the film thickness of the intended liquid crystal alignment film.

本發明之液晶配向處理劑所使用之溶劑,只要為可溶解特定聚合物(A)及特定聚合物(B)的溶劑(亦稱良溶劑)時,並未有特別之限定。以下將列舉良溶劑的具體例示,但並不僅限定於該些例示。 The solvent used for the liquid crystal alignment agent of the present invention is not particularly limited as long as it is a solvent (also referred to as a good solvent) capable of dissolving the specific polymer (A) and the specific polymer (B). Specific examples of the good solvent will be listed below, but are not limited to the examples.

例如,N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、二甲基亞碸、γ-丁內酯、1,3-二甲基-四氫咪唑酮、甲基乙基酮、環己酮、環戊酮或4-羥基-4-甲基-2-戊酮等。 For example, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethyl Anthracene, γ-butyrolactone, 1,3-dimethyl-tetrahydroimidazolidone, methyl ethyl ketone, cyclohexanone, cyclopentanone or 4-hydroxy-4-methyl-2-pentanone.

其中,又以使用N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮、γ-丁內酯為佳。 Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, and γ-butyrolactone are preferably used.

此外,特定聚合物(A)及特定聚合物(B)對溶劑具有高度溶解性之情形,以使用前述式〔D-1〕~式〔D-3〕所示溶劑為佳。 Further, in the case where the specific polymer (A) and the specific polymer (B) are highly soluble in the solvent, it is preferred to use the solvent represented by the above formula [D-1] to the formula [D-3].

本發明之液晶配向處理劑中之良溶劑,以佔液晶配向處理劑所含溶劑全體的20質量%~99質量%為佳。其中,又以20質量%~90質量%為佳。更佳者為30質量%~80質量%。 The good solvent in the liquid crystal alignment agent of the present invention is preferably 20% by mass to 99% by mass based on the total amount of the solvent contained in the liquid crystal alignment agent. Among them, it is preferably 20% by mass to 90% by mass. More preferably, it is 30% by mass to 80% by mass.

本發明之液晶配向處理劑,於無損本發明之效果之範圍,於塗佈液晶配向處理劑之際,可使用提升液晶配向膜的塗膜性或表面平滑性之溶劑(亦稱為貧溶劑)。以下將列舉貧溶劑之具體例示,但並不僅限定於該些例 示。 The liquid crystal alignment treatment agent of the present invention can use a solvent (also referred to as a poor solvent) for improving the coating property or surface smoothness of the liquid crystal alignment film when the liquid crystal alignment treatment agent is applied, without impairing the effects of the present invention. . Specific examples of the poor solvent will be listed below, but are not limited to the examples. Show.

例如,乙醇、異丙醇、1-丁醇、2-丁醇、異丁醇、tert-丁醇、1-戊醇、2-戊醇、3-戊醇、2-甲基-1-丁醇、異戊醇、tert-戊醇、3-甲基-2-丁醇、新戊醇、1-己醇、2-甲基-1-戊醇、2-甲基-2-戊醇、2-乙基-1-丁醇、1-庚醇、2-庚醇、3-庚醇、1-辛醇、2-辛醇、2-乙基-1-己醇、環己醇、1-甲基環己醇、2-甲基環己醇、3-甲基環己醇、1,2-乙二醇、1,2-丙二醇、1,3-丙二醇、1,2-丁二醇、1,3-丁二醇、1,4-丁二醇、2,3-丁二醇、1,5-戊烷二醇、2-甲基-2,4-戊烷二醇、2-乙基-1,3-已二醇、二丙醚、二丁醚、二己醚、二噁烷、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、二乙二醇甲基乙醚、二乙二醇二丁醚、2-戊酮、3-戊酮、2-己酮、2-庚酮、4-庚酮、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、丙烯碳酸酯、乙烯碳酸酯、2-(甲氧基甲氧基)乙醇、乙二醇單丁醚、乙二醇單異戊醚、乙二醇單己醚、2-(己基氧基)乙醇、糠醇、二乙二醇、丙二醇、丙二醇單丁醚、1-(丁氧基乙氧基)丙醇、丙二醇單甲醚乙酸酯、二丙二醇、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇二甲醚、三丙二醇單甲醚、乙二醇單甲醚乙酸酯、乙二醇單乙醚乙酸酯、乙二醇單丁醚乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2- (2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、三乙二醇、三乙二醇單甲醚、三乙二醇單乙醚、乳酸甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸n-丁酯、乙酸丙二醇單乙醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸甲酯、乳酸乙酯、乳酸n-丙酯、乳酸n-丁酯、乳酸異戊酯或前述式〔D-1〕~式〔D-3〕所示溶劑等。 For example, ethanol, isopropanol, 1-butanol, 2-butanol, isobutanol, tert-butanol, 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butene Alcohol, isoamyl alcohol, tert-pentanol, 3-methyl-2-butanol, neopentyl alcohol, 1-hexanol, 2-methyl-1-pentanol, 2-methyl-2-pentanol, 2-ethyl-1-butanol, 1-heptanol, 2-heptanol, 3-heptanol, 1-octanol, 2-octanol, 2-ethyl-1-hexanol, cyclohexanol, 1 -methylcyclohexanol, 2-methylcyclohexanol, 3-methylcyclohexanol, 1,2-ethanediol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol , 1,3-butanediol, 1,4-butanediol, 2,3-butanediol, 1,5-pentanediol, 2-methyl-2,4-pentanediol, 2- Ethyl-1,3-hexanediol, dipropyl ether, dibutyl ether, dihexyl ether, dioxane, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1, 2 -butoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol methyl ether, diethylene glycol dibutyl ether, 2-pentanone, 3-pentanone, 2- Hexanone, 2-heptanone, 4-heptanone, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl Acid ester, ethylene glycol single B Acid ester, ethylene glycol diacetate, propylene carbonate, ethylene carbonate, 2-(methoxymethoxy)ethanol, ethylene glycol monobutyl ether, ethylene glycol monoisoamyl ether, ethylene glycol single Hexyl ether, 2-(hexyloxy)ethanol, decyl alcohol, diethylene glycol, propylene glycol, propylene glycol monobutyl ether, 1-(butoxyethoxy)propanol, propylene glycol monomethyl ether acetate, dipropylene glycol, Dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, tripropylene glycol monomethyl ether, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate Ester, ethylene glycol monoacetate, ethylene glycol diacetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2- (2-ethoxyethoxy)ethyl acetate, diethylene glycol acetate, triethylene glycol, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, methyl lactate, lactate B Ester, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl 3-ethoxypropionate Ethyl ester, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, lactic acid Methyl ester, ethyl lactate, n-propyl lactate, n-butyl lactate, isoamyl lactate or a solvent represented by the above formula [D-1] to formula [D-3].

其中,又以使用1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁醚、乙二醇單丁醚或二丙二醇二甲醚為佳。 Among them, 1-hexanol, cyclohexanol, 1,2-ethanediol, 1,2-propanediol, propylene glycol monobutyl ether, ethylene glycol monobutyl ether or dipropylene glycol dimethyl ether is preferably used.

該些貧溶劑,以佔液晶配向處理劑中所含溶劑全體的1質量%~80質量%為佳。其中,又以10質量%~80質量%為佳。更佳為20質量%~70質量%。 The amount of the poor solvent is preferably from 1% by mass to 80% by mass based on the total amount of the solvent contained in the liquid crystal alignment agent. Among them, it is preferably 10% by mass to 80% by mass. More preferably, it is 20% by mass to 70% by mass.

本發明之液晶配向處理劑中,以導入由具有環氧基、異氰酸酯基、環氧丙烷基或環碳酸酯基的交聯性化合物、羥基、羥烷基及低級烷氧基烷基所選出之至少1種的取代基的交聯性化合物,或導入具有聚合性不飽和鍵結的交聯性化合物者為佳。該些取代基或聚合性不飽和鍵結,於交聯性化合物中必須具有2個以上。 In the liquid crystal alignment treatment agent of the present invention, it is selected by introducing a crosslinkable compound having an epoxy group, an isocyanate group, an oxypropylene group or a cyclic carbonate group, a hydroxyl group, a hydroxyalkyl group and a lower alkoxyalkyl group. A crosslinkable compound having at least one substituent or a crosslinkable compound having a polymerizable unsaturated bond is preferred. These substituents or polymerizable unsaturated bonds must have two or more of the crosslinkable compounds.

具有環氧基或異氰酸酯基之交聯性化合物,例如,雙酚丙酮縮水甘油醚、酚-酚醛清漆環氧樹脂、甲酚-酚醛清漆環氧樹脂、三縮水甘油異三聚氰酸酯、四縮水甘油胺基二亞苯、四縮水甘油-m-二甲苯二胺、四縮水 甘油-1,3-雙(胺基乙基)環己烷、四苯基縮水甘油醚乙烷、三苯基縮水甘油醚乙烷、雙酚六氟乙醯二縮水甘油醚、1,3-雙(1-(2,3-環氧丙氧基)-1-三氟甲基-2,2,2-三氟甲基)苯、4,4-雙(2,3-環氧丙氧基)九氟聯苯基、三縮水甘油-p-胺基酚、四縮水甘油甲基二甲苯二胺、2-(4-(2,3-環氧丙氧基)苯基)-2-(4-(1,1-雙(4-(2,3-環氧丙氧基)苯基)乙基)苯基)丙烷或1,3-雙(4-(1-(4-(2,3-環氧丙氧基)苯基)-1-(4-(1-(4-(2,3-環氧丙氧基)苯基)-1-甲基乙基)苯基)乙基)苯氧基)-2-丙醇等。 a crosslinkable compound having an epoxy group or an isocyanate group, for example, bisphenol acetone glycidyl ether, phenol novolak epoxy resin, cresol novolac epoxy resin, triglycidyl isocyanurate, four Glycidylamine diphenylene, tetraglycidyl-m-xylenediamine, tetrahydration Glycerol-1,3-bis(aminoethyl)cyclohexane, tetraphenyl glycidyl ether ethane, triphenyl glycidyl ether ethane, bisphenol hexafluoroacetic acid diglycidyl ether, 1,3- Bis(1-(2,3-epoxypropoxy)-1-trifluoromethyl-2,2,2-trifluoromethyl)benzene, 4,4-bis(2,3-epoxypropoxylate) Base) nonafluorobiphenyl, triglycidyl-p-aminophenol, tetraglycidylmethylxylenediamine, 2-(4-(2,3-epoxypropoxy)phenyl)-2- (4-(1,1-bis(4-(2,3-epoxypropoxy)phenyl)ethyl)phenyl)propane or 1,3-bis(4-(1-(4-(2) ,3-glycidoxy)phenyl)-1-(4-(1-(4-(2,3-epoxypropoxy)phenyl)-1-methylethyl)phenyl) Phenyl)-2-propanol and the like.

具有環氧丙烷基之交聯性化合物,例如,至少具有2個下述式〔4A〕所示環氧丙烷基的交聯性化合物。 A crosslinkable compound having an oxypropylene group, for example, a crosslinkable compound having at least two oxypropylene groups represented by the following formula [4A].

具體而言,例如,國際公開公報WO2011/132751(2011.10.27公開)之58頁~59頁所揭示之式〔4a〕~式〔4k〕所示交聯性化合物等。 Specifically, for example, a crosslinkable compound represented by the formula [4a] to the formula [4k] disclosed in pages 58 to 59 of the publication of WO2011/132751 (2011.10.27).

具有環碳酸酯基之交聯性化合物,例如,至少具有2個下述式〔5A〕所示環碳酸酯基之交聯性化合物。 The crosslinkable compound having a cyclic carbonate group is, for example, a crosslinkable compound having at least two cyclic carbonate groups represented by the following formula [5A].

具體而言,例如,國際公開公報WO2012/014898(2012.2.2公開)之76頁~82頁所揭示之式〔5-1〕~式〔5-42〕所示交聯性化合物。 Specifically, for example, a crosslinkable compound represented by the formula [5-1] to the formula [5-42] disclosed in pages 76 to 82 of International Publication WO2012/014898 (published in 2012.2.2).

具有由羥基及烷氧基所成群所選出之至少1種的取代基之交聯性化合物,例如,具有羥基或烷氧基的胺基樹脂,例如,三聚氰胺樹脂、尿素樹脂、呱樹脂、乙炔脲-甲醛樹脂、琥珀醯基醯胺-甲醛樹脂或乙烯尿素-甲醛樹脂等。具體而言,可使用胺基的氫原子被羥甲基或烷氧基甲基或其二者所取代之三聚氰胺衍生物、苯併呱衍生物,或乙炔脲。該三聚氰胺衍生物或苯併呱衍生物,亦可以2聚物或3聚物方式存在。該些以每一個三環,平均具有3個以上,6個以下之羥甲基或烷氧基甲基者為佳。 A crosslinkable compound having at least one substituent selected from the group consisting of a hydroxyl group and an alkoxy group, for example, an amine-based resin having a hydroxyl group or an alkoxy group, for example, a melamine resin, a urea resin, or a hydrazine Resin, acetylene urea-formaldehyde resin, amber decyl amide-formaldehyde resin or ethylene urea-formaldehyde resin. Specifically, a melamine derivative or a benzindene in which an amino group hydrogen atom is substituted with a methylol group or an alkoxymethyl group or both thereof can be used. Derivative, or acetylene urea. The melamine derivative or benzopyrene The derivative may also be present as a 2-mer or a 3-mer. Each of these three It is preferred that the ring has an average of 3 or more and 6 or less methylol groups or alkoxymethyl groups.

該些三聚氰胺衍生物或苯併呱衍生物之例示,例如,市售品之每一個三環平均有3.7個取代之甲氧基甲基的MX-750、每一個三環平均有5.8個取代之甲氧基甲基的MW-30(以上,三和化學公司製)或CYMEL-300、301、303、350、370、771、325、327、703、712等之甲氧基甲基化三聚氰胺、CYMEL-235、236、238、212、253、254等之甲氧基甲基化丁氧基甲基化三聚氰 胺、CYMEL-506、508等之丁氧基甲基化三聚氰胺、CYMEL-1141等含羧基之甲氧基甲基化異丁氧基甲基化三聚氰胺、CYMEL-1123等甲氧基甲基化乙氧基甲基化苯併呱、CYMEL-1123-10等甲氧基甲基化丁氧基甲基化苯併呱、CYMEL-1128等丁氧基甲基化苯併呱、CYMEL-1125-80等含羧基之甲氧基甲基化乙氧基甲基化苯併呱(以上,三井氰酸公司製)等。又,乙炔脲之例如,CYMEL-1170等丁氧基甲基化乙炔脲、CYMEL-1172等羥甲基化乙炔脲等,POWER-LINK1174所示之甲氧基羥甲基化乙炔脲等。 These melamine derivatives or benzopyrene Examples of derivatives, for example, each of the three commercially available products The ring has an average of 3.7 substituted methoxymethyl MX-750, each three MW-30 (above, manufactured by Sanwa Chemical Co., Ltd.) or CYMEL-300, 301, 303, 350, 370, 771, 325, 327, 703, 712, etc., having an average of 5.8 substituted methoxymethyl groups. Oxyoxymethylated melamine, CYMEL-235, 236, 238, 212, 253, 254, etc. methoxymethylated butoxymethylated melamine, CYMEL-506, 508, etc. butoxymethylated melamine Carboxy-containing methoxymethylated isobutoxymethylated melamine such as CYMEL-1141, methoxymethylated ethoxymethylated benzopyrene such as CYMEL-1123 , CYMEL-1123-10 and other methoxymethylated butoxymethylated benzopyrene , CYMEL-1128 and other butoxymethylated benzopyrene a carboxy-containing methoxymethylated ethoxymethylated benzopyrene such as CYMEL-1125-80 (above, manufactured by Mitsui Cyanide Co., Ltd.). Further, examples of the acetylene urea include a butoxymethylated acetylene urea such as CYMEL-1170, a methylolated acetylene urea such as CYMEL-1172, and the like, and a methoxymethylolated acetylene urea represented by POWER-LINK 1174.

具有羥基或烷氧基的苯或酚性化合物,例如,1,3,5-三(甲氧基甲基)苯、1,2,4-三(異丙氧基甲基)苯、1,4-雙(sec-丁氧基甲基)苯或2,6-二羥基甲基-p-tert-丁基酚等。 a benzene or a phenolic compound having a hydroxyl group or an alkoxy group, for example, 1,3,5-tris(methoxymethyl)benzene, 1,2,4-tris(isopropoxymethyl)benzene, 1, 4-bis(sec-butoxymethyl)benzene or 2,6-dihydroxymethyl-p-tert-butylphenol.

更具體而言,例如,國際公開公報WO2011/132751(2011.10.27公開)之62頁~66頁所揭示之式〔6-1〕~式〔6-48〕所示交聯性化合物等。 More specifically, for example, a crosslinkable compound represented by the formula [6-1] to the formula [6-48] disclosed in pages 62 to 66 of International Publication WO01/132751 (2011.10.27).

具有聚合性不飽和鍵結的交聯性化合物,例如,分子內具有3個三羥甲基丙烷三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、二季戊四醇五(甲基)丙烯酸酯、三(甲基)丙烯醯氧基乙氧基三羥甲基丙烷或丙三醇聚縮水甘油醚聚(甲基)丙烯酸酯等之聚合性不飽和基的交聯性化合物,此外,又例如,乙二醇二(甲基)丙烯酸酯、二乙二醇二(甲基)丙烯酸酯、四乙二醇二(甲基)丙烯酸酯、 聚乙二醇二(甲基)丙烯酸酯、丙二醇二(甲基)丙烯酸酯、聚丙二醇二(甲基)丙烯酸酯、丁二醇二(甲基)丙烯酸酯、新戊二醇二(甲基)丙烯酸酯、氧化乙烯雙酚A型二(甲基)丙烯酸酯、氧化丙烯雙酚型二(甲基)丙烯酸酯、1,6-己二醇二(甲基)丙烯酸酯、丙三醇二(甲基)丙烯酸酯、季戊四醇二(甲基)丙烯酸酯、乙二醇二縮水甘油醚二(甲基)丙烯酸酯、二乙二醇二縮水甘油醚二(甲基)丙烯酸酯、酞酸二縮水甘油酯二(甲基)丙烯酸酯或羥基三甲基乙酸新戊二醇二(甲基)丙烯酸酯等之分子內具有2個聚合性不飽和基的交聯性化合物,此外,又如,2-羥基乙基(甲基)丙烯酸酯、2-羥基丙基(甲基)丙烯酸酯、2-羥基丁基(甲基)丙烯酸酯、2-苯氧基-2-羥基丙基(甲基)丙烯酸酯、2-(甲基)丙烯醯氧基-2-羥基丙基酞酸酯、3-氯-2-羥基丙基(甲基)丙烯酸酯、丙三醇單(甲基)丙烯酸酯、2-(甲基)丙烯醯氧基乙基磷酸酯或N-羥甲基(甲基)丙烯醯胺等之分子內具有1個聚合性不飽和基的交聯性化合物等。 A crosslinkable compound having a polymerizable unsaturated bond, for example, has three trimethylolpropane tri(meth)acrylates, pentaerythritol tri(meth)acrylate, dipentaerythritol penta(meth)acrylic acid in the molecule. a crosslinkable compound of a polymerizable unsaturated group such as an ester, tris(meth)acryloxyethoxyethoxytrimethylolpropane or glycerol polyglycidyl ether poly(meth)acrylate, in addition, For example, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, Polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(methyl) Acrylate, oxyethylene bisphenol A type di(meth) acrylate, propylene oxide bisphenol type di(meth) acrylate, 1,6-hexanediol di(meth) acrylate, glycerol II (Meth) acrylate, pentaerythritol di(meth) acrylate, ethylene glycol diglycidyl ether di(meth) acrylate, diethylene glycol diglycidyl ether di(meth) acrylate, decanoic acid a crosslinkable compound having two polymerizable unsaturated groups in the molecule such as glycidyl di(meth)acrylate or hydroxytrimethylacetic acid neopentyl glycol di(meth)acrylate, and, in addition, 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate, 2-hydroxybutyl (meth) acrylate, 2-phenoxy-2-hydroxypropyl (methyl) Acrylate, 2-(meth)acryloxy-2-hydroxypropyl phthalate, 3-chloro-2-hydroxypropyl (meth) acrylate, glycerol mono(meth) acrylate 2-(methyl) propylene A crosslinkable compound having one polymerizable unsaturated group in the molecule such as methoxyethyl phosphate or N-methylol (meth) acrylamide.

此外,亦可使用下述式〔7A〕所示化合物。 Further, a compound represented by the following formula [7A] can also be used.

(式〔7A〕中,E1表示由環己烷環、雙環己烷環、苯環、聯苯基環、聯三苯環、萘環、茀環、蒽環及菲環所選出之至少1種,E2表示由下述式〔7a〕或式〔7b〕所選出 之基,n表示1~4之整數)。 (In the formula [7A], E 1 represents at least 1 selected from a cyclohexane ring, a bicyclohexane ring, a benzene ring, a biphenyl ring, a terphenyl ring, a naphthalene ring, an anthracene ring, an anthracene ring, and a phenanthrene ring. And E 2 represents a group selected by the following formula [7a] or formula [7b], and n represents an integer of 1 to 4).

上述化合物為交聯性化合物之一例示,但並不僅限定於該些內容。又,本發明之液晶配向處理劑所使用之交聯性化合物,可為1種類亦可、2種類以上之組合亦可。 The above compound is exemplified as one of the crosslinkable compounds, but is not limited to these contents. In addition, the crosslinkable compound to be used in the liquid crystal alignment agent of the present invention may be one type or a combination of two or more types.

本發明之液晶配向處理劑中,交聯性化合物之含量,相對於全部聚合物成份100質量份,以0.1質量份~150質量份為佳。其中,又以進行交聯反應可達目的之效果等觀點,相對於全部聚合物成份100質量份,以0.1質量份~100質量份為佳。更佳者為1質量份~50質量份。 In the liquid crystal alignment treatment agent of the present invention, the content of the crosslinkable compound is preferably from 0.1 part by mass to 150 parts by mass based on 100 parts by mass of the total polymer component. In addition, from the viewpoint of the effect of achieving the purpose of the crosslinking reaction, it is preferably 0.1 parts by mass to 100 parts by mass based on 100 parts by mass of all the polymer components. More preferably, it is 1 part by mass to 50 parts by mass.

本發明之液晶配向處理劑,於無損本發明之效果之範圍,於塗佈液晶配向處理劑之際,可使用提高液晶配向膜的膜厚均勻性或表面平滑性等化合物。 In the liquid crystal alignment treatment agent of the present invention, when the liquid crystal alignment treatment agent is applied, a compound which improves the film thickness uniformity or surface smoothness of the liquid crystal alignment film can be used without departing from the effects of the present invention.

提高液晶配向膜的膜厚均勻性或表面平滑性之化合物,例如,氟系界面活性劑、聚矽氧系界面活性劑、非離子系界面活性劑等。 A compound which improves the film thickness uniformity or surface smoothness of the liquid crystal alignment film, for example, a fluorine-based surfactant, a polyoxyn-based surfactant, a nonionic surfactant, or the like.

更具體而言,例如,F-Top EF301、EF303、EF352(以上,道康寧化學製程公司製)、MEGAFACE F171、F173、R-30(以上,大日本塗料公司製)、FLUORAD FC430、FC431(以上,住友3M公司製)、AsahiGuard AG710、SurflonS-382、SC101、SC102、SC103、SC104、SC105、SC106(以上,旭硝子公司製)等。 More specifically, for example, F-Top EF301, EF303, EF352 (above, manufactured by Dow Corning Chemical Manufacturing Co., Ltd.), MEGAFACE F171, F173, R-30 (above, manufactured by Dainippon Coatings Co., Ltd.), FLUORAD FC430, FC431 (above, Sumitomo 3M), AsahiGuard AG710, Surflon S-382, SC101, SC102, SC103, SC104, SC105, SC106 (above) , Asahi Glass Co., Ltd.).

該些界面活性劑之使用比例,相對於液晶配向處理劑所含有的全部聚合物成份100質量份,較佳為0.01質量份~2質量份,更佳為0.01質量份~1質量份。 The use ratio of the surfactants is preferably 0.01 parts by mass to 2 parts by mass, more preferably 0.01 parts by mass to 1 part by mass, based on 100 parts by mass of all the polymer components contained in the liquid crystal alignment agent.

此外,本發明之液晶配向處理劑中,作為促進液晶配向膜中之電荷移動所使用的促進元件解除電荷之化合物,例如可添加國際公開公報WO2011/132751(2011.10.27公開)之69頁~73頁所揭示之、式〔M1〕~式〔M156〕所示含氮雜環之胺化合物。此胺化合物,可直接添加於液晶配向處理劑中亦可,其可使用適當之溶劑調整為濃度0.1質量%~10質量%,較佳為1質量%~7質量%之溶液方式添加為佳。此溶劑只要可溶解上述特定聚合物(A)及特定聚合物(B)之溶劑時,並未有特別之限定。 Further, in the liquid crystal alignment treatment agent of the present invention, as a compound which accelerates the charge transfer in the liquid crystal alignment film, the charge releasing compound can be added, for example, from 69 pages to 73 of International Publication WO2011/132751 (2011.10.27 publication). The nitrogen-containing heterocyclic amine compound represented by the formula [M1] to the formula [M156] disclosed in the above. The amine compound may be added directly to the liquid crystal alignment treatment agent, and it may be preferably added in a solution having a concentration of 0.1% by mass to 10% by mass, preferably 1% by mass to 7% by mass, using a suitable solvent. The solvent is not particularly limited as long as it can dissolve the solvent of the specific polymer (A) and the specific polymer (B).

本發明之液晶配向處理劑中,除上述貧溶劑、交聯性化合物、提高樹脂被膜或液晶配向膜的膜厚均勻性或表面平滑性的化合物及促進解除電荷之化合物以外,只要為不損害本發明效果之範圍,可添加以改變液晶配向膜的介電係數或導電性等電氣特性為目的的介電體或導電物質。 In the liquid crystal alignment treatment agent of the present invention, the poor solvent, the crosslinkable compound, the compound for improving the film thickness uniformity or the surface smoothness of the resin film or the liquid crystal alignment film, and the compound for promoting the charge release are not damaged. A dielectric or a conductive material for the purpose of changing the electrical properties such as the dielectric constant or the electrical conductivity of the liquid crystal alignment film can be added to the range of the effects of the invention.

<液晶配向膜‧液晶顯示元件> <Liquid alignment film ‧ Liquid crystal display element>

本發明之液晶配向處理劑為,於塗佈、燒結於基板上之後,可經施以摩擦處理或光照射等配向處理,而作為液晶配向膜使用者。又,於垂直配向等用途之情形中,亦可不施以配向處理而作為液晶配向膜使用。此時所使用之基板,只要為具有高度透明性之基板時,並未有特別之限定,除玻璃基板以外,其他亦可使用丙烯酸基板或聚碳酸酯基板等塑膠基板等。就製程簡單化之觀點,就進行液晶驅動之觀點,以使用形成有ITO電極等之基板為佳。又,為反射型之液晶顯示元件中,若僅為單側之基板時,亦可使用矽晶圓等不透明之基板,該情形之電極,亦可使用鋁等反射光線之材料。 The liquid crystal alignment treatment agent of the present invention can be applied as a liquid crystal alignment film by applying an alignment treatment such as rubbing treatment or light irradiation after being applied and sintered on a substrate. Further, in the case of use in a vertical alignment or the like, it may be used as a liquid crystal alignment film without applying an alignment treatment. The substrate to be used in this case is not particularly limited as long as it is a substrate having high transparency, and a plastic substrate such as an acrylic substrate or a polycarbonate substrate may be used in addition to the glass substrate. From the viewpoint of simplifying the process, it is preferable to use a substrate on which an ITO electrode or the like is formed from the viewpoint of liquid crystal driving. Further, in the case of a reflective liquid crystal display device, when it is only a single-sided substrate, an opaque substrate such as a germanium wafer may be used. In this case, a material that reflects light such as aluminum may be used.

液晶配向處理劑之塗佈方法,並未有特別之限定,工業上,一般可使用網版印刷、平版印刷、凸版印刷或噴墨法等方式進行。其他之塗佈方法,例如,浸漬法、輥塗佈法、縫狀塗佈法、旋轉法或噴霧法等,其可配合目的而使用該些方法使用即可。 The coating method of the liquid crystal alignment agent is not particularly limited, and industrially, it can be generally carried out by screen printing, lithography, letterpress printing, or inkjet method. Other coating methods, for example, a dipping method, a roll coating method, a slit coating method, a spinning method, or a spray method, may be used in combination with the purpose.

液晶配向處理劑塗佈於基板上之後,可使用加熱板、熱循環型烘箱或IR(紅外線)型烘箱等加熱手段,配合液晶配向處理劑所使用的溶劑,於30~300℃,較佳為30~250℃之溫度,使溶劑蒸發而形成液晶配向膜。燒結後的液晶配向膜之厚度,若過厚時就液晶顯示元件的消費電力之觀點而言為不利,過薄時將會造成液晶顯示元件 信賴性降低等情形,故較佳為5~300nm,更佳為10~100nm。欲使液晶成為水平配向或傾斜配向之情形,可對燒結後的液晶配向膜進行摩擦或照射偏光紫外線照射等方式進行處理。 After the liquid crystal alignment agent is applied onto the substrate, a heating means such as a hot plate, a heat cycle type oven, or an IR (infrared) type oven may be used, and a solvent used for the liquid crystal alignment agent may be used at 30 to 300 ° C, preferably The temperature of 30 to 250 ° C causes the solvent to evaporate to form a liquid crystal alignment film. The thickness of the liquid crystal alignment film after sintering is unfavorable from the viewpoint of the power consumption of the liquid crystal display element when it is too thick, and the liquid crystal display element is caused when it is too thin. Since the reliability is lowered, it is preferably 5 to 300 nm, more preferably 10 to 100 nm. In order to make the liquid crystal horizontally or obliquely aligned, the liquid crystal alignment film after sintering may be treated by rubbing or irradiating with polarized ultraviolet rays.

本發明之液晶顯示元件,可依上述之手法,本發明之液晶配向處理劑製得附有液晶配向膜之基板之後,再依公知方法製作液晶晶胞而作為液晶顯示元件。 In the liquid crystal display device of the present invention, a liquid crystal alignment cell can be produced by a liquid crystal alignment film of the present invention, and a liquid crystal cell can be produced as a liquid crystal display device by a known method.

液晶晶胞之製作方法,可例如,準備形成有液晶配向膜的一對之基板,於一側的基板之液晶配向膜上散佈間隔器,使液晶配向膜面為內側之方式,將另一側的基板貼合,並減壓注液晶後予以密封之方法,或,將液晶滴入散佈有間隔器之液晶配向膜面之後,再貼合基板進行密封之方法等例示。 For the method of fabricating a liquid crystal cell, for example, a pair of substrates on which a liquid crystal alignment film is formed may be prepared, and a spacer may be spread on a liquid crystal alignment film of one substrate to make the liquid crystal alignment film surface inner side, and the other side The substrate is bonded together, and the liquid crystal is sealed under reduced pressure, or the liquid crystal is dropped into the liquid crystal alignment film surface on which the spacer is dispersed, and then the substrate is bonded and sealed.

此外,本發明之液晶配向處理劑,亦適合使用於具備有電極之一對的基板之間具有液晶層,該一對之基板間配置含有至少經由活性能量線及熱中至少一者而聚合之聚合性化合物的液晶組成物,而於電極間持續施以電壓,並經由照射活性能量線之照射及加熱中之至少一者使聚合性化合物聚合的步驟所製造之液晶顯示元件。其中,活性能量線又以使用紫外線為佳。紫外線之波長為300~400nm,較佳為310~360nm。經由加熱進行聚合之情形,其加熱溫度為40~120℃,較佳為60~80℃。又,可使紫外線與加熱同時進行亦可。 Further, the liquid crystal alignment treatment agent of the present invention is also suitably used for a liquid crystal layer between substrates having one pair of electrodes, and the polymerization between the pair of substrates is carried out by polymerization of at least one of an active energy ray and heat. A liquid crystal display device produced by the step of polymerizing a polymerizable compound by applying a voltage to the liquid crystal composition of the compound and continuing to apply a voltage between the electrodes and irradiating the active energy ray. Among them, the active energy ray is preferably UV-based. The wavelength of the ultraviolet light is 300 to 400 nm, preferably 310 to 360 nm. In the case where the polymerization is carried out by heating, the heating temperature is 40 to 120 ° C, preferably 60 to 80 ° C. Further, it is also possible to carry out the simultaneous irradiation of the ultraviolet rays and the heating.

上述液晶顯示元件,為可使用PSA(Polymer Sustained Alignment)方式,以控制液晶分子的預傾角者。PSA方式為,於液晶材料中混入少量的光聚合性化合物,例如混入光聚合性單體,並於組合液晶晶胞之後,於對液晶層施加特定電壓之狀態下,使用紫外線等照射光聚合性化合物,以所生成之聚合物控制液晶分子的預傾角。聚合物生成時的液晶分子之配向狀態,於去除電壓之後仍被記憶,其可經由控制形成於液晶層的電場之方式,調整液晶分子的預傾角。又,PSA方式中,因不必須進行摩擦處理,故適合使用於極不易使用摩擦處理控制預傾角的垂直配向型之液晶層的形成方法。 The above liquid crystal display element is PSA (Polymer) Sustained Alignment) to control the pretilt angle of liquid crystal molecules. In the PSA method, a small amount of a photopolymerizable compound is mixed with a liquid crystal material, for example, a photopolymerizable monomer is mixed, and after a liquid crystal cell is combined, a photopolymerizable property is irradiated with ultraviolet rays or the like while a specific voltage is applied to the liquid crystal layer. A compound that controls the pretilt angle of the liquid crystal molecules with the polymer formed. The alignment state of the liquid crystal molecules at the time of polymer formation is still memorized after the voltage is removed, and the pretilt angle of the liquid crystal molecules can be adjusted by controlling the electric field formed in the liquid crystal layer. Further, in the PSA method, since it is not necessary to perform the rubbing treatment, it is suitable for a method of forming a vertical alignment type liquid crystal layer which is extremely difficult to use a rubbing treatment to control the pretilt angle.

即,本發明之液晶顯示元件為,於使用上述手法由本發明之液晶配向處理劑製得附有液晶配向膜之基板之後,製作液晶晶胞,並使用紫外線的照射及加熱中之至少一者使聚合性化合物聚合,而可以控制液晶分子之配向者。 In other words, the liquid crystal display device of the present invention is obtained by preparing a liquid crystal cell by using a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention, and using at least one of irradiation and heating using ultraviolet rays. The polymerizable compound is polymerized to control the alignment of the liquid crystal molecules.

以下舉一例說明使用PSA方式製作液晶晶胞之例,即,準備形成有液晶配向膜的一對之基板,於一側的基板之液晶配向膜上散佈間隔器,使液晶配向膜面為內側之方式,將另一側的基板貼合,並減壓注液晶後予以密封之方法,或,將液晶滴入散佈有間隔器之液晶配向膜面之後,再貼合基板進行密封之方法等等。 Hereinafter, an example in which a liquid crystal cell is produced by a PSA method, that is, a pair of substrates on which a liquid crystal alignment film is formed, is prepared, and a spacer is spread on a liquid crystal alignment film of one substrate so that the liquid crystal alignment film surface is inside. In the method, the substrate on the other side is bonded, and the liquid crystal is injected under reduced pressure to seal it, or the liquid crystal is dropped into the liquid crystal alignment film surface on which the spacer is dispersed, and then the substrate is bonded and sealed.

液晶中,混合有經由熱或紫外線照射而可聚合之聚合性化合物。聚合性化合物,例如,分子內具有1個以上的丙烯酸酯基或甲基丙烯酸酯基等聚合性不飽和基 的化合物等。此時,聚合性化合物,相對於液晶成份100質量份,以0.01~10質量份為佳,更佳為0.1~5質量份。聚合性化合物未達0.01質量份時,聚合性化合物將無法聚合,而無法控制液晶之配向,超過10質量份時,因未反應的聚合性化合物過多,而會造成液晶顯示元件的殘影特性降低。 In the liquid crystal, a polymerizable compound polymerizable by heat or ultraviolet irradiation is mixed. The polymerizable compound has, for example, one or more polymerizable unsaturated groups such as an acrylate group or a methacrylate group in the molecule. Compounds, etc. In this case, the polymerizable compound is preferably 0.01 to 10 parts by mass, more preferably 0.1 to 5 parts by mass, per 100 parts by mass of the liquid crystal component. When the amount of the polymerizable compound is less than 0.01 parts by mass, the polymerizable compound cannot be polymerized, and the alignment of the liquid crystal cannot be controlled. When the amount is more than 10 parts by mass, the residual property of the liquid crystal display element is lowered due to excessive unreacted polymerizable compound. .

液晶晶胞製作之後,對液晶晶胞持續施加交流或直流電壓中,使用熱或照射紫外線使聚合性化合物聚合。如此,即可控制液晶分子之配向。 After the liquid crystal cell is produced, the alternating polymer or DC voltage is continuously applied to the liquid crystal cell, and the polymerizable compound is polymerized by using heat or ultraviolet light. In this way, the alignment of the liquid crystal molecules can be controlled.

此外,本發明之液晶配向處理劑,為使用於具備有電極之一對的基板之間具有液晶層,前述一對的基板之間,配置有含有經由活性能量線及熱中至少一者而聚合的聚合性基之液晶配向膜,並經由於電極間施加電壓等步驟所製得的液晶顯示元件,即,其又以使用於SC-PVA模式者為佳。其中,活性能量線以紫外線為適當者。紫外線之波長為300~400nm,較佳為310~360nm。為使用加熱進行聚合之情形,加熱溫度為40~120℃,較佳為60~80℃。又,也可以使用紫外線與加熱同時進行。 Further, the liquid crystal alignment treatment agent of the present invention has a liquid crystal layer between substrates provided with one pair of electrodes, and the substrate between the pair of substrates is disposed to be polymerized via at least one of an active energy ray and heat. The liquid crystal alignment element which is a polymerizable group liquid crystal alignment film and which is obtained by applying a voltage or the like between the electrodes, that is, it is preferably used in the SC-PVA mode. Among them, the active energy ray is suitable for ultraviolet rays. The wavelength of the ultraviolet light is 300 to 400 nm, preferably 310 to 360 nm. In the case of polymerization using heating, the heating temperature is 40 to 120 ° C, preferably 60 to 80 ° C. Further, it is also possible to use ultraviolet rays simultaneously with heating.

使用活性能量線及熱之至少一者予以聚合,而製得含有聚合性基的液晶配向膜之方法中,例如可使用將含有聚合性基的化合物添加於液晶配向處理劑中之方法,或使用含有聚合性基的聚合物成份之方法等。 In the method of producing a liquid crystal alignment film containing a polymerizable group by polymerization using at least one of an active energy ray and heat, for example, a method of adding a polymerizable group-containing compound to a liquid crystal alignment treatment agent, or using A method of polymerizing a polymer component containing a polymerizable group.

舉例說明SC-PVA模式的液晶晶胞的製作例示,例如,準備本發明之形成有液晶配向膜的一對之基 板,於一側的基板之液晶配向膜上散佈間隔器,使液晶配向膜面為內側之方式,將另一側的基板貼合,並減壓注液晶後予以密封之方法,或,將液晶滴入散佈有間隔器之液晶配向膜面之後,再貼合基板進行密封之方法等。 An example of fabrication of a liquid crystal cell of the SC-PVA mode is exemplified, for example, preparing a pair of substrates of the present invention in which a liquid crystal alignment film is formed. a plate in which a spacer is disposed on a liquid crystal alignment film of a substrate on one side, and a liquid crystal alignment film surface is disposed inside, a substrate on the other side is bonded, and a liquid crystal is decompressed and sealed, or a liquid crystal is sealed. After dropping the liquid crystal alignment film surface on which the spacer is dispersed, the substrate is bonded to the method of sealing.

製作液晶晶胞之後,於對液晶晶胞持續施加交流或直流電壓中,經照射熱或紫外線時,可控制液晶分子的配向。 After the liquid crystal cell is produced, the alignment of the liquid crystal molecules can be controlled by continuously applying an alternating current or a direct current voltage to the liquid crystal cell, and irradiating heat or ultraviolet rays.

如以上所述般,本發明之液晶配向處理劑為,一種即使長時間暴露於高溫及光照射之後,也可得到具有安定的預傾角之液晶配向膜。此外,亦為一種即使長時間暴露於光線照射之後,可抑制電壓保持率之降低,且可快速減緩因直流電壓所蓄積之殘留電荷液晶配向膜。因此,具有由本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件,為具有優良信賴性者,而適合被使用於大畫面且高精密的液晶電視,或中小型汽車導航系統或智慧型手機等。 As described above, the liquid crystal alignment treatment agent of the present invention is a liquid crystal alignment film having a stable pretilt angle even after exposure to high temperature for a long period of time and light irradiation. In addition, it is also a kind of residual charge liquid crystal alignment film which can suppress the decrease of the voltage holding ratio even after long-term exposure to light irradiation, and can quickly alleviate the accumulation of the DC voltage. Therefore, the liquid crystal display element having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is excellent in reliability, and is suitable for use in a large-screen and high-precision liquid crystal television, or a small-sized car navigation system or an intelligent type. Mobile phones, etc.

[實施例] [Examples]

以下將列舉實施例對本發明作更詳細之說明,但並不僅限定於該些內容。 The present invention will be described in more detail below by way of examples, but is not limited thereto.

「本發明之合成例、實施例及比較例所使用之簡稱」 "Abbreviations used in the synthesis examples, examples and comparative examples of the present invention"

合成例、實施例及比較例所使用之簡稱,係如以下所 示。 The abbreviations used in the synthesis examples, examples, and comparative examples are as follows. Show.

<製作本發明之聚醯亞胺系聚合物所使用的單體> <Monomer used in the production of the polyimine-based polymer of the present invention> (本發明之特定二胺化合物(1)) (Specific diamine compound (1) of the present invention)

A1:下述式〔A1〕所示二胺化合物 A1: a diamine compound represented by the following formula [A1]

A2:下述式〔A2〕所示二胺化合物 A2: a diamine compound represented by the following formula [A2]

A3:下述式〔A3〕所示二胺化合物 A3: a diamine compound represented by the following formula [A3]

(本發明之特定二胺化合物(2)) (Specific diamine compound (2) of the present invention)

B1:下述式〔B1〕所示二胺化合物 B1: a diamine compound represented by the following formula [B1]

(本發明之特定側鏈型二胺化合物) (Specific side chain type diamine compound of the present invention)

C1:1,3-二胺基-4-〔4-(反-4-n-庚基環己基)苯氧基〕苯 C1: 1,3-diamino-4-[4-(trans-4-n-heptylcyclohexyl)phenoxy]benzene

C2:1,3-二胺基-4-〔4-(反-4-n-庚基環己基)苯氧基甲基〕苯 C2: 1,3-diamino-4-[4-(trans-4-n-heptylcyclohexyl)phenoxymethyl]benzene

C3:1,3-二胺基-4-{4-〔反-4-(反-4-n-戊基環己基)環己基〕苯氧基}苯 C3: 1,3-diamino-4-{4-[trans-4-(trans-4-n-pentylcyclohexyl)cyclohexyl]phenoxy}benzene

C4:下述式〔C4〕所示二胺化合物 C4: a diamine compound represented by the following formula [C4]

(其他二胺化合物) (other diamine compounds)

D1:p-伸苯基二胺 D1: p-phenylenediamine

D2:3,5-二胺基安息香酸 D2: 3,5-diamino benzoic acid

D3:1,3-二胺基-4-十八烷基氧苯 D3: 1,3-diamino-4-octadecyloxybenzene

(本發明之特定四羧酸成份) (Specific tetracarboxylic acid component of the present invention)

E1:1,2,3,4-環丁烷四羧酸二酐 E1:1,2,3,4-cyclobutane tetracarboxylic dianhydride

E2:雙環〔3,3,0〕辛烷-2,4,6,8-四羧酸二酐 E2: Bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride

E3:下述式〔E3〕所示四羧酸二酐 E3: tetracarboxylic dianhydride represented by the following formula [E3]

E4:下述式〔E4〕所示四羧酸二酐 E4: tetracarboxylic dianhydride represented by the following formula [E4]

E5:下述式〔E5〕所示四羧酸二酐 E5: tetracarboxylic dianhydride represented by the following formula [E5]

「本發明所使用之交聯性化合物」 "Crosslinking compound used in the present invention"

K1:下述式〔K1〕所示交聯性化合物 K1: a crosslinkable compound represented by the following formula [K1]

<本發明所使用之溶劑> <Solvent used in the present invention>

NMP:N-甲基-2-吡咯啶酮 NMP: N-methyl-2-pyrrolidone

NEP:N-乙基-2-吡咯啶酮 NEP: N-ethyl-2-pyrrolidone

γ-BL:γ-丁內酯 γ-BL: γ-butyrolactone

BCS:乙二醇單丁醚 BCS: ethylene glycol monobutyl ether

PB:丙二醇單丁醚 PB: propylene glycol monobutyl ether

EC:二乙二醇單乙醚 EC: diethylene glycol monoethyl ether

DME:二丙二醇二甲醚 DME: Dipropylene glycol dimethyl ether

「本發明之聚醯亞胺系聚合物分子量之測定」 "Determination of molecular weight of polyimine-based polymer of the present invention"

合成例中之聚醯亞胺前驅體及聚醯亞胺之分子量,為使用常溫凝膠滲透色層分析儀(GPC)裝置(GPC-101)(昭和電工公司製)、管柱(KD-803,KD-805)(Shodex公司製),依以下方式測定者。 The molecular weight of the polyimine precursor and the polyimine in the synthesis example is a normal temperature gel permeation chromatography (GPC) device (GPC-101) (manufactured by Showa Denko Co., Ltd.) and a column (KD-803). , KD-805) (manufactured by Shodex Co., Ltd.), measured as follows.

管柱溫度:50℃ Column temperature: 50 ° C

溶離液:N,N’-二甲基甲醯胺(添加劑為,溴化鋰-水和 物(LiBr‧H2O)為30mmol/L(公升)、磷酸‧無水結晶(o-磷酸)為30mmol/L、四氫呋喃(THF)為10ml/L) Dissolution: N,N'-dimethylformamide (additive, lithium bromide-water (LiBr‧H 2 O) is 30 mmol/L (liter), phosphoric acid ‧ anhydrous crystal (o-phosphoric acid) is 30 mmol/ L, tetrahydrofuran (THF) is 10ml / L)

流速:1.0ml/分 Flow rate: 1.0ml/min

檢量線製作用之標準樣品:TSK標準聚氧乙烯(分子量;約900,000、150,000、100,000及30,000)(東曹公司製)及聚乙二醇(分子量;約12,000、4,000及1,000)(Polymer Laboratories公司製)。 Standard samples for the production of calibration lines: TSK standard polyoxyethylene (molecular weight; about 900,000, 150,000, 100,000 and 30,000) (made by Tosoh Corporation) and polyethylene glycol (molecular weight; about 12,000, 4,000 and 1,000) (Polymer Laboratories) Company system).

「本發明之聚醯亞胺的醯亞胺化率之測定」 "Determination of the oxime imidization ratio of the polyimine of the present invention"

合成例中之聚醯亞胺的醯亞胺化率係依下式測定者。即,將聚醯亞胺粉末20mg置入NMR(核磁共振)採樣管(NMR標準採樣管, 5(草野科學公司製)),添加氘代二甲基亞碸(DMSO-d6,0.05質量%TMS(四甲基矽烷)混合品)(0.53ml),施以超音波使其完全溶解。使用NMR測定機(JNW-ECA500)(日本電子DATUM公司製)測定此溶液的500MHz之質子NMR。醯亞胺化率為,以醯亞胺化前後未變化的結構所產生之質子作為基準質子予以決定,使用此質子的波峰積算值,與9.5ppm~10.0ppm附近出現的醯胺酸的NH基所產生的質子波峰積算值,並依下式求得者。 The oxime imidization ratio of the polyimine in the synthesis example is determined by the following formula. That is, 20 mg of polyimine powder was placed in an NMR (nuclear magnetic resonance) sampling tube (NMR standard sampling tube, 5 (manufactured by Kusano Scientific Co., Ltd.), deuterated dimethyl hydrazine (DMSO-d6, 0.05% by mass of TMS (tetramethyl decane) mixed product) (0.53 ml) was added, and ultrasonic waves were applied thereto to completely dissolve. The 500 MHz proton NMR of this solution was measured using an NMR measuring machine (JNW-ECA500) (manufactured by JEOL DATUM Co., Ltd.). The sulfhydrylation rate is determined by the protons produced by the unaltered structure before and after the imidization as the reference proton. The peak value of the proton is used, and the NH group of the proline is present near 9.5 ppm to 10.0 ppm. The resulting proton peak product is calculated and evaluated according to the following formula.

醯亞胺化率(%)=(1-α‧x/y)×100 醯 imidization rate (%) = (1-α‧x/y) × 100

上述式中,x為由醯胺酸的NH基產生的質子波峰積算值、y為基準質子的波峰積算值、α為聚醯胺酸(醯亞胺化率為0%)之情形中,相對於醯胺酸的1個NH基質子之基準質子的個數比例。 In the above formula, x is a proton peak product value generated by the NH group of valine acid, y is a peak product integrated value of the reference proton, and α is a polyproline (the imidization ratio is 0%). The ratio of the number of reference protons to one NH proton of proline.

「本發明之聚醯亞胺系聚合物之合成」 "Synthesis of Polyimine Polymer of the Present Invention" <合成例1> <Synthesis Example 1>

將E1(4.50g,23.0mmol)、A1(1.85g,9.30mmol)、C1(0.88g,2.32mmol)及D1(1.26g,11.6mmol)於NMP(25.5g)中混合,於40℃下反應8小時,得樹脂固形分濃度25質量%的聚醯胺酸溶液(1)。此聚醯胺酸的數平均分子量為24,200、重量平均分子量為86,500。 E1 (4.50 g, 23.0 mmol), A1 (1.85 g, 9.30 mmol), C1 (0.88 g, 2.32 mmol) and D1 (1.26 g, 11.6 mmol) were mixed in NMP (25.5 g) and reacted at 40 ° C After 8 hours, a polyamic acid solution (1) having a resin solid content concentration of 25% by mass was obtained. The polyamic acid had a number average molecular weight of 24,200 and a weight average molecular weight of 86,500.

<合成例2> <Synthesis Example 2>

將E1(4.10g,20.9mmol)、B1(3.16g,10.6mmol)、D1(0.46g,4.24mmol)及D2(0.97g,6.35mmol)於NMP(26.1g)中混合,於40℃下反應8小時,得樹脂固形分濃度25質量%的聚醯胺酸溶液(2)。此聚醯胺酸的數平均分子量為25,200、重量平均分子量為89,100。 E1 (4.10g, 20.9mmol), B1 (3.16g, 10.6mmol), D1 (0.46g, 4.24mmol) and D2 (0.97g, 6.35mmol) were mixed in NMP (26.1g) and reacted at 40 ° C After 8 hours, a polyamic acid solution (2) having a resin solid concentration of 25% by mass was obtained. The polyamic acid had a number average molecular weight of 25,200 and a weight average molecular weight of 89,100.

<合成例3> <Synthesis Example 3>

將E2(3.96g,15.8mmol)、A1(1.91g,9.61mmol)、C1(6.09g,16.0mmol)及D2(0.97g,6.41mmol)於NEP(32.1g)中混合,於80℃下反應5小時後,再加入E1(3.10g,15.8mmol)與NEP(16.0g),於40℃下反應6小時,得樹脂固形分濃度為25質量%的聚醯胺酸溶液(3)。此聚醯胺酸的數平均分子量為20,100、重量平均分子量為64,100。 E2 (3.96 g, 15.8 mmol), A1 (1.91 g, 9.61 mmol), C1 (6.09 g, 16.0 mmol) and D2 (0.97 g, 6.41 mmol) were mixed in NEP (32.1 g) and reacted at 80 ° C After 5 hours, E1 (3.10 g, 15.8 mmol) and NEP (16.0 g) were further added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (3) having a resin solid concentration of 25% by mass. The polyamic acid had a number average molecular weight of 20,100 and a weight average molecular weight of 64,100.

<合成例4> <Synthesis Example 4>

於合成例3之合成手法所得之聚醯胺酸溶液(3)(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.45g)及吡啶(2.50g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(4)。此聚醯亞胺的醯亞胺化率為55%,數平均分子量為18,500、重量平均分子量為49,300。 In the polyamic acid solution (3) (30.0 g) obtained by the synthetic method of Synthesis Example 3, after adding NEP to 6% by mass, acetic anhydride (3.45 g) and pyridine (as the ruthenium amide) were added. 2.50 g), and reacted at 60 ° C for 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (4). The polyamidimide had a quinone imidization ratio of 55%, a number average molecular weight of 18,500, and a weight average molecular weight of 49,300.

<合成例5> <Synthesis Example 5>

將E2(4.47g,17.9mmol)、B1(3.24g,10.9mmol)、C1(2.75g,7.23mmol)及D2(2.75g,18.1mmol)於NEP(33.4g)中混合,於80℃下反應5小時後,再加入E1(3.50g,17.9mmol)與NEP(16.7g),於40℃下反應6小時,得樹脂固形分濃度為25質量%的聚醯胺酸溶液(5)。此聚醯胺酸的數平均分子量為22,100、重量平均分子量為68,500。 E2 (4.47 g, 17.9 mmol), B1 (3.24 g, 10.9 mmol), C1 (2.75 g, 7.23 mmol) and D2 (2.75 g, 18.1 mmol) were mixed in NEP (33.4 g) and reacted at 80 ° C After 5 hours, E1 (3.50 g, 17.9 mmol) and NEP (16.7 g) were further added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (5) having a resin solid concentration of 25% by mass. The polyamic acid had a number average molecular weight of 22,100 and a weight average molecular weight of 68,500.

<合成例6> <Synthesis Example 6>

於合成例5之合成手法所得之聚醯胺酸溶液(5)(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.40g)及吡啶(2.65g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而 製得聚醯亞胺粉末(6)。此聚醯亞胺的醯亞胺化率為58%,數平均分子量為19,800、重量平均分子量為52,900。 In the polyamic acid solution (5) (30.0 g) obtained by the synthetic method of Synthesis Example 5, after adding NEP to 6% by mass, acetic anhydride (3.40 g) and pyridine as a ruthenium amide catalyst were added. 2.65 g), and reacted at 60 ° C for 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol and dried under reduced pressure at 100 ° C. A polyimide pigment (6) was obtained. This polyimine had a quinone imidization ratio of 58%, a number average molecular weight of 19,800, and a weight average molecular weight of 52,900.

<合成例7> <Synthesis Example 7>

將E2(1.37g,5.46mmol)、A2(1.18g,5.53mmol)、C2(2.91g,7.38mmol)、D1(0.20g,1.84mmol)及D2(0.56g,3.69mmol)於NMP(17.4g)中混合,於80℃下反應5小時後,再加入E1(2.50g,12.8mmol)與NMP(8.72g),於40℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E2 (1.37 g, 5.46 mmol), A2 (1.18 g, 5.53 mmol), C2 (2.91 g, 7.38 mmol), D1 (0.20 g, 1.84 mmol) and D2 (0.56 g, 3.69 mmol) in NMP (17.4 g) After mixing for 5 hours at 80 ° C, E1 (2.50 g, 12.8 mmol) and NMP (8.72 g) were further added and reacted at 40 ° C for 6 hours to obtain a polymer having a solid concentration of 25% by mass. Proline solution.

於所得聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.45g)及吡啶(3.30g),於80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(7)。此聚醯亞胺的醯亞胺化率為80%,數平均分子量為17,100、重量平均分子量為47,800。 After the NMP was diluted to 6 mass% in the obtained polyamic acid solution (30.0 g), acetic anhydride (4.45 g) and pyridine (3.30 g) as a ruthenium amide catalyst were added, and the reaction was carried out at 80 ° C. hour. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (7). The polyimine had an oxime imidization ratio of 80%, a number average molecular weight of 17,100, and a weight average molecular weight of 47,800.

<合成例8> <Synthesis Example 8>

將E2(1.37g,5.46mmol)、B1(1.38g,4.61mmol)、C2(1.09g,2.77mmol)及D2(1.68g,11.1mmol)於NMP(16.0g)中混合,於80℃下反應5小時後,再加入E1(2.50g,12.8mmol)與NMP(8.02g),於40℃下反應6小時,得樹脂 固形分濃度為25質量%的聚醯胺酸溶液。 E2 (1.37g, 5.46mmol), B1 (1.38g, 4.61mmol), C2 (1.09g, 2.77mmol) and D2 (1.68g, 11.1mmol) were mixed in NMP (16.0g) and reacted at 80 ° C After 5 hours, E1 (2.50 g, 12.8 mmol) and NMP (8.02 g) were further added and reacted at 40 ° C for 6 hours to obtain a resin. A polyamic acid solution having a solid concentration of 25% by mass.

於所得聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.50g)及吡啶(3.35g),於80℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(8)。此聚醯亞胺的醯亞胺化率為81%,數平均分子量為18,800、重量平均分子量為49,800。 After the NMP was diluted to 6% by mass in the obtained polyamic acid solution (30.0 g), acetic anhydride (4.50 g) and pyridine (3.35 g) as a ruthenium amide catalyst were added, and the mixture was reacted at 80 ° C. hour. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (8). The polyimine had an oxime imidization ratio of 81%, a number average molecular weight of 18,800, and a weight average molecular weight of 49,800.

<合成例9> <Synthesis Example 9>

將E3(7.20g,32.1mmol)、A2(2.78g,13.0mmol)、C2(5.14g,13.0mmol)及D2(0.99g,6.51mmol)於NEP(48.3g)中混合,於40℃下反應8小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液(9)。此聚醯胺酸的數平均分子量為21,200、重量平均分子量為65,400。 E3 (7.20 g, 32.1 mmol), A2 (2.78 g, 13.0 mmol), C2 (5.14 g, 13.0 mmol) and D2 (0.99 g, 6.51 mmol) were mixed in NEP (48.3 g) and reacted at 40 ° C After 8 hours, a polyamic acid solution (9) having a resin solid concentration of 25% by mass was obtained. The polyamic acid had a number average molecular weight of 21,200 and a weight average molecular weight of 65,400.

<合成例10> <Synthesis Example 10>

於合成例9之合成手法所得之聚醯胺酸溶液(9)(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.40g)及吡啶(2.63g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(10)。此聚醯亞胺的醯亞胺化率為57%,數平均分子量為18,200、重量平均分子量為 48,300。 In the polyamic acid solution (9) (30.0 g) obtained by the synthetic method of Synthesis Example 9, after adding NEP to 6% by mass, acetic anhydride (3.40 g) and pyridine as a ruthenium-imiding catalyst were added. 2.63 g), and reacted at 60 ° C for 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (10). The polyamidimide has a ruthenium iodide ratio of 57%, a number average molecular weight of 18,200, and a weight average molecular weight of 48,300.

<合成例11> <Synthesis Example 11>

將E3(3.85g,17.2mmol)、A3(0.53g,2.61mmol)、C4(2.14g,4.35mmol)及D2(1.59g,10.4mmol)於NMP(24.3g)中混合,於40℃下反應8小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E3 (3.85 g, 17.2 mmol), A3 (0.53 g, 2.61 mmol), C4 (2.14 g, 4.35 mmol) and D2 (1.59 g, 10.4 mmol) were mixed in NMP (24.3 g) and reacted at 40 ° C After 8 hours, a polyamic acid solution having a resin solid concentration of 25% by mass was obtained.

於所得聚醯胺酸溶液(30.0g)中加入NMP,稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.90g)及吡啶(2.65g),於60℃下反應3.5小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(11)。此聚醯亞胺的醯亞胺化率為68%,數平均分子量為17,500、重量平均分子量為47,900。 NMP was added to the obtained polyamic acid solution (30.0 g), and after diluting to 6% by mass, acetic anhydride (3.90 g) and pyridine (2.65 g) as a ruthenium catalyst were added, and the reaction was carried out at 60 ° C. hour. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (11). The polyimine had a hydrazine imidation ratio of 68%, a number average molecular weight of 17,500, and a weight average molecular weight of 47,900.

<合成例12> <Synthesis Example 12>

將E4(1.64g,5.46mmol)、B1(1.65g,5.53mmol)、C1(1.40g,3.69mmol)、D1(0.20g,1.84mmol)及D2(1.12g,7.38mmol)於NMP(17.0g)中混合,於80℃下反應6小時後,再加入E1(2.50g,12.8mmol)與NMP(8.52g),於40℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E4 (1.64 g, 5.46 mmol), B1 (1.65 g, 5.53 mmol), C1 (1.40 g, 3.69 mmol), D1 (0.20 g, 1.84 mmol) and D2 (1.12 g, 7.38 mmol) in NMP (17.0 g) After mixing and reacting at 80 ° C for 6 hours, E1 (2.50 g, 12.8 mmol) and NMP (8.52 g) were further added and reacted at 40 ° C for 6 hours to obtain a polymer having a solid concentration of 25% by mass. Proline solution.

於所得聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐 (4.15g)及吡啶(2.95g),於70℃下反應3小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(12)。此聚醯亞胺的醯亞胺化率為64%,數平均分子量為18,100、重量平均分子量為49,600。 After the NMP was diluted to 6% by mass in the obtained polyaminic acid solution (30.0 g), acetic anhydride was added as a ruthenium catalyst. (4.15 g) and pyridine (2.95 g) were reacted at 70 ° C for 3 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (12). The polyimine had a hydrazide conversion ratio of 64%, a number average molecular weight of 18,100, and a weight average molecular weight of 49,600.

<合成例13> <Synthesis Example 13>

將E4(2.87g,9.56mmol)、A3(0.98g,4.84mmol)、C3(2.44g,5.65mmol)、D1(0.26g,2.42mmol)及D2(0.49g,3.23mmol)於NEP(16.6g)中混合,於80℃下反應6小時後,再加入E1(1.25g,6.37mmol)與NEP(8.30g),於40℃下反應6小時,得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E4 (2.87 g, 9.56 mmol), A3 (0.98 g, 4.84 mmol), C3 (2.44 g, 5.65 mmol), D1 (0.26 g, 2.42 mmol) and D2 (0.49 g, 3.23 mmol) in NEP (16.6 g) The mixture was mixed and reacted at 80 ° C for 6 hours, and then E1 (1.25 g, 6.37 mmol) and NEP (8.30 g) were added, and reacted at 40 ° C for 6 hours to obtain a polycondensate having a resin solid content concentration of 25% by mass. Amino acid solution.

於所得聚醯胺酸溶液(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(4.55g)及吡啶(3.35g),於80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(13)。此聚醯亞胺的醯亞胺化率為81%,數平均分子量為16,300、重量平均分子量為45,100。 After the NEPP was diluted to 6 mass% in the obtained polyamic acid solution (30.0 g), acetic anhydride (4.55 g) and pyridine (3.35 g) as a ruthenium catalyst were added, and the reaction was carried out at 80 ° C. hour. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (13). The polyamidimide had a ruthenium iodide ratio of 81%, a number average molecular weight of 16,300, and a weight average molecular weight of 45,100.

<合成例14> <Synthesis Example 14>

將E4(3.57g,11.9mmol)、A1(1.37g,6.89mmol)、C4(1.70g,3.44mmol)及D2(1.05g,6.89mmol)於NMP(17.4g) 中混合,於80℃下反應6小時後,再加入E1(1.00g,5.10mmol)與NMP(8.69g),於40℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E4 (3.57g, 11.9mmol), A1 (1.37g, 6.89mmol), C4 (1.70g, 3.44mmol) and D2 (1.05g, 6.89mmol) in NMP (17.4g) After mixing and reacting at 80 ° C for 6 hours, E1 (1.00 g, 5.10 mmol) and NMP (8.69 g) were further added and reacted at 40 ° C for 6 hours to obtain a polythene having a resin solid concentration of 25% by mass. Amino acid solution.

於所得聚醯胺酸溶液(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.75g)及吡啶(2.35g),於80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(14)。此聚醯亞胺的醯亞胺化率為53%,數平均分子量為17,800、重量平均分子量為48,900。 After the NEPP was diluted to 6% by mass in the obtained polyaminic acid solution (30.0 g), acetic anhydride (3.75 g) and pyridine (2.35 g) as a ruthenium catalyst were added, and the reaction was carried out at 80 ° C. hour. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (14). The polyimine had a ruthenium iodide ratio of 53%, a number average molecular weight of 17,800, and a weight average molecular weight of 48,900.

<合成例15> <Synthesis Example 15>

將E2(1.73g,6.91mmol)、A1(0.70g,3.50mmol)、A2(0.75g,3.50mmol)、C2(2.76g,7.00mmol)及D2(0.53g,3.50mmol)於NMP(17.3g)中混合,於80℃下反應6小時後,再加入E5(2.20g,10.4mmol)與NMP(8.67g),於80℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液(15)。此聚醯胺酸的數平均分子量為20,100、重量平均分子量為62,600。 E2 (1.73g, 6.91mmol), A1 (0.70g, 3.50mmol), A2 (0.75g, 3.50mmol), C2 (2.76g, 7.00mmol) and D2 (0.53g, 3.50mmol) in NMP (17.3g) After mixing for 6 hours at 80 ° C, E5 (2.20 g, 10.4 mmol) and NMP (8.67 g) were further added and reacted at 80 ° C for 6 hours to obtain a polymer having a solid concentration of 25% by mass. Proline solution (15). The polyamic acid had a number average molecular weight of 20,100 and a weight average molecular weight of 62,600.

<合成例16> <Synthesis Example 16>

將E2(0.88g,3.54mmol)、B1(1.60g,5.37mmol)、C1(1.36g,3.58mmol)及D2(1.36g,8.95mmol)於NMP(16.4g)中混合,於80℃下反應6小時後,再加入E5(3.00g, 14.1mmol)與NMP(8.21g),於80℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液(16)。此聚醯胺酸的數平均分子量為21,600、重量平均分子量為65,100。 E2 (0.88g, 3.54mmol), B1 (1.60g, 5.37mmol), C1 (1.36g, 3.58mmol) and D2 (1.36g, 8.95mmol) were mixed in NMP (16.4g) and reacted at 80 ° C After 6 hours, add E5 (3.00g, 14.1 mmol) and NMP (8.21 g) were reacted at 80 ° C for 6 hours to obtain a polyamic acid solution (16) having a resin solid concentration of 25% by mass. The polyamic acid had a number average molecular weight of 21,600 and a weight average molecular weight of 65,100.

<合成例17> <Synthesis Example 17>

於依合成例16之合成手法所得之聚醯胺酸溶液(16)(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.50g)及吡啶(3.30g),於80℃下反應3小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(17)。此聚醯亞胺的醯亞胺化率為81%,數平均分子量為18,800、重量平均分子量為52,200。 In the polyamic acid solution (16) (30.0 g) obtained by the synthetic method of Synthesis Example 16, after adding NMP to 6 mass%, acetic anhydride (4.50 g) and pyridine as a ruthenium catalyst were added. (3.30 g), reacted at 80 ° C for 3 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (17). The polyimine had an oxime imidation ratio of 81%, a number average molecular weight of 18,800, and a weight average molecular weight of 52,200.

<合成例18> <Synthesis Example 18>

將E2(1.73g,6.91mmol)、A3(0.89g,4.38mmol)、C3(2.65g,6.13mmol)及D2(1.07g,7.00mmol)於NEP(17.1g)中混合,於80℃下反應6小時後,再加入E5(2.20g,10.4mmol)與NEP(8.54g),於80℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E2 (1.73g, 6.91mmol), A3 (0.89g, 4.38mmol), C3 (2.65g, 6.13mmol) and D2 (1.07g, 7.00mmol) were mixed in NEP (17.1g) and reacted at 80 °C After 6 hours, E5 (2.20 g, 10.4 mmol) and NEP (8.54 g) were further added, and the mixture was reacted at 80 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25% by mass.

於所得聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(4.10g)及吡啶(3.05g),於70℃下反應2.5小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以 甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(18)。此聚醯亞胺的醯亞胺化率為74%,數平均分子量為17,900、重量平均分子量為48,300。 After the NMP was diluted to 6% by mass in the obtained polyamidic acid solution (30.0 g), acetic anhydride (4.10 g) and pyridine (3.05 g) as a ruthenium catalyst were added, and the reaction was carried out at 70 ° C. hour. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate is The mixture was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder (18). The polyamidimide had a ruthenium iodide ratio of 74%, a number average molecular weight of 17,900, and a weight average molecular weight of 48,300.

<合成例19> <Synthesis Example 19>

將E2(0.80g,3.18mmol)、A1(0.96g,4.83mmol)、C1(3.37g,8.86mmol)及D2(0.37g,2.42mmol)於NMP(16.4g)中混合,於80℃下反應6小時後,再加入E5(2.70g,12.7mmol)與NMP(8.20g),於80℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E2 (0.80 g, 3.18 mmol), A1 (0.96 g, 4.83 mmol), C1 (3.37 g, 8.86 mmol) and D2 (0.37 g, 2.42 mmol) were mixed in NMP (16.4 g) and reacted at 80 ° C After 6 hours, E5 (2.70 g, 12.7 mmol) and NMP (8.20 g) were further added and reacted at 80 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25% by mass.

於所得聚醯胺酸溶液(30.0g)中,加入NMP稀釋至6質量%之後,加入作為醯亞胺化觸媒之乙酸酐(3.75g)及吡啶(2.55g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(19)。此聚醯亞胺的醯亞胺化率為55%,數平均分子量為16,800、重量平均分子量為46,200。 After the NMP was diluted to 6% by mass in the obtained polyamic acid solution (30.0 g), acetic anhydride (3.75 g) and pyridine (2.55 g) as a ruthenium amide catalyst were added, and the reaction was carried out at 60 ° C. 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (19). The polyimine had a quinone imidization ratio of 55%, a number average molecular weight of 16,800, and a weight average molecular weight of 46,200.

<合成例20> <Synthesis Example 20>

將E1(5.00g,25.5mmol)、C1(0.98g,2.58mmol)及D1(2.51g,23.2mmol)於NMP(25.5g)中混合,於40℃下反應8小時,製得樹脂固形分濃度25質量%的聚醯胺酸溶液(20)。此聚醯胺酸的數平均分子量為25,800、重量平均分子量為88,900。 E1 (5.00 g, 25.5 mmol), C1 (0.98 g, 2.58 mmol) and D1 (2.51 g, 23.2 mmol) were mixed in NMP (25.5 g), and reacted at 40 ° C for 8 hours to obtain a solid concentration of the resin. 25 mass% polylysine solution (20). The polyamic acid had a number average molecular weight of 25,800 and a weight average molecular weight of 88,900.

<合成例21> <Synthesis Example 21>

將E1(5.00g,25.5mmol)、D1(1.96g,18.1mmol)及D2(1.18g,7.75mmol)於NMP(24.4g)中混合,於40℃下反應8小時,製得樹脂固形分濃度25質量%的聚醯胺酸溶液(21)。此聚醯胺酸的數平均分子量為27,100、重量平均分子量為90,100。 E1 (5.00 g, 25.5 mmol), D1 (1.96 g, 18.1 mmol) and D2 (1.18 g, 7.75 mmol) were mixed in NMP (24.4 g), and reacted at 40 ° C for 8 hours to obtain a solid concentration of the resin. 25 mass% polylysine solution (21). The polyamic acid had a number average molecular weight of 27,100 and a weight average molecular weight of 90,100.

<合成例22> <Synthesis Example 22>

將E2(4.08g,16.3mmol)、C1(6.29g,16.5mmol)、D1(1.07g,9.92mmol)及D2(1.01g,6.61mmol)於NEP(31.3g)中混合,於80℃下反應5小時後,再加入E1(3.20g,16.3mmol)與NEP(15.7g),於40℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液(22)。此聚醯胺酸的數平均分子量為22,500、重量平均分子量為66,900。 E2 (4.08 g, 16.3 mmol), C1 (6.29 g, 16.5 mmol), D1 (1.07 g, 9.92 mmol) and D2 (1.01 g, 6.61 mmol) were mixed in NEP (31.3 g) and reacted at 80 ° C After 5 hours, E1 (3.20 g, 16.3 mmol) and NEP (15.7 g) were further added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (22) having a resin solid concentration of 25% by mass. The polyamic acid had a number average molecular weight of 22,500 and a weight average molecular weight of 66,900.

<合成例23> <Synthesis Example 23>

於依合成例22之合成手法所得之聚醯胺酸溶液(22)(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.40g)及吡啶(2.50g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(23)。此聚醯亞胺的醯亞胺化率為55%,數平均分子量為19,200、重量平均分子量為 50,600。 In the polyamic acid solution (22) (30.0 g) obtained by the synthetic method of Synthesis Example 22, after adding NEP to 6 mass%, acetic anhydride (3.40 g) and pyridine as a ruthenium catalyst were added. (2.50 g), and reacted at 60 ° C for 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (23). The polyamidimide has a quinone imidization ratio of 55%, a number average molecular weight of 19,200, and a weight average molecular weight of 50,600.

<合成例24> <Synthesis Example 24>

將E2(4.72g,18.9mmol)、C1(2.91g,7.64mmol)、D1(1.24g,11.5mmol)及D2(2.91g,19.1mmol)於NEP(31.0g)中混合,於80℃下反應5小時後,再加入E1(3.70g,18.9mmol)與NEP(15.5g),於40℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液(24)。此聚醯胺酸的數平均分子量為23,000、重量平均分子量為68,800。 E2 (4.72 g, 18.9 mmol), C1 (2.91 g, 7.64 mmol), D1 (1.24 g, 11.5 mmol) and D2 (2.91 g, 19.1 mmol) were mixed in NEP (31.0 g) and reacted at 80 ° C After 5 hours, E1 (3.70 g, 18.9 mmol) and NEP (15.5 g) were further added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (24) having a resin solid concentration of 25% by mass. This polyamic acid had a number average molecular weight of 23,000 and a weight average molecular weight of 68,800.

<合成例25> <Synthesis Example 25>

於依合成例24之合成手法所得之聚醯胺酸溶液(24)(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.40g)及吡啶(2.65g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(25)。此聚醯亞胺的醯亞胺化率為57%,數平均分子量為20,100、重量平均分子量為54,100。 In the polyamic acid solution (24) (30.0 g) obtained by the synthetic method of Synthesis Example 24, after adding NEP to 6% by mass, acetic anhydride (3.40 g) and pyridine as a ruthenium catalyst were added. (2.65 g), and reacted at 60 ° C for 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (25). The polyamidimide had a ruthenium iodide ratio of 57%, a number average molecular weight of 20,100, and a weight average molecular weight of 54,100.

<合成例26> <Synthesis Example 26>

將E2(2.04g,8.16mmol)、A1(0.99g,4.96mmol)、D2(0.50g,3.31mmol)及D3(3.11g,8.26mmol)於NEP(16.5g)中混合,於80℃下反應5小時後,再加入E1(1.60g, 8.16mmol)與NEP(8.25g),於40℃下反應6小時,得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E2 (2.04 g, 8.16 mmol), A1 (0.99 g, 4.96 mmol), D2 (0.50 g, 3.31 mmol) and D3 (3.11 g, 8.26 mmol) were mixed in NEP (16.5 g) and reacted at 80 ° C After 5 hours, add E1 (1.60g, 8.16 mmol) and NEP (8.25 g) were reacted at 40 ° C for 6 hours to obtain a polyaminic acid solution having a resin solid concentration of 25% by mass.

於所得聚醯胺酸溶液(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.45g)及吡啶(2.65g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(26)。此聚醯亞胺的醯亞胺化率為54%,數平均分子量為17,600、重量平均分子量為49,200。 After the NEPP was diluted to 6% by mass in the obtained polyamic acid solution (30.0 g), acetic anhydride (3.45 g) and pyridine (2.65 g) as a ruthenium catalyst were added, and the reaction was carried out at 60 ° C. 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (26). The polyimine had a ruthenium iodide ratio of 54%, a number average molecular weight of 17,600, and a weight average molecular weight of 49,200.

<合成例27> <Synthesis Example 27>

將E2(2.23g,8.92mmol)、B1(1.62g,5.42mmol)、D2(1.38g,9.04mmol)及D3(1.36g,3.62mmol)於NEP(16.7g)中混合,於80℃下反應5小時後,再加入E1(1.75g,8.92mmol)與NEP(8.34g),於40℃下反應6小時,製得樹脂固形分濃度為25質量%的聚醯胺酸溶液。 E2 (2.23 g, 8.92 mmol), B1 (1.62 g, 5.42 mmol), D2 (1.38 g, 9.04 mmol) and D3 (1.36 g, 3.62 mmol) were mixed in NEP (16.7 g) and reacted at 80 ° C After 5 hours, E1 (1.75 g, 8.92 mmol) and NEP (8.34 g) were further added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25% by mass.

於所得聚醯胺酸溶液(30.0g)中,加入NEP稀釋至6質量%後,加入作為醯亞胺化觸媒之乙酸酐(3.45g)及吡啶(2.65g),再於60℃下反應2小時。將此反應溶液投入甲醇(460ml)中,濾出所得沈澱物。此沈澱物以甲醇洗淨,於100℃下減壓乾燥,而製得聚醯亞胺粉末(27)。此聚醯亞胺的醯亞胺化率為57%,數平均分子量為18,600、重量平均分子量為51,500。 After the NEPP was diluted to 6% by mass in the obtained polyamic acid solution (30.0 g), acetic anhydride (3.45 g) and pyridine (2.65 g) as a ruthenium catalyst were added, and the reaction was carried out at 60 ° C. 2 hours. The reaction solution was poured into methanol (460 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (27). This polyimine had a ruthenium iodide ratio of 57%, a number average molecular weight of 18,600, and a weight average molecular weight of 51,500.

本發明之聚醯亞胺系聚合物係如表2~表4所 示。 The polyimide-based polymer of the present invention is as shown in Tables 2 to 4 Show.

「本發明之液晶配向處理劑之製造」 "Manufacture of Liquid Crystal Alignment Treatment Agent of the Present Invention"

下述實施例1~實施例19及比較例1~比較例8中,為記載液晶配向處理劑之製造例。又,該液晶配向處理劑,亦被使用於評估內容中。 In the following Examples 1 to 19 and Comparative Examples 1 to 8, the production examples of the liquid crystal alignment treatment agent are described. Further, the liquid crystal alignment treatment agent is also used in the evaluation contents.

本發明之液晶配向處理劑係如表5~表7所示。 The liquid crystal alignment treatment agent of the present invention is shown in Tables 5 to 7.

使用本發明之實施例及比較例所得之液晶配向處理劑,進行「液晶配向處理劑的噴霧塗佈性之評估」、「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」、「減緩殘留電荷之評估(一般晶胞)」及「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」。 Using the liquid crystal alignment treatment agent obtained in the examples and the comparative examples of the present invention, "evaluation of spray coating property of liquid crystal alignment treatment agent", "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", and " Evaluation of voltage holding ratio (general unit cell), "evaluation of residual charge (general unit cell)" and "production of liquid crystal cell and evaluation of liquid crystal alignment (PSA unit cell)".

「液晶配向處理劑的噴霧塗佈性之評估」 "Evaluation of spray coating properties of liquid crystal alignment agents"

將本發明之實施例4所得之液晶配向處理劑(4)、實施例9所得之液晶配向處理劑(9)及實施例15所得之液晶配向處理劑(15),使用細孔徑1μm的膜式過濾器進行加壓過濾,進行噴霧塗佈性之評估。噴霧塗佈機,為使用HIS-200(日立Plant Technologies公司製)者。塗佈為,於經純水及IPA洗淨之ITO(氧化銦錫)蒸鍍基板上,依噴嘴間距為0.423mm、掃瞄間距為0.5mm、塗佈速度為40mm/秒、由塗佈至預乾燥為止的時間為60秒、預乾燥於加熱板上為70℃、5分鐘之條件下進行。 The liquid crystal alignment treatment agent (4) obtained in Example 4 of the present invention, the liquid crystal alignment treatment agent (9) obtained in Example 9, and the liquid crystal alignment treatment agent (15) obtained in Example 15 were formed into a membrane having a pore diameter of 1 μm. The filter was subjected to pressure filtration to evaluate the spray coating property. The spray coater was a HIS-200 (manufactured by Hitachi Plant Technologies Co., Ltd.). The coating was applied to an ITO (Indium Tin Oxide) vapor-deposited substrate washed with pure water and IPA at a nozzle pitch of 0.423 mm, a scanning pitch of 0.5 mm, and a coating speed of 40 mm/sec. The time until pre-drying was 60 seconds, and pre-drying was performed on the hot plate at 70 ° C for 5 minutes.

確認所得附有液晶配向膜之基板的塗膜性。 具體而言,於鈉燈下以目視進行塗膜之觀察,確認有無沙孔。由其結果得知,無論任一實施例所得之液晶配向膜,於塗膜上皆未發線沙孔,而製得具有優良塗膜性之液晶配向膜。 The coating property of the obtained substrate with the liquid crystal alignment film was confirmed. Specifically, the coating film was visually observed under a sodium lamp to confirm the presence or absence of sand holes. As a result, it was found that the liquid crystal alignment film obtained in any of the examples had no sand holes on the coating film, and a liquid crystal alignment film having excellent film properties was obtained.

「液晶晶胞之製作及預傾角之評估(一般晶胞)」 "Production of Liquid Crystal Cell and Evaluation of Pretilt Angle (General Cell)"

將本發明之實施例及比較例所得之液晶配向處理劑,使用細孔徑1μm的膜式過濾器進行加壓過濾,進行液晶晶胞之製作(一般晶胞)。將此溶液旋轉塗佈於經純水及IPA洗淨之40×30mm的附有ITO電極之基板(縱40mm×橫30mm、厚度0.7mm)之ITO面上,於加熱板上以100℃、5分鐘、熱循環型無塵烘箱中以230℃、30分鐘進行加熱處理,製得膜厚為100nm的附有聚醯亞胺液晶配向膜之ITO基板。又,本發明之實施例4所得之液晶配向處理劑(4)、實施例9所得之液晶配向處理劑(9)及實施例15所得之液晶配向處理劑(15),為依與上述「液晶配向處理劑的噴霧塗佈性之評估」為相同之條件下,製作附有液晶配向膜之基板,隨後,於熱循環型無塵烘箱中,以230℃、30分鐘進行加熱處理,製得膜厚為100nm的附有聚醯亞胺液晶配向膜之ITO基板。 The liquid crystal alignment treatment agent obtained in the examples and the comparative examples of the present invention was subjected to pressure filtration using a membrane filter having a pore size of 1 μm to prepare a liquid crystal cell (general unit cell). This solution was spin-coated on an ITO surface of a 40×30 mm substrate (length 40 mm × width 30 mm, thickness 0.7 mm) washed with pure water and IPA, and dried at 100 ° C, 5 on a hot plate. The ITO substrate with a polyimine liquid crystal alignment film having a film thickness of 100 nm was heat-treated at 230 ° C for 30 minutes in a minute, heat cycle type dust-free oven. Further, the liquid crystal alignment treatment agent (4) obtained in Example 4 of the present invention, the liquid crystal alignment treatment agent (9) obtained in Example 9, and the liquid crystal alignment treatment agent (15) obtained in Example 15 are in accordance with the above "liquid crystal". The evaluation of the spray coating property of the alignment treatment agent was carried out under the same conditions to prepare a substrate with a liquid crystal alignment film, followed by heat treatment at 230 ° C for 30 minutes in a heat cycle type dust-free oven to obtain a film. An ITO substrate having a thickness of 100 nm and having a polyimide film alignment film.

將此ITO基板的塗膜面置於滾筒徑為120mm之摩擦裝置,使用人造絲布,以滾筒迴轉數為1000rpm、滾筒行進速度為50mm/sec、加壓量為0.1mm之條件下進行摩擦處理。 The coating film surface of the ITO substrate was placed in a friction device having a drum diameter of 120 mm, and rayon cloth was used, and rubbing treatment was performed under the conditions of a drum rotation number of 1000 rpm, a drum traveling speed of 50 mm/sec, and a pressing amount of 0.1 mm. .

準備2片所得之附有液晶配向膜的ITO基板,以液晶配向膜面向內側之方式挾夾6μm之間隔器予以組合,使用密封劑接著周圍之方式製作空晶胞。將此空晶胞使用減壓注入法,注入向列液晶後,將注入口密封而製得液晶晶胞(一般晶胞)。 Two sheets of the obtained ITO substrate with the liquid crystal alignment film were prepared, and a spacer of 6 μm was sandwiched so that the liquid crystal alignment film faces inward, and an empty cell was formed by using a sealant and then surrounding. This empty unit cell was injected into the nematic liquid crystal by a reduced pressure injection method, and the injection port was sealed to obtain a liquid crystal cell (general unit cell).

又,於使用實施例1所得之液晶配向處理劑(1)及比較例(1)所得之液晶配向處理劑(21)所製得的液晶晶胞中,液晶為使用MLC-2003(默克‧日本公司製)。又,該些以外的實施例及比較例所得之液晶配向處理劑所使用得晶胞中,其液晶為使用MLC-6608(默克‧日本公司製)。 Further, in the liquid crystal cell obtained by using the liquid crystal alignment treatment agent (1) obtained in Example 1 and the liquid crystal alignment treatment agent (21) obtained in Comparative Example (1), the liquid crystal was MLC-2003 (Merck ‧ Japanese company system). In the liquid crystal cells used in the liquid crystal alignment treatment agents obtained in the examples and the comparative examples, the liquid crystal was MLC-6608 (manufactured by Merck & Co., Ltd.).

其次,對該液晶晶胞(一般晶胞)之預傾角進行測定。預傾角,於進行液晶之等向性處理(95℃下施以5分鐘加熱處理)之後,測定將其進行加熱處理(120℃下施以5小時加熱處理)後的液晶晶胞。 Next, the pretilt angle of the liquid crystal cell (general unit cell) was measured. The pretilt angle was subjected to an isotropic treatment of liquid crystal (heat treatment at 95 ° C for 5 minutes), and then the liquid crystal cell after heat treatment (heat treatment at 120 ° C for 5 hours) was measured.

此外,於對依上述相同條件下所製作之液晶晶胞進行等向性處理之後,亦對於以365nm換算為10J/cm2的紫外線照射後之液晶晶胞進行測定。又,預傾角為使用PAS-301(ELSICON製),於室溫下進行測定。此外,紫外線之照射,為使用桌上型UV硬化裝置(HCT3B28HEX-1)(SEN LIGHT製)進行測定。 Further, after the isotropic treatment of the liquid crystal cell prepared under the same conditions as described above, the liquid crystal cell after irradiation with ultraviolet rays of 10 J/cm 2 in terms of 365 nm was also measured. Further, the pretilt angle was measured at room temperature using PAS-301 (manufactured by ELSICON). Further, the irradiation of ultraviolet rays was carried out by using a desktop type UV curing device (HCT3B28HEX-1) (manufactured by SEN LIGHT).

評估為,對於經液晶等向性處理後(亦稱為Iso處理後)之預傾角,以經加熱處理後(亦稱為高溫處理後)及經紫外線照射後(亦稱為紫外線照射後)之預傾角的變 化越小者,顯示為良好(表8~表10中,為標示經Iso處理後、高溫處理後及紫外線照射後的預傾角之值)。 It is evaluated as the pretilt angle after liquid crystal isotropic treatment (also known as Iso treatment) after heat treatment (also known as high temperature treatment) and after ultraviolet irradiation (also known as ultraviolet irradiation). Pretilt angle change The smaller the amount, the better (in Table 8 to Table 10, the value of the pretilt angle after Iso treatment, high temperature treatment, and ultraviolet irradiation).

表8~表10中,為標記實施例及比較例所得之結果。 In Tables 8 to 10, the results obtained by labeling the examples and the comparative examples are shown.

「電壓保持率之評估(一般晶胞)」 "Evaluation of Voltage Retention Rate (General Cell)"

使用依與上述「液晶晶胞之製作及預傾角之評估(一般晶胞)」相同條件下所製作的液晶晶胞(一般晶胞),進行電壓保持率之評估。具體而言,於依上述手法所得之液晶晶胞(一般晶胞)上,於80℃之溫度下,施加1V的電壓60μs後,測定50ms後的電壓,並計算電壓究竟可保持至何種程度之結果,作為電壓保持率(亦稱為VHR)。又,測定為使用電壓保持率測定裝置(VHR-1)(東陽科技公司製),於Voltage:±1V、Pulse Width:60μs、Flame Period:50ms之設定下進行。 The liquid crystal cell (general cell) prepared under the same conditions as the above-mentioned "production of liquid crystal cell and evaluation of pretilt angle (general cell)" was used to evaluate the voltage holding ratio. Specifically, on the liquid crystal cell (general unit cell) obtained by the above method, a voltage of 1 V is applied at a temperature of 80 ° C for 60 μs, and the voltage after 50 ms is measured, and the degree to which the voltage can be maintained is calculated. As a result, it is used as a voltage holding ratio (also referred to as VHR). Further, the measurement was carried out using a voltage holding ratio measuring device (VHR-1) (manufactured by Toyo Kagyo Co., Ltd.) under the settings of Voltage: ±1 V, Pulse Width: 60 μs, and Flame Period: 50 ms.

此外,對於測定上述液晶晶胞製作後之即時電壓保持率結束後的液晶晶胞,使用桌上型UV硬化裝置(HCT3B28HEX-1)(SEN LIGHT公司製),照射365nm換算為50J/cm2的紫外線,並依與上述相同條件下進行電壓保持率之測定。 In addition, the liquid crystal cell after the completion of the instantaneous voltage holding ratio after the production of the liquid crystal cell was measured, and a table type UV curing device (HCT3B28HEX-1) (manufactured by SEN LIGHT Co., Ltd.) was used, and the irradiation was performed at 365 nm in an amount of 50 J/cm 2 . Ultraviolet rays were measured under the same conditions as above.

評估為,對液晶晶胞製作後即時的電壓保持率之值為越高,此外,對液晶晶胞製作後即時的電壓保持率之值而言,經紫外線照射後之值的降低越小者,則標記為良好(表11~表13中,為標記液晶晶胞製作後即時,及 紫外線照射後之VHR之值)。 It is evaluated that the value of the voltage holding ratio immediately after the liquid crystal cell is produced is higher, and the value of the voltage holding ratio immediately after the liquid crystal cell is produced is smaller as the value after the ultraviolet irradiation is smaller. Marked as good (in Tables 11 to 13), immediately after the marking liquid crystal cell is fabricated, and The value of VHR after ultraviolet irradiation).

表11~表13中,為標記實施例及比較例所得之結果。 In Tables 11 to 13, the results obtained by labeling the examples and the comparative examples are shown.

「減緩殘留電荷之評估(一般晶胞)」 "Evaluation of Residual Charge Reduction (General Cell)"

使用依與上述「液晶晶胞之製作及預傾角之評估(一般晶胞)」相同條件下所製作的液晶晶胞(一般晶胞),進行減緩殘留電荷之評估。具體而言,為對液晶晶胞施加直流電壓10V、30分鐘,使其短路1秒鐘後,測定於1800秒間於液晶晶胞內所發生之電位。於其中,使用50秒後的殘留電荷之值,作為減緩殘留電荷之評估。又,測定為使用6254型液晶物性評估裝置(東陽科技公司製)。 The liquid crystal cell (general unit cell) produced under the same conditions as the above-mentioned "production of liquid crystal cell and evaluation of pretilt angle (general cell)" was used to evaluate the residual charge. Specifically, a direct current voltage of 10 V for 30 minutes was applied to the liquid crystal cell, and after short-circuiting for 1 second, the potential generated in the liquid crystal cell was measured at 1800 seconds. Here, the value of the residual charge after 50 seconds was used as an evaluation for slowing down the residual charge. Further, it was measured to use a 6254 liquid crystal physical property evaluation device (manufactured by Toyo Corporation).

此外,於測定上述液晶晶胞製作後即時的殘留電荷結束後的液晶晶胞,使用桌上型UV硬化裝置(HCT3B28HEX-1)(SEN LIGHT公司製),照射365nm換算為30J/cm2的紫外線,並依上述相同之條件進行殘留電荷之測定。 In addition, the liquid crystal cell after the completion of the residual charge immediately after the production of the liquid crystal cell was measured and irradiated with ultraviolet rays of 30 J/cm 2 at 365 nm using a desktop UV curing device (HCT3B28HEX-1) (manufactured by SEN LIGHT Co., Ltd.). The residual charge was measured under the same conditions as above.

評估為,液晶晶胞製作後即時,及紫外線照射後的殘留電荷之值越小時,表示為良好(表11~表13中,為標記液晶晶胞製作後即時,及紫外線照射後的殘留電荷之值)。 It is evaluated that the liquid crystal cell is immediately after the production, and the value of the residual charge after the ultraviolet irradiation is small, which is expressed as good (in Tables 11 to 13), immediately after the production of the labeled liquid crystal cell, and the residual charge after the ultraviolet irradiation. value).

表11~表13中,為標記實施例及比較例所得之結果。 In Tables 11 to 13, the results obtained by labeling the examples and the comparative examples are shown.

「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」 "Production of Liquid Crystal Cell and Evaluation of Liquid Crystal Alignment (PSA Cell)"

將實施例3所得之液晶配向處理劑(3)、實施例5所得之液晶配向處理劑(5)、實施例6所得之液晶配向處理劑(6)、實施例8所得之液晶配向處理劑(8)及實施例16所得之液晶配向處理劑(16),使用細孔徑1μm的膜式過濾器進行加壓過濾,並進行液晶晶胞之製作及液晶配向性之評估(PSA晶胞)。將此溶液旋轉塗佈於經純水及IPA洗淨之中心具有間隔的20μm的10×10mm之圖型的附有ITO電極之基板(縱40mm×橫30mm、厚度0.7mm),與中心具有附有10×40mm的ITO電極之基板(縱40mm×橫30mm、厚度0.7mm)之ITO面上,於加熱板上以100℃、5分鐘、熱循環型無塵烘箱中以230℃、30分鐘進行加熱處理,得膜厚為100nm之聚醯亞胺塗膜。 The liquid crystal alignment treatment agent (3) obtained in Example 3, the liquid crystal alignment treatment agent (5) obtained in Example 5, the liquid crystal alignment treatment agent (6) obtained in Example 6, and the liquid crystal alignment treatment agent obtained in Example 8 ( 8) The liquid crystal alignment treatment agent (16) obtained in Example 16 was subjected to pressure filtration using a membrane filter having a pore size of 1 μm, and liquid crystal cell production and liquid crystal alignment (PSA unit cell) were evaluated. This solution was spin-coated on a substrate with an ITO electrode (length 40 mm × width 30 mm, thickness 0.7 mm) of a 10 μm 10 × 10 mm pattern having a space of 100 °m in the center of pure water and IPA washing, and attached to the center. The ITO surface of a substrate having a 10×40 mm ITO electrode (40 mm in length × 30 mm in width, 0.7 mm in thickness) was placed on a hot plate at 300 ° C for 5 minutes in a heat-recycling type dust-free oven at 230 ° C for 30 minutes. The film was heat-treated to obtain a polyimide film having a film thickness of 100 nm.

將此附有液晶配向膜之基板,以液晶配向膜面作為內側之方式,挾夾6μm的間隔器予以組合,並以密封劑接著周圍而製得空晶胞。此空晶胞使用減壓注入法,注入於向列型液晶(MLC-6608)(默克‧日本公司製)之下述式所示聚合性化合物(1),混合相對於向列型液晶(MLC-6608)之100質量%為0.3質量%的聚合性化合物(1)所得之液晶後,密封注入口,製得液晶晶胞。 The substrate to which the liquid crystal alignment film was attached was combined so that the liquid crystal alignment film surface was inside, and a spacer of 6 μm was sandwiched, and an empty cell was obtained by encapsulating the periphery. This empty cell is injected into a nematic liquid crystal (MLC-6608) (manufactured by Merck & Co., Inc.) as a polymerizable compound (1) represented by the following formula, and mixed with a nematic liquid crystal (for the liquid crystal cell). After the liquid crystal obtained by the polymerizable compound (1) of 100% by mass of 100% by mass of MLC-6608), the injection port was sealed to obtain a liquid crystal cell.

對所得之液晶晶胞,於持續施加交流5V之電壓中,使用照度60mW之金屬鹵化物燈,切斷350nm以下之波長,使用365nm換算為20J/cm2的紫外線進行照射,製得液晶配向方向受到控制的液晶晶胞(PSA晶胞)。使用紫外線照射液晶晶胞之際,其照射裝置內的溫度為50℃。 In the obtained liquid crystal cell, a metal halide lamp having an illuminance of 60 mW was used, and a wavelength of 350 nm or less was cut by using a metal halide lamp having an illuminance of 60 mW, and irradiation was performed using ultraviolet rays of 20 J/cm 2 in terms of 365 nm to obtain a liquid crystal alignment direction. Controlled liquid crystal cell (PSA unit cell). When the liquid crystal cell was irradiated with ultraviolet rays, the temperature in the irradiation device was 50 °C.

測定此液晶晶胞於紫外線照射前與紫外線照射後的液晶之應答速度。應答速度為,測定由透過率90%至透過率10%為止的T90→T10。 The response speed of the liquid crystal cell before the ultraviolet irradiation and the liquid crystal after the ultraviolet irradiation was measured. The response speed was measured from T90 to T10 from a transmittance of 90% to a transmittance of 10%.

任一實施例所得之PSA晶胞,與紫外線照射前之液晶晶胞相比較時,得知紫外線照射後之液晶晶胞的應答速度更為快速,而確認液晶之配向方向受到控制。又,無論任一液晶晶胞,於使用偏光顯微鏡(ECLIPSE E600WPOL)(尼康公司製)觀察時,皆確認液晶為呈現均勻配向。 When the PSA unit cell obtained in any of the examples was compared with the liquid crystal cell before the ultraviolet irradiation, it was found that the response speed of the liquid crystal cell after the ultraviolet irradiation was faster, and it was confirmed that the alignment direction of the liquid crystal was controlled. Further, in any of the liquid crystal cells, it was confirmed that the liquid crystal exhibited uniform alignment when observed using a polarizing microscope (ECLIPSE E600WPOL) (manufactured by Nikon Corporation).

<實施例1> <Example 1>

於依合成例1之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(1)(5.00g)及合成例2之合成手法所 得之樹脂固形分濃度25質量%的聚醯胺酸溶液(2)(3.33g)中,加入NMP(18.2g)及BCS(8.16g),於25℃下攪拌6小時,得液晶配向處理劑(1)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 A polyamic acid solution (1) (5.00 g) having a solid content of 25% by mass of a resin obtained by the synthetic method of Synthesis Example 1 and a synthetic method of Synthesis Example 2. NMP (18.2 g) and BCS (8.16 g) were added to a polyamic acid solution (2) (3.33 g) having a solid concentration of 25% by mass of a resin, and stirred at 25 ° C for 6 hours to obtain a liquid crystal alignment treatment agent. (1). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(1),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (1), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例2> <Example 2>

於依合成例3之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(3)(4.50g)及合成例5之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(5)(4.50g)中,加入NEP(14.4g)及PB(14.1g),於25℃下攪拌6小時,製得液晶配向處理劑(2)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The resin having a solid concentration of 25% by mass of the polyaminic acid solution (3) (4.50 g) obtained by the synthetic method of Synthesis Example 3 and the synthetic method of Synthesis Example 5 have a solid concentration of 25% by mass of polyamine. NEP (14.4 g) and PB (14.1 g) were added to the acid solution (5) (4.50 g), and the mixture was stirred at 25 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (2). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得之液晶配向處理劑(2),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (2), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage retention rate (general cell)" and "evaluation of residual charge" General unit cell)".

<實施例3> <Example 3>

於依合成例4之合成手法所得之聚醯亞胺粉末(4)(1.15g)及合成例6之合成手法所得之聚醯亞胺粉末(6) (1.15g)中,加入NEP(21.6g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(14.4g),於40℃下攪拌4小時,製得液晶配向處理劑(3)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 Polyimine powder (4) (1.15 g) obtained by the synthetic method of Synthesis Example 4 and polyimine powder obtained by the synthetic method of Synthesis Example 6 (6) In (1.15 g), NEP (21.6 g) was added, and the mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, PB (14.4 g) was added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (3). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得之液晶配向處理劑(3),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」、「減緩殘留電荷之評估(一般晶胞)」及「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」。 Using the obtained liquid crystal alignment treatment agent (3), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)", and "evaluation of residual charge" "General cell") and "Production of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell)".

<實施例4> <Example 4>

於依合成例4之合成手法所得之聚醯亞胺粉末(4)(0.65g)及合成例6之合成手法所得之聚醯亞胺粉末(6)(0.43g)中,加入NEP(14.9g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(5.97g)、PB(8.96g)及K1(0.032g),於40℃下攪拌6小時,製得液晶配向處理劑(4)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NEP (14.9 g) was added to the polyimine powder (6) (0.43 g) obtained by the synthetic method of Synthesis Example 4 and the polyimine powder (6) (0.43 g) obtained by the synthetic method of Synthesis Example 6. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, BCS (5.97 g), PB (8.96 g) and K1 (0.032 g) were added, and the mixture was stirred at 40 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (4). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(4),進行「液晶配向處理劑的噴霧塗佈性之評估」、「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment agent (4), "evaluation of spray coating property of liquid crystal alignment treatment agent", "production of liquid crystal cell and evaluation of pretilt angle (general cell)", and evaluation of voltage holding ratio ( "General unit cell" and "Evaluation of residual charge reduction (general unit cell)".

<實施例5> <Example 5>

於依合成例7之合成手法所得之聚醯亞胺粉末(7)(1.65g)及合成例8之合成手法所得之聚醯亞胺粉末(8)(0.71g)中,加入NMP(20.3g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(12.9g)及DME(3.69g),於40℃下攪拌4小時,製得液晶配向處理劑(5)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NMP (20.3 g) was added to the polyimine powder (8) (0.71 g) obtained by the synthetic method of Synthesis Example 7 and the polyimine powder (8) (0.71 g) obtained by the synthetic method of Synthesis Example 8. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, BCS (12.9 g) and DME (3.69 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (5). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(5),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」、「減緩殘留電荷之評估(一般晶胞)」及「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」。 Using the obtained liquid crystal alignment agent (5), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)", "evaluation of residual charge" (general "Unit cell" and "Production of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell)".

<實施例6> <Example 6>

於依合成例9之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(9)(3.50g)及合成例5之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(5)(5.25g)中,加入NEP(14.0g)、PB(10.3g)及EC(3.43g),於25℃下攪拌6小時,製得液晶配向處理劑(6)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The resin obtained by the synthetic method of Synthesis Example 9 has a solid concentration of 25% by mass of a polyaminic acid solution (9) (3.50 g) and a synthetic method of Synthesis Example 5, and a resin having a solid concentration of 25% by mass of polyamine. NEP (14.0 g), PB (10.3 g) and EC (3.43 g) were added to the acid solution (5) (5.25 g), and the mixture was stirred at 25 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (6). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(6),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」、「減緩殘留電荷之評估(一般晶胞)」及「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」。 Using the obtained liquid crystal alignment agent (6), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)", "evaluation of residual charge" (general "Unit cell" and "Production of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell)".

<實施例7> <Example 7>

於依合成例10之合成手法所得之聚醯亞胺粉末(10)(1.75g)中,加入NEP(15.0g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(11.0g)及DME(1.37g),於40℃下攪拌4小時,製得溶液。 NEP (15.0 g) was added to the polyimine powder (10) (1.75 g) obtained by the synthetic method of Synthesis Example 10, and the mixture was stirred at 70 ° C for 24 hours to dissolve. To this solution, PB (11.0 g) and DME (1.37 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a solution.

另一方面,於依合成例6之合成手法所得之聚醯亞胺粉末(6)(0.44g)中,加入NEP(3.80g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(2.70g)及DME(0.34g),於40℃下攪拌4小時,製得溶液。 On the other hand, NEP (3.80 g) was added to the polyimine powder (6) (0.44 g) obtained by the synthetic method of Synthesis Example 6, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. To this solution, PB (2.70 g) and DME (0.34 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a solution.

將上述所得之2個溶液混合,再加入K1(0.153g),於40℃下攪拌6小時,製得液晶配向處理劑(7)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The two solutions obtained above were mixed, K1 (0.153 g) was further added, and the mixture was stirred at 40 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (7). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(7),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (7), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例8> <Example 8>

於依合成例11之合成手法所得之聚醯亞胺粉末(11)(0.75g)及合成例8之合成手法所得之聚醯亞胺粉末(8)(1.39g)中,加入NMP(6.71g)及NEP(13.4g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(13.4g)及 K1(0.107g),於40℃下攪拌6小時,製得液晶配向處理劑(8)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NMP (6.71 g) was added to the polyimine powder (8) (1.39 g) obtained by the synthetic method of Synthesis Example 11 and the polyimine powder (8) (1.39 g) obtained by the synthetic method of Synthesis Example 8. And NEP (13.4 g) was stirred at 70 ° C for 24 hours to dissolve. In this solution, PB (13.4g) and K1 (0.107 g) was stirred at 40 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (8). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(8),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」、「減緩殘留電荷之評估(一般晶胞)」及「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」。 Using the obtained liquid crystal alignment treatment agent (8), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)", and "evaluation of residual charge" (general "Unit cell" and "Production of liquid crystal cell and evaluation of liquid crystal alignment (PSA cell)".

<實施例9> <Example 9>

於依合成例11之合成手法所得之聚醯亞胺粉末(11)(0.55g)及合成例8之合成手法所得之聚醯亞胺粉末(8)(0.83g)中,加入NEP(15.2g)及γ-BL(3.79g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(15.2g)及DME(3.79g),於40℃下攪拌4小時,製得液晶配向處理劑(9)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 In the polyimine powder (8) (0.83 g) obtained by the synthetic method of Synthesis Example 11 and the polyimine powder (8) (0.83 g) obtained by the synthetic method of Synthesis Example 8, NEP (15.2 g) was added. And γ-BL (3.79 g) were stirred at 70 ° C for 24 hours to dissolve. To the solution, PB (15.2 g) and DME (3.79 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (9). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(9),進行「液晶配向處理劑的噴霧塗佈性之評估」、「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (9), "evaluation of spray coating property of liquid crystal alignment treatment agent", "production of liquid crystal cell and evaluation of pretilt angle (general cell)", and evaluation of voltage holding ratio ( "General unit cell" and "Evaluation of residual charge reduction (general unit cell)".

<實施例10> <Example 10>

於依合成例4之合成手法所得之聚醯亞胺粉末(4)(1.10g)中,加入NMP(1.73g)及NEP(6.90g),於70℃下 攪拌24小時,使其溶解。於此溶液中,加入BCS(1.73g)及PB(6.90g),於40℃下攪拌4小時,製得溶液。 In the polyimine powder (4) (1.10 g) obtained by the synthetic method of Synthesis Example 4, NMP (1.73 g) and NEP (6.90 g) were added at 70 ° C. Stir for 24 hours to dissolve. To this solution, BCS (1.73 g) and PB (6.90 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a solution.

另一方面,於依合成例12之合成手法所得之聚醯亞胺粉末(12)(1.10g)中,加入NMP(1.73g)及NEP(6.90g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(1.73g)及PB(6.90g),於40℃下攪拌4小時,製得溶液。 On the other hand, NMP (1.73 g) and NEP (6.90 g) were added to the polyimine powder (12) (1.10 g) obtained by the synthetic method of Synthesis Example 12, and the mixture was stirred at 70 ° C for 24 hours. It dissolves. To this solution, BCS (1.73 g) and PB (6.90 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a solution.

將上述所得之2個溶液混合,於25℃下攪拌6小時,製得液晶配向處理劑(10)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The two solutions obtained above were mixed and stirred at 25 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (10). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(10),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (10), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例11> <Example 11>

於依合成例13之合成手法所得之聚醯亞胺粉末(13)(1.25g)及合成例8之合成手法所得之聚醯亞胺粉末(8)(0.83g)中,加入NEP(13.1g)及γ-BL(3.26g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(13.1g)及EC(3.26g),於40℃下攪拌4小時,製得液晶配向處理劑(11)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 In the polyimine powder (13) (1.25 g) obtained by the synthetic method of Synthesis Example 13 and the polyimine powder (8) (0.83 g) obtained by the synthetic method of Synthesis Example 8, NEP (13.1 g) was added. And γ-BL (3.26 g) were stirred at 70 ° C for 24 hours to dissolve. To the solution, BCS (13.1 g) and EC (3.26 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (11). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(11),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (11), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage retention rate (general cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例12> <Example 12>

於依合成例10之合成手法所得之聚醯亞胺粉末(10)(0.65g)及合成例8之合成手法所得之聚醯亞胺粉末(8)(1.52g)中,加入NMP(17.0g)及γ-BL(1.70g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(6.79g)及PB(8.49g),於40℃下攪拌4小時,製得液晶配向處理劑(12)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NMP (17.0 g) was added to the polyimine powder (8) (1.52 g) obtained by the synthetic method of Synthesis Example 10 and the polyimine powder (8) (1.52 g) obtained by the synthetic method of Synthesis Example 8. And γ-BL (1.70 g), and stirred at 70 ° C for 24 hours to dissolve. To the solution, BCS (6.79 g) and PB (8.49 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (12). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(12),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (12), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例13> <Example 13>

於依合成例15之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(15)(4.50g)及合成例16之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(16)(4.50g)中,加入NMP(14.4g)、BCS(3.53g)、PB(10.6g)及K1(0.225g),於40℃下攪拌6小時,製得液晶配向處理劑 (13)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The polyacetamide solution (15) (4.50 g) having a solid concentration of 25% by mass of the resin obtained by the synthetic method of Synthesis Example 15 and the resin having a solid concentration of 25% by mass of the synthetic method of Synthesis Example 16 To the acid solution (16) (4.50 g), NMP (14.4 g), BCS (3.53 g), PB (10.6 g) and K1 (0.225 g) were added, and the mixture was stirred at 40 ° C for 6 hours to obtain a liquid crystal alignment treatment agent. (13). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(13),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (13), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例14> <Example 14>

於依合成例7之合成手法所得之聚醯亞胺粉末(7)(0.90g)及合成例17之合成手法所得之聚醯亞胺粉末(17)(1.35g)中,加入NEP(15.9g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(5.29g)及PB(14.1g),於40℃下攪拌4小時,製得液晶配向處理劑(14)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 In the polyimine powder (17) (1.35 g) obtained by the synthetic method of Synthesis Example 7 and the polyimine powder (17) (1.35 g) obtained by the synthetic method of Synthesis Example 17, NEP (15.9 g) was added. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, BCS (5.29 g) and PB (14.1 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (14). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(14),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (14), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例15> <Example 15>

於依合成例7之合成手法所得之聚醯亞胺粉末(7)(0.55g)及合成例17之合成手法所得之聚醯亞胺粉末(17)(0.83g)中,加入NMP(3.79g)及NEP(15.2g),於70℃下攪 拌24小時,使其溶解。於此溶液中,加入PB(19.0g),於40℃下攪拌4小時,製得液晶配向處理劑(15)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NMP (3.79 g) was added to the polyimine powder (17) (0.83 g) obtained by the synthetic method of Synthesis Example 7 and the polyimine powder (17) (0.83 g) obtained by the synthetic method of Synthesis Example 17. ) and NEP (15.2g), stirred at 70 ° C Mix for 24 hours to dissolve. To the solution, PB (19.0 g) was added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (15). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(15),進行「液晶配向處理劑的噴霧塗佈性之評估」、「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (15), "evaluation of spray coating property of liquid crystal alignment treatment agent", "production of liquid crystal cell and evaluation of pretilt angle (general cell)", and evaluation of voltage retention rate ( "General unit cell" and "Evaluation of residual charge reduction (general unit cell)".

<實施例16> <Example 16>

於依合成例18之合成手法所得之聚醯亞胺粉末(18)(1.25g)中,加入NMP(8.82g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(2.94g)及PB(7.86g),於40℃下攪拌4小時,製得溶液。 NMP (8.82 g) was added to the polyimine powder (18) (1.25 g) obtained by the synthetic method of Synthesis Example 18, and the mixture was stirred at 70 ° C for 24 hours to dissolve. To this solution, BCS (2.94 g) and PB (7.86 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a solution.

另一方面,於依合成例17之合成手法所得之聚醯亞胺粉末(17)(0.83g)中,加入NMP(5.88g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(1.96g)及PB(5.24g),於40℃下攪拌4小時,製得溶液。 On the other hand, NMP (5.88 g) was added to the polyimine powder (17) (0.83 g) obtained by the synthetic method of Synthesis Example 17, and the mixture was stirred at 70 ° C for 24 hours to be dissolved. To this solution, BCS (1.96 g) and PB (5.24 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a solution.

將上述所得之2個溶液混合,於25℃下攪拌4小時,製得液晶配向處理劑(16)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The two solutions obtained above were mixed and stirred at 25 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (16). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(16),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」、「減緩殘留電荷之評估(一般晶胞)」 及「液晶晶胞之製作及液晶配向性之評估(PSA晶胞)」。 Using the obtained liquid crystal alignment agent (16), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)", "evaluation of residual charge" (general Unit cell) And "Production of Liquid Crystal Cell and Evaluation of Liquid Crystal Alignment (PSA Cell)".

<實施例17> <Example 17>

於依實施例16之製作方法所得之液晶配向處理劑(16)(20.0g)中,加入K1(0.06g),於40℃下攪拌6小時,液晶配向處理劑(17)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 To the liquid crystal alignment treatment agent (16) (20.0 g) obtained by the method of Example 16, K1 (0.06 g) was added, and the mixture was stirred at 40 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (17). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(17),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (17), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例18> <Example 18>

於依合成例19之合成手法所得之聚醯亞胺粉末(19)(0.45g)及合成例6之合成手法所得之聚醯亞胺粉末(6)(1.80g)中,加入NEP(21.2g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(3.53g)及PB(10.6g),於40℃下攪拌4小時,製得液晶配向處理劑(18)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 In the polyimine powder (19) (0.45 g) obtained by the synthetic method of Synthesis Example 19 and the polyimine powder (6) (1.80 g) obtained by the synthetic method of Synthesis Example 6, NEP (21.2 g) was added. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, BCS (3.53 g) and PB (10.6 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (18). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(18),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (18), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)" and "evaluation of residual charge" (general Unit cell)".

<實施例19> <Example 19>

於依合成例19之合成手法所得之聚醯亞胺粉末(19)(1.63g)及合成例5之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(5)(6.50g)中,加入NEP(19.4g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入BCS(6.47g)及PB(6.47g),於40℃下攪拌4小時,製得液晶配向處理劑(19)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 Polyurethane powder (19) (1.63 g) obtained by the synthetic method of Synthesis Example 19 and a synthetic method of Synthesis Example 5, a solid concentration of a resin having a solid concentration of 25% by mass of a polyaminic acid solution (5) (6.50 g) Among them, NEP (19.4 g) was added, and the mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, BCS (6.47 g) and PB (6.47 g) were added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (19). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(19),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (19), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)" and "evaluation of residual charge" (general Unit cell)".

<比較例1> <Comparative Example 1>

於依合成例20之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(20)(4.95g)及合成例21之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(21)(3.30g)中,加入NMP(18.0g)及BCS(8.08g),於25℃下攪拌6小時,製得液晶配向處理劑(20)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The polyacetamide solution (20) (4.95 g) having a solid concentration of 25% by mass of the resin obtained by the synthetic method of Synthesis Example 20 and the resin having a solid concentration of 25% by mass of the synthetic method of Synthesis Example 21 NMP (18.0 g) and BCS (8.08 g) were added to the acid solution (21) (3.30 g), and the mixture was stirred at 25 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (20). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(20),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之 評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (20), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "voltage retention rate" Evaluation (general unit cell) and "evaluation of residual charge (general unit cell)".

<比較例2> <Comparative Example 2>

於依合成例3之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(3)(4.50g)及合成例24之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(24)(4.50g)中,加入NEP(14.4g)及PB(14.1g),於25℃下攪拌6小時,液晶配向處理劑(21)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The resin having a solid concentration of 25% by mass of the polyaminic acid solution (3) (4.50 g) obtained by the synthetic method of Synthesis Example 3 and the synthetic method of Synthesis Example 24 have a solid concentration of 25% by mass of polyamine. To the acid solution (24) (4.50 g), NEP (14.4 g) and PB (14.1 g) were added, and the mixture was stirred at 25 ° C for 6 hours, and the liquid crystal alignment treatment agent (21). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(21),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (21), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)" and "evaluation of residual charge" (general Unit cell)".

<比較例3> <Comparative Example 3>

於依合成例22之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(22)(4.50g)及合成例5之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(5)(4.50g)中,加入NEP(14.4g)及PB(14.1g),於25℃下攪拌6小時,製得液晶配向處理劑(22)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The polyamic acid solution (22) (4.50 g) of the resin having a solid concentration of 25% by mass in the synthetic method of Synthesis Example 22 and the resin having a solid concentration of 25% by mass of the synthetic method of Synthesis Example 5 NEP (14.4 g) and PB (14.1 g) were added to the acid solution (5) (4.50 g), and the mixture was stirred at 25 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (22). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(22),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之 評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (22), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "voltage retention rate" Evaluation (general unit cell) and "evaluation of residual charge (general unit cell)".

<比較例4> <Comparative Example 4>

於依合成例22之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(22)(4.50g)及合成例24之合成手法所得之樹脂固形分濃度25質量%的聚醯胺酸溶液(24)(4.50g)中,加入NEP(14.4g)及PB(14.1g),於25℃下攪拌6小時,製得液晶配向處理劑(23)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 The resin obtained by the synthetic method of Synthesis Example 22 has a solid concentration of 25% by mass of a polyaminic acid solution (22) (4.50 g) and a synthetic method of Synthesis Example 24, and has a resin solid concentration of 25% by mass of polydecylamine. To the acid solution (24) (4.50 g), NEP (14.4 g) and PB (14.1 g) were added, and the mixture was stirred at 25 ° C for 6 hours to obtain a liquid crystal alignment treatment agent (23). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(23),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (23), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)" and "evaluation of residual charge" (general Unit cell)".

<比較例5> <Comparative Example 5>

於依合成例4之合成手法所得之聚醯亞胺粉末(4)(1.10g)及合成例25之合成手法所得之聚醯亞胺粉末(25)(1.10g)中,加入NEP(20.7g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(13.8g),於40℃下攪拌4小時,製得液晶配向處理劑(24)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NEP (20.7 g) was added to the polyimine powder (25) (1.10 g) obtained by the synthetic method of Synthesis Example 4, and the polyimine powder (25) (1.10 g) obtained by the synthetic method of Synthesis Example 25. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, PB (13.8 g) was added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (24). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(24),進行「液晶晶 胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (24), "liquid crystal crystal" Evaluation of cell fabrication and pretilt angle (general cell), "evaluation of voltage retention (general cell)" and "evaluation of residual charge (general cell)".

<比較例6> <Comparative Example 6>

於依合成例23之合成手法所得之聚醯亞胺粉末(23)(1.10g)及合成例6之合成手法所得之聚醯亞胺粉末(6)(1.10g)中,加入NEP(20.7g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(13.8g),於40℃下攪拌4小時,製得液晶配向處理劑(25)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 In the polyimine powder (6) (1.10 g) obtained by the synthetic method of Synthesis Example 23 and the polyimine powder (6) (1.10 g) obtained by the synthetic method of Synthesis Example 6, NEP (20.7 g) was added. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, PB (13.8 g) was added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (25). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(25),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (25), "production of liquid crystal cell and evaluation of pretilt angle (general cell)", "evaluation of voltage holding ratio (general cell)" and "evaluation of residual charge" (general Unit cell)".

<比較例7> <Comparative Example 7>

於依合成例23之合成手法所得之聚醯亞胺粉末(23)(1.10g)及合成例25之合成手法所得之聚醯亞胺粉末(25)(1.10g)中,加入NEP(20.7g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(13.8g),於40℃下攪拌4小時,製得液晶配向處理劑(26)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NEP (20.7 g) was added to the polyimine powder (25) (1.10 g) obtained by the synthetic method of Synthesis Example 23, and the polyimine powder (25) (1.10 g) obtained by the synthetic method of Synthesis Example 25. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, PB (13.8 g) was added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (26). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(26),進行「液晶晶 胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (26), "liquid crystal crystal" Evaluation of cell fabrication and pretilt angle (general cell), "evaluation of voltage retention (general cell)" and "evaluation of residual charge (general cell)".

<比較例8> <Comparative Example 8>

於依合成例26之合成手法所得之聚醯亞胺粉末(26)(1.10g)及合成例27之合成手法所得之聚醯亞胺粉末(27)(1.10g)中,加入NEP(20.7g),於70℃下攪拌24小時,使其溶解。於此溶液中,加入PB(13.8g),於40℃下攪拌4小時,製得液晶配向處理劑(27)。此液晶配向處理劑中,未發現混濁或析出等異常現象,而確認為均勻之溶液。 NEP (20.7 g) was added to the polyimine powder (27) (1.10 g) obtained by the synthetic method of Synthetic Example 26, and the polyimine powder (27) (1.10 g) obtained by the synthetic method of Synthesis Example 27. The mixture was stirred at 70 ° C for 24 hours to dissolve. To the solution, PB (13.8 g) was added, and the mixture was stirred at 40 ° C for 4 hours to obtain a liquid crystal alignment treatment agent (27). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or precipitation was observed, and it was confirmed to be a homogeneous solution.

使用所得液晶配向處理劑(27),進行「液晶晶胞之製作及預傾角之評估(一般晶胞)」、「電壓保持率之評估(一般晶胞)」及「減緩殘留電荷之評估(一般晶胞)」。 Using the obtained liquid crystal alignment treatment agent (27), "production of liquid crystal cell and evaluation of pretilt angle (general unit cell)", "evaluation of voltage holding ratio (general unit cell)" and "evaluation of residual charge" (general use) Unit cell)".

由上述之結果得知,本發明之實施例的液晶配向處理劑,與比較例的液晶配向處理劑比較結果得知, 液晶晶胞中,即使進行高溫處理及紫外線照射,亦顯示出安定的預傾角。此外,即使進行紫外線照射時,仍可抑制電壓保持率之降低,且可快速減緩因直流電壓所蓄積之殘留電荷的效果。即,本發明之液晶配向處理劑,可形成一種即使長時間暴露於高溫及光照射之後,仍可產生安定的預傾角之液晶配向膜,此外,亦為一種即使長時間暴露於光線照射之後,可抑制電壓保持率之降低,且可快速減緩因直流電壓所蓄積之殘留電荷液晶配向膜。 From the above results, it is understood that the liquid crystal alignment treatment agent of the embodiment of the present invention is compared with the liquid crystal alignment treatment agent of the comparative example, In the liquid crystal cell, even if high temperature treatment and ultraviolet irradiation are performed, a stable pretilt angle is exhibited. Further, even when ultraviolet irradiation is performed, the decrease in the voltage holding ratio can be suppressed, and the effect of the residual charge accumulated by the DC voltage can be quickly alleviated. That is, the liquid crystal alignment treatment agent of the present invention can form a liquid crystal alignment film which can produce a stable pretilt angle even after prolonged exposure to high temperature and light irradiation, and is also a kind of liquid crystal alignment film which is exposed to light even after prolonged exposure. The voltage holding ratio can be suppressed from being lowered, and the residual charge liquid crystal alignment film accumulated by the DC voltage can be quickly alleviated.

具體而言,使用本發明之特定聚合物(A)與特定聚合物(B)之液晶配向處理劑的實施例,與未使用其中任一者所得之液晶配向處理劑的實施例之比較,即,實施例2與比較例2或比較例3之比較,及實施例3與比較例5或比較例6之比較。與僅使用該些特定聚合物(A)的比較例或僅使用特定聚合物(B)的比較例,由其對應之實施例相比較時,得知對於紫外線照射而言,其電壓保持率大幅降低,且殘留電荷之數值亦為更大。 Specifically, the embodiment using the liquid crystal alignment treatment agent of the specific polymer (A) of the present invention and the specific polymer (B) is compared with the embodiment of the liquid crystal alignment treatment agent obtained without using any of them, that is, Comparison of Example 2 with Comparative Example 2 or Comparative Example 3, and Example 3 with Comparative Example 5 or Comparative Example 6. Comparing with the comparative examples using only the specific polymers (A) or the comparative examples using only the specific polymer (B), when compared with the corresponding examples, it was found that the voltage holding ratio was large for ultraviolet irradiation. Lower, and the value of residual charge is also larger.

又,使用本發明之特定聚合物(A)與特定聚合物(B)之液晶配向處理劑的實施例,與不具有本發明之三級含氮原子的結構的聚合物與使用不具有特定結構(2)之聚合物的液晶配向處理劑之比較例,即,實施例1與比較例1之比較、實施例2與比較例4之比較,及實施例3與比較例7之比較。該些比較例與對應之實施例相比較時,得知對於紫外線照射,其電壓保持率大幅降低,此外,殘留電荷之數值亦為更大。 Further, the embodiment using the liquid crystal alignment treatment agent of the specific polymer (A) of the present invention and the specific polymer (B), and the polymer having no structure of the tertiary nitrogen atom of the present invention have no specific structure. A comparative example of the liquid crystal alignment treatment agent of the polymer (2), that is, a comparison between Example 1 and Comparative Example 1, a comparison between Example 2 and Comparative Example 4, and a comparison between Example 3 and Comparative Example 7. When these comparative examples were compared with the corresponding examples, it was found that the voltage holding ratio was largely lowered for ultraviolet irradiation, and the value of the residual electric charge was also larger.

此外,使用本發明之特定聚合物(A)與特定聚合物(B)之液晶配向處理劑的實施例,與以往型之使用具有側鏈結構的聚合物的液晶配向處理劑之比較例的比較,即,實施例3與比較例8之比較。此比較例,與對應之實施例相比較時,得知於進行高溫處理及紫外線照射後的預傾角之變化幅度更大,且,對於紫外線照射而言,其電壓保持率大幅降低,此外,殘留電荷之數值亦為更大。其中,特別是電壓保持率之降低為更大。 Further, a comparison of an example of a liquid crystal alignment treatment agent using a specific polymer (A) of the present invention and a specific polymer (B), and a comparative example of a liquid crystal alignment treatment agent using a polymer having a side chain structure of a conventional type That is, the comparison between Example 3 and Comparative Example 8. In this comparative example, when compared with the corresponding examples, it was found that the change in the pretilt angle after the high-temperature treatment and the ultraviolet irradiation was larger, and the voltage holding ratio was largely lowered for the ultraviolet irradiation, and further, the residual The value of the charge is also larger. Among them, in particular, the reduction in voltage holding ratio is larger.

[產業上之利用性] [Industrial use]

本發明之液晶配向處理劑,可提供一種即使長時間暴露於高溫及光照射之後,也可產生安定的預傾角之液晶配向膜。此外,亦提供一種即使長時間暴露於光線照射之後,可抑制電壓保持率之降低,且可快速減緩因直流電壓所蓄積之殘留電荷液晶配向膜。此外,也可提供一種具有上述液晶配向膜之液晶顯示元件、可提供上述液晶配向膜之液晶配向處理劑等。 The liquid crystal alignment treatment agent of the present invention can provide a liquid crystal alignment film which can produce a stable pretilt angle even after prolonged exposure to high temperature and light irradiation. In addition, it is also possible to suppress a decrease in the voltage holding ratio even after long-time exposure to light irradiation, and to quickly alleviate the residual charge liquid crystal alignment film accumulated by the DC voltage. Further, a liquid crystal display element having the above liquid crystal alignment film, a liquid crystal alignment treatment agent which can provide the above liquid crystal alignment film, and the like can be provided.

因此,具有由本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件,為具有優良信賴性者,且極適合使用於大畫面且具有高精密度的液晶電視等,對於TN元件、STN元件、TFT液晶元件,特別是垂直配向型之液晶顯示元件為有用者。 Therefore, the liquid crystal display element having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is excellent in reliability, and is highly suitable for a large-screen and high-precision liquid crystal television, etc., for TN elements and STN elements. A TFT liquid crystal element, in particular, a vertical alignment type liquid crystal display element is useful.

此外,由本發明之液晶配向處理劑所得之液晶配向膜,於製作液晶顯示元件之際,對於必須照射紫外 線的液晶顯示元件而言,為有用者。即,其對於經於具備有電極之一對的基板之間具有液晶層,前述一對的基板之間,配置含有至少經由活性能量線及熱中至少一者而聚合之聚合性化合物的液晶組成物,該液晶組成物係經由於前述電極間持續施加電壓,而使前述聚合性化合物聚合之步驟所製造的液晶顯示元件,與於具備有電極之一對的基板之間具有液晶層,前述一對的基板之間,配置有經由活性能量線及熱之至少一者而可聚合之含有聚合性基的液晶配向膜,該液晶配向膜係經由於前述電極間持續施加電壓,而使前述聚合性基聚合之步驟所製得之液晶顯示元件亦為有用者。 Further, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention is required to be irradiated with ultraviolet rays when the liquid crystal display element is produced. The liquid crystal display element of the line is useful. In other words, a liquid crystal layer is provided between the substrates including the pair of electrodes, and a liquid crystal composition containing at least one polymerizable compound polymerized by at least one of an active energy ray and heat is disposed between the pair of substrates. The liquid crystal composition has a liquid crystal layer between the liquid crystal display element produced by the step of polymerizing the polymerizable compound and a substrate having one pair of electrodes, and the pair of the liquid crystal layer is continuously applied with a voltage between the electrodes. A liquid crystal alignment film containing a polymerizable group polymerizable via at least one of an active energy ray and heat is disposed between the substrates, and the liquid crystal alignment film is continuously applied with a voltage between the electrodes to form the polymerizable group. Liquid crystal display elements produced by the polymerization step are also useful.

Claims (25)

一種含有下述(A)成份及(B)成份之液晶配向處理劑,(A)成份:含有由具有具氮原子的結構之聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物,(B)成份:含有由具有下述式〔2〕所示之結構的聚醯亞胺前驅體及聚醯亞胺所選出之至少任一種的聚合物,又,(A)成份及(B)成份之聚合物中之至少任一者,為含有下述式〔3〕所示之結構, (式〔2〕中,Y1及Y7各自獨立表示單鍵、碳數1~10之伸烷基、-O-、-N(R1)-(R1表示氫原子或碳數1~3之伸烷基)、-CON(R2)-(R2表示氫原子或碳數1~3之伸烷基)、-N(R3)CO-(R3表示氫原子或碳數1~3之伸烷基)、-CH2O-、-COO-及-OCO-所選出之至少1種的有機基,Y2及Y6各自獨立表示碳數1~10之伸烷基,Y3及Y5各自獨立表示氫原子或碳數1~10之伸烷基,Y4表示氧原子或硫原子) (式〔3〕中,B1表示單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-,B2表示單鍵或-(CH2)b-(b為1~15之整數),B3表示單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-,B4表示由苯環、環己烷環或雜環所選出的2價之環狀基,或具有膽固醇骨架之碳數17~51的2價之有機基,前述環狀基上的任意之氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,B5表示由苯環、環己烷環或雜環所選出的2價之環狀基,該些環狀基上的任意之氫原子,可被碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代,n表示0~4之整數,B6表示碳數1~18之烷基、碳數1~18之含氟烷基、碳數1~18之烷氧基或碳數1~18之含氟烷氧基)。 A liquid crystal alignment treatment agent containing the following (A) component and (B) component, (A) component: at least one selected from the group consisting of a polyimide precursor having a structure having a nitrogen atom and a polyimine. Polymer (B): a polymer containing at least one selected from the group consisting of a polyimine precursor having a structure represented by the following formula [2] and a polyimine, and (A) component And at least any one of the polymers of the component (B) is a structure represented by the following formula [3]. (In the formula [2], Y 1 and Y 7 each independently represent a single bond, an alkylene group having 1 to 10 carbon atoms, -O-, -N(R 1 )- (R 1 represents a hydrogen atom or a carbon number of 1~). 3 alkylene), -CON(R 2 )- (R 2 represents a hydrogen atom or an alkylene group having 1 to 3 carbon atoms), -N(R 3 )CO- (R 3 represents a hydrogen atom or a carbon number of 1) At least one organic group selected from ~3 alkylene), -CH 2 O-, -COO-, and -OCO-, and Y 2 and Y 6 each independently represent an alkylene group having 1 to 10 carbon atoms, Y 3 and Y 5 each independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms, and Y 4 represents an oxygen atom or a sulfur atom) (In the formula [3], B 1 represents a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-, B 2 Represents a single bond or -(CH 2 ) b - (b is an integer from 1 to 15), B 3 represents a single bond, -(CH 2 ) c - (c is an integer from 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-, B 4 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, or a divalent group having a carbon number of 17 to 51 having a cholesterol skeleton The organic group, any hydrogen atom on the above cyclic group, may be an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, and a carbon number of 1 to 3; 3 is substituted by a fluorine-containing alkoxy group or a fluorine atom, and B 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a hetero ring, and any hydrogen atom on the ring group may be It is substituted by an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom, and n is represented by n. An integer of 0 to 4, and B 6 represents an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms. ). 如請求項1之液晶配向處理劑,其中,前述(A)成份中之具有氮原子的結構,為由下述式〔1a〕~式〔1c〕所示之結構所選出之至少1種的結構, (式〔1a〕中,X1表示苯環或含氮芳香族雜環,X2表 示被氫原子或碳數1~12的脂肪族基所取代之二取代胺基,式〔1b〕中,X3及X7各自獨立表示具有6~15個碳原子,且具有1~2個苯環之芳香族基,X4及X6各自獨立表示氫原子或碳數1~5之伸烷基,X5表示碳數2~5之伸烷基或聯苯基,m表示0或1之整數,式〔1c〕中,X8及X10各自獨立表示由下述式〔1c-a〕及式〔1c-b〕所示之結構所選出之至少1種的結構,X9表示碳數1~5之伸烷基或苯環) The liquid crystal alignment agent of claim 1, wherein the structure having a nitrogen atom in the component (A) is at least one selected from the structures represented by the following formulas [1a] to [1c]. , (In the formula [1a], X 1 represents a benzene ring or a nitrogen-containing aromatic hetero ring, and X 2 represents a disubstituted amino group substituted with a hydrogen atom or an aliphatic group having 1 to 12 carbon atoms, in the formula [1b], X 3 and X 7 each independently represent an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings, and X 4 and X 6 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms. X 5 represents an alkylene group or a biphenyl group having 2 to 5 carbon atoms, and m represents an integer of 0 or 1. In the formula [1c], X 8 and X 10 each independently represent a formula [1c-a] and a formula At least one structure selected from the structures shown in [1c-b], X 9 represents an alkylene group or a benzene ring having a carbon number of 1 to 5) 如請求項1之液晶配向處理劑,其中,前述(A)成份之聚合物為,使用下述式〔1-1〕所示二胺化合物作為原料的一部份而製得之聚合物, (式〔1-1〕中,XA表示具有由前述式〔1a〕~式〔1c〕所示之結構所選出之至少1種的結構之有機基,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基)。 The liquid crystal alignment treatment agent according to claim 1, wherein the polymer of the component (A) is a polymer obtained by using a diamine compound represented by the following formula [1-1] as a part of a raw material, (In the formula [1-1], X A represents an organic group having a structure selected from at least one of the structures represented by the above formulas [1a] to [1c], and A 1 and A 2 each independently represent a hydrogen atom. Or an alkyl group having a carbon number of 1 to 5). 如請求項3之液晶配向處理劑,其中,前述二胺化合物,為使用下述式〔1a-1〕~式〔1c-1〕所示二胺化合物作為原料的一部份而製得之聚合物, (式〔1a-1〕中,X1表示苯環或含氮芳香族雜環,X2表示被氫原子或碳數1~12的脂肪族基所取代之二取代胺基,式〔1b-1〕中,X3及X7各自獨立表示具有6~15個碳原子,且具有1~2個苯環之芳香族基,X4及X6各自獨立表示氫原子或碳數1~5之伸烷基,X5表示碳數2~5之伸烷基或聯苯基,m表示0或1之整數,式〔1c-1〕中,X8及X10各自獨立表示由前述式〔1c-a〕及式〔1c-b〕所示之結構所選出之至少1種的結構,X9表示碳數1~5之伸烷基或苯環,式〔1a-1〕~式〔1c-1〕中,A1~A6各自獨立表示氫原子或碳數1~5之伸烷基)。 The liquid crystal alignment treatment agent according to claim 3, wherein the diamine compound is obtained by using a diamine compound represented by the following formula [1a-1] to formula [1c-1] as a raw material. Object, (In the formula [1a-1], X 1 represents a benzene ring or a nitrogen-containing aromatic hetero ring, and X 2 represents a disubstituted amino group substituted by a hydrogen atom or an aliphatic group having 1 to 12 carbon atoms, and the formula [1b- In 1], X 3 and X 7 each independently represent an aromatic group having 6 to 15 carbon atoms and having 1 to 2 benzene rings, and X 4 and X 6 each independently represent a hydrogen atom or a carbon number of 1 to 5. An alkyl group, X 5 represents an alkylene group or a biphenyl group having a carbon number of 2 to 5, and m represents an integer of 0 or 1. In the formula [1c-1], X 8 and X 10 each independently represent the formula [1c] -a) and at least one structure selected from the structures represented by the formula [1c-b], and X 9 represents an alkylene group or a benzene ring having a carbon number of 1 to 5, and a formula [1a-1] to a formula [1c- In 1], A 1 to A 6 each independently represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. 如請求項4之液晶配向處理劑,其中,前述二胺化合物為由下述式〔1-1a〕~式〔1-4a〕所示二胺化合物所選出之至少1種的二胺化合物, (式〔1-3a〕中,R1表示氫原子或碳數1~5之伸烷基,式〔1-4a〕中,n表示1~10之整數,式〔1-1a〕~式〔1-4a〕中,A1~A8各自獨立表示氫原子或碳數1~5之伸烷基)。 The liquid crystal alignment treatment agent according to claim 4, wherein the diamine compound is at least one diamine compound selected from the diamine compounds represented by the following formula [1-1a] to formula [1-4a]. (In the formula [1-3a], R 1 represents a hydrogen atom or an alkylene group having 1 to 5 carbon atoms; in the formula [1-4a], n represents an integer of 1 to 10, and the formula [1-1a] to the formula [ In 1-4a], A 1 to A 8 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms. 如請求項1之液晶配向處理劑,其中,前述(B)成份之聚合物為使用下述式〔2-1〕所示二胺化合物作為原料的一部份而製得之聚合物, (式〔2-1〕中,YA表示具有前述式〔2〕所示之結構的有機基,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基)。 The liquid crystal alignment treatment agent according to claim 1, wherein the polymer of the component (B) is a polymer obtained by using a diamine compound represented by the following formula [2-1] as a raw material. (In the formula [2-1], Y A represents an organic group having a structure represented by the above formula [2], and each of A 1 and A 2 independently represents a hydrogen atom or an alkylene group having 1 to 5 carbon atoms). 如請求項6之液晶配向處理劑,其中,前述二胺化合物為使用下述式〔2a〕所示二胺化合物作為原料的一部份而製得之聚合物, (式〔2a〕中,Y1及Y7各自獨立表示單鍵、碳數1~10之伸烷基、-O-、-N(R1)-(R1表示氫原子或碳數1~3之伸烷基)、-CON(R2)-(R2表示氫原子或碳數1~3之伸烷基)、-N(R3)CO-(R3表示氫原子或碳數1~3之伸烷基)、 -CH2O-、-COO-及-OCO-所選出之至少1種的有機基,Y2及Y6各自獨立表示碳數1~10之伸烷基,Y3及Y5各自獨立表示氫原子或碳數1~10之伸烷基,Y4表示氧原子或硫原子,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基)。 The liquid crystal alignment treatment agent according to claim 6, wherein the diamine compound is a polymer obtained by using a diamine compound represented by the following formula [2a] as a raw material. (In the formula [2a], Y 1 and Y 7 each independently represent a single bond, an alkylene group having 1 to 10 carbon atoms, -O-, -N(R 1 )- (R 1 represents a hydrogen atom or a carbon number of 1~). 3 alkylene), -CON(R 2 )- (R 2 represents a hydrogen atom or an alkylene group having 1 to 3 carbon atoms), -N(R 3 )CO- (R 3 represents a hydrogen atom or a carbon number of 1) At least one organic group selected from ~3 alkylene), -CH 2 O-, -COO-, and -OCO-, and Y 2 and Y 6 each independently represent an alkylene group having 1 to 10 carbon atoms, Y 3 and Y 5 each independently represent a hydrogen atom or an alkylene group having 1 to 10 carbon atoms, Y 4 represents an oxygen atom or a sulfur atom, and A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms) . 如請求項7之液晶配向處理劑,其中,前述二胺化合物為由下述式〔2-1a〕~式〔2-3a〕所示二胺化合物所選出之至少1種的二胺化合物, (式〔2-1a〕~式〔2-3a〕中,A1~A6各自獨立表示氫原子或碳數1~5之伸烷基)。 The liquid crystal alignment treatment agent according to claim 7, wherein the diamine compound is at least one diamine compound selected from the diamine compounds represented by the following formula [2-1a] to formula [2-3a]. (In the formula [2-1a] to the formula [2-3a], A 1 to A 6 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms). 如請求項1之液晶配向處理劑,其中,前述(A)成份及(B)成份中之至少任一者的聚合物為以下述式〔3a〕所示二胺化合物作為原料的一部份使用所得者, (式〔3a〕中,B表示前述式〔3〕,A1及A2各自獨立表示氫原子或碳數1~5之伸烷基,m表示1~4之整數)。 The liquid crystal alignment agent of claim 1, wherein the polymer of at least one of the components (A) and (B) is a part of a diamine compound represented by the following formula [3a]. The recipient, (In the formula [3a], B represents the above formula [3], and A 1 and A 2 each independently represent a hydrogen atom or an alkylene group having 1 to 5 carbon atoms, and m represents an integer of 1 to 4). 如請求項1之液晶配向處理劑,其中,前述(A)成份之聚合物及(B)成份之聚合物為,由使用下述式〔4〕所示四羧酸成份所得之聚醯亞胺前驅體及聚醯亞胺所選出之至少1種的聚合物, (式〔4〕中,Z表示由下述式〔4a〕~式〔4k〕所示之結構所選出之至少1種的結構) (式〔4a〕中,Z1~Z4表示氫原子、甲基、乙基、丙 基、氯原子或苯環,其可分別為相同亦可、相異亦可,式〔4g〕中,Z5及Z6表示氫原子或甲基,其可分別為相同亦可、相異亦可)。 The liquid crystal alignment agent of claim 1, wherein the polymer of the component (A) and the polymer of the component (B) are polyfluorene obtained by using a tetracarboxylic acid component represented by the following formula [4]. a precursor and at least one polymer selected from the group consisting of polyimine, (In the formula [4], Z represents at least one structure selected from the structures represented by the following formulas [4a] to [4k]) (In the formula [4a], Z 1 to Z 4 represent a hydrogen atom, a methyl group, an ethyl group, a propyl group, a chlorine atom or a benzene ring, which may be the same or different, respectively, in the formula [4g], Z 5 and Z 6 represent a hydrogen atom or a methyl group, which may be the same or different, respectively. 如請求項10之液晶配向處理劑,其中,前述四羧酸成份為,前述式〔4〕中之Z為由前述式〔4a〕及式〔4e〕~式〔4g〕所示之結構所選出之至少1種的結構的四羧酸成份。 The liquid crystal alignment treatment agent according to claim 10, wherein the tetracarboxylic acid component is selected from the structure represented by the above formula [4a] and the formula [4e] to the formula [4g]. A tetracarboxylic acid component having at least one structure. 如請求項4之液晶配向處理劑,其中,前述(A)成份之聚合物中,前述式〔1a-1〕~式〔1c-1〕所示二胺化合物,於全部的二胺成份100莫耳%中,為5莫耳%~95莫耳%。 The liquid crystal alignment treatment agent according to claim 4, wherein the polymer of the component (A), the diamine compound represented by the above formula [1a-1] to the formula [1c-1], is contained in all the diamine components. In the ear %, it is 5 mol% to 95 mol%. 如請求項7之液晶配向處理劑,其中,前述(B)成份之聚合物中,前述式〔2a〕所示二胺化合物,於全部的二胺成份100莫耳%中,為5莫耳%~95莫耳%。 The liquid crystal alignment agent of claim 7, wherein the diamine compound represented by the above formula [2a] in the polymer of the component (B) is 5 mol% based on 100 mol% of the total diamine component. ~95 moles %. 如請求項1之液晶配向處理劑,其中,前述(B)成份之聚合物,相對於前述(A)成份之聚合物100質量份,為0.5質量份~950質量份。 The liquid crystal alignment agent of claim 1, wherein the polymer of the component (B) is 0.5 parts by mass to 950 parts by mass based on 100 parts by mass of the polymer of the component (A). 如請求項1之液晶配向處理劑,其中,液晶配向處理劑的溶劑為,含有由N-甲基-2-吡咯啶酮、N-乙基-2-吡咯啶酮及γ-丁內酯所選出之至少1種的溶劑。 The liquid crystal alignment treatment agent according to claim 1, wherein the solvent of the liquid crystal alignment treatment agent comprises N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone and γ-butyrolactone. Select at least one solvent. 如請求項1之液晶配向處理劑,其中,液晶配向處理劑的溶劑為,含有由1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁醚、乙二醇單丁醚及二丙二醇二甲醚所選出之至少1種的溶劑。 The liquid crystal alignment treatment agent of claim 1, wherein the solvent of the liquid crystal alignment treatment agent comprises 1-hexanol, cyclohexanol, 1,2-ethanediol, 1,2-propanediol, propylene glycol monobutyl ether, At least one solvent selected from ethylene glycol monobutyl ether and dipropylene glycol dimethyl ether. 如請求項1之液晶配向處理劑,其中,液晶配向處理劑中,含有由具有環氧基、異氰酸酯基、環氧丙烷基或環碳酸酯基的交聯性化合物、具有由羥基、羥烷基或低級烷氧基烷基所成群所選出之至少1種的取代基的交聯性化合物,及由具有聚合性不飽和鍵結的交聯性化合物所選出之至少1種的交聯性化合物。 The liquid crystal alignment treatment agent of claim 1, wherein the liquid crystal alignment treatment agent contains a crosslinkable compound having an epoxy group, an isocyanate group, an oxypropylene group or a cyclic carbonate group, and has a hydroxyl group or a hydroxyalkyl group. a crosslinkable compound of at least one substituent selected from the group consisting of lower alkoxyalkyl groups, and at least one crosslinkable compound selected from a crosslinkable compound having a polymerizable unsaturated bond . 一種液晶配向膜,其特徵為,由請求項1~請求項17之任一項之液晶配向處理劑所製得。 A liquid crystal alignment film obtained by the liquid crystal alignment treatment agent according to any one of claims 1 to 17. 一種液晶配向膜,其特徵為,使用請求項1~請求項17之任一項之液晶配向處理劑,經噴墨法所製得。 A liquid crystal alignment film obtained by an inkjet method using a liquid crystal alignment treatment agent according to any one of claims 1 to 17. 一種液晶顯示元件,其特徵為,具有請求項18之液晶配向膜。 A liquid crystal display element characterized by having the liquid crystal alignment film of claim 18. 一種液晶顯示元件,其特徵為,具有請求項19之液晶配向膜。 A liquid crystal display element comprising the liquid crystal alignment film of claim 19. 如請求項18之液晶配向膜,其係使用於一種具備有電極之一對的基板之間具有液晶層,前述一對的基板之間,配置含有經由活性能量線及熱中至少一者而聚合之聚合性化合物的液晶組成物,該液晶組成物係經由於前述電極間持續施加電壓,而使前述聚合性化合物聚合之步驟所製得之液晶顯示元件。 The liquid crystal alignment film according to claim 18, wherein the liquid crystal layer is provided between the substrates having one pair of electrodes, and the substrate between the pair of substrates is disposed to be polymerized via at least one of an active energy ray and heat. A liquid crystal composition of a polymerizable compound which is obtained by a step of polymerizing the polymerizable compound by continuously applying a voltage between the electrodes. 一種液晶顯示元件,其特徵為,具有請求項22之液晶配向膜。 A liquid crystal display element characterized by having the liquid crystal alignment film of claim 22. 如請求項18之液晶配向膜,其係使用於一種具備有電極之一對的基板之間具有液晶層,前述一對的基板 之間,配置有含有經由活性能量線及熱中至少一者而聚合的聚合性基之液晶配向膜,該液晶配向膜係經由於前述電極間持續施加電壓,而使前述聚合性基聚合之步驟所製得之液晶顯示元件。 The liquid crystal alignment film of claim 18, which is used for a liquid crystal layer between a substrate having one pair of electrodes, the pair of substrates A liquid crystal alignment film containing a polymerizable group polymerized by at least one of an active energy ray and a heat, wherein the step of polymerizing the polymerizable group is continued by applying a voltage between the electrodes A liquid crystal display element produced. 一種液晶顯示元件,其特徵為,具有請求項24之液晶配向膜。 A liquid crystal display element characterized by having the liquid crystal alignment film of claim 24.
TW103133595A 2013-09-26 2014-09-26 Liquid crystal alignment treatment agent and liquid crystal display element using same TWI673548B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013200045 2013-09-26
JP2013-200045 2013-09-26

Publications (2)

Publication Number Publication Date
TW201527846A true TW201527846A (en) 2015-07-16
TWI673548B TWI673548B (en) 2019-10-01

Family

ID=52743501

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103133595A TWI673548B (en) 2013-09-26 2014-09-26 Liquid crystal alignment treatment agent and liquid crystal display element using same

Country Status (5)

Country Link
JP (1) JP6501073B2 (en)
KR (1) KR102255769B1 (en)
CN (1) CN105765453B (en)
TW (1) TWI673548B (en)
WO (1) WO2015046374A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI729013B (en) * 2015-10-14 2021-06-01 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI776974B (en) * 2017-11-20 2022-09-11 日商Jsr股份有限公司 Manufacturing method of liquid crystal element

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6620428B2 (en) * 2015-05-29 2019-12-18 三菱瓦斯化学株式会社 Polyimide resin
JP6547565B2 (en) * 2015-10-02 2019-07-24 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal element
WO2017170943A1 (en) * 2016-03-31 2017-10-05 日産化学工業株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP7089231B2 (en) * 2016-09-29 2022-06-22 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR102482055B1 (en) * 2016-11-15 2022-12-27 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element
CN111032828A (en) * 2017-08-22 2020-04-17 捷恩智株式会社 Liquid crystal composition, liquid crystal display element and application of liquid crystal composition in liquid crystal display element
CN111263913B (en) * 2017-10-25 2023-03-28 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
CN111868620B (en) * 2018-03-19 2023-11-03 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JP7322694B2 (en) * 2019-12-24 2023-08-08 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal element
JPWO2022176713A1 (en) * 2021-02-16 2022-08-25

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202987A (en) * 1977-12-09 1980-05-13 Ciba-Geigy Corporation Bis-anthranilates
JP2762551B2 (en) 1989-04-25 1998-06-04 東レ株式会社 Liquid crystal alignment film and liquid crystal display device
JP3201172B2 (en) 1994-09-08 2001-08-20 ジェイエスアール株式会社 Liquid crystal alignment agent
JP4085206B2 (en) 1996-02-15 2008-05-14 日産化学工業株式会社 Diaminobenzene derivative, polyimide and liquid crystal alignment film using the same
JP3613421B2 (en) 1996-05-31 2005-01-26 Jsr株式会社 Liquid crystal alignment agent
JP3650982B2 (en) 1996-10-02 2005-05-25 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
WO2011115077A1 (en) * 2010-03-15 2011-09-22 日産化学工業株式会社 Liquid crystal alignment agent containing end-modified polyamic acid ester, and liquid crystal alignment film
CN102947755B (en) * 2010-04-30 2015-08-26 日产化学工业株式会社 Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells
JP5771948B2 (en) * 2010-10-28 2015-09-02 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element
TWI518116B (en) * 2010-10-28 2016-01-21 Nissan Chemical Ind Ltd Liquid crystal aligning agent, and liquid crystal alignment film
CN103959151B (en) * 2011-09-30 2016-08-31 日产化学工业株式会社 Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells
KR102044049B1 (en) * 2011-11-29 2019-11-12 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI729013B (en) * 2015-10-14 2021-06-01 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI776974B (en) * 2017-11-20 2022-09-11 日商Jsr股份有限公司 Manufacturing method of liquid crystal element

Also Published As

Publication number Publication date
KR20160060733A (en) 2016-05-30
JPWO2015046374A1 (en) 2017-03-09
KR102255769B1 (en) 2021-05-27
CN105765453A (en) 2016-07-13
JP6501073B2 (en) 2019-04-17
TWI673548B (en) 2019-10-01
WO2015046374A1 (en) 2015-04-02
CN105765453B (en) 2019-04-12

Similar Documents

Publication Publication Date Title
TWI673548B (en) Liquid crystal alignment treatment agent and liquid crystal display element using same
TWI586757B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TWI568796B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI628232B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TWI650345B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI669344B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI547743B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element
TW201141912A (en) Liquid crystal display element and liquid crystal aligning agent
TWI564283B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI638008B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI635135B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
JP6668754B2 (en) Composition, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
TWI520984B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
TWI623518B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI654222B (en) Liquid crystal alignment treatment agent and liquid crystal display element using the same
TWI649411B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI627202B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI499588B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
TWI575022B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW201609968A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
WO2016076412A1 (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element